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Abstract  
Mesoporous silica nanoparticles (MSNs) feature several advantageous properties that render 
them promising nanoagents for applications in nanomedicine. Specifically, MSNs contain 
high surface area and large pore volume for high drug loading capacity, tunable pore size and 
internal surface chemistry for accommodation of a variety of guest molecules, stable 
frameworks for the protection of cargos from premature degradation, and versatile 
functionalization on the external surface for a broad spectrum of applications (e.g., controlled 
release or targeted delivery). Although the debut of MSNs in intracellular drug delivery was 
later than for the other advanced nanocarriers, such as liposomes and polyplexes, the 
significant recent progress of MSNs in biomedical research makes them one of the major 
family of nanomaterials for drug delivery systems. Moreover, since the recent development 
of siRNA and protein therapies have progressed rapidly, the synthesis of large-pore MSNs for 
encapsulating such sizable biomolecules becomes highly desirable. 
The present work focuses on synthesizing and tailoring the surface properties of large-pore 
MSNs to create robust and multifunctional nanovehicles for protein delivery. Two types of 
large-pore MSNs with distinct mesostructures were synthesized: the SBA-15 MSNs and the 
stellate MSNs. The SBA-15 MSNs feature ordered hexagonal mesostructure with narrow 
pore size distribution of 7 nm. The synthesis was achieved by employing dual surfactants, 
FC-4 and Pluornic P123, in mildly acidic conditions for silica condensation followed by a 
hydrothermal treatment for ordered mesostructure formation. However, the as-synthesized 
silica particles exhibit a broad size distribution. After size separation by filtration, the 
resulting particles in suspension are in the size range of 100 – 200 nm. On the contrary, the 
stellate MSNs display homogeneous particle morphology and narrow particle size 
distribution (around 100 nm) upon completion of the silica condensation. The particles 
contain ultra-large pores (10 – 30 nm) with a conical shape that allows for efficient diffusion 
and accommodation of macromolecules. The synthesis of stellate MSNs was conducted via a 
facile route where tetraethoxysilane (TEOS, silica precursor) condenses around surfactant 
micelles formed by cetyltrimethylammonium p-toluene sulfonate (CTATos) in a near neutral 
precursor solution. This synthesis method appears to be amenable for upscaling. A delayed 
co-condensation approach was applied for both the synthesis of SBA-15 MSNs and stellate 
MSNs, yielding core-shell bifunctionalized SBA-15 MSNs and stellate MSNs, respectively. 
Cellular studies demonstrated good cellular uptake efficiencies and good biocompatibilities 
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for both the SBA-15 MSNs and stellate MSNs, respectively. Due to the favorable particle 
morphology and the facile synthesis approach, stellate MSNs were used in the following 
applications.  
Core-shell stellate MSNs were modified with a aza-dibenzocyclooctyne (DBCO)-derivative 
on their inner surface to enable copper-free click chemistry reactions for immobilization of 
azide-terminated cargos. For example, 5-carboxytetramethylrhodamine azide (5-TAMRA 
Azide) dye was used as model cargo for in vitro cargo release tracking. In combination with 
stimuli-responsive linkers, such as redox-sensitive disulfide bridged or pH-sensitive acetal 
linkers between DBCO moieties and the surface of MSNs, we were able to control the cargo 
uptake and trigger the cargo release in buffers under specific conditions (e.g., buffers 
containing reducing agent glutathione or low pH). 
To construct a generalized nanocarrier for protein delivery, nitrilotriacetic acid-metal ion 
(NTA-M
2+
) complexes were employed as anchors on the internal surface of stellate MSNs for 
pH-responsive controlled His-tagged protein immobilization and release. In a joint project 
with Prof. Leonhardt (LMU), we intended to directly transport chromobodies (fluorescently 
labeled single domain antibody fragments) intracellularly via our large-pore MSNs for 
antigen targeting and visualization in living cells. The NTA-Ca-modified MSNs 
demonstrated a high chromobody loading capacity (70 g/mg MSN) and the successful 
transport of chromobodies into living cells. Several strategies were applied in order to resolve 
the endosomal entrapment of the internalized MSN-Cbs (chromobody-loaded MSNs). 
Among these strategies, the endosomolytic agent  chloroquine enabled the most significant 
enhancement of chromobody release in the cytosol.   
To systematically study the protein delivery efficiency of the NTA-M
2+
-complex-modified 
MSNs, a cell sensor based on a chemically inducible two-component fluorescent system was 
established for tracking the MSN-mediated protein delivery process. The cell sensor is 
background-free and molecularly ratiometric, which exclusively detects delivered protein that 
is both functionally viable and bioavailable. We applied this sensor in parallel with the MTT 
assay to maximize the protein delivery efficiency as well as the biocompatibility of our NTA-
Ni-modified stellate MSNs. The in vitro protein transfection efficiency reaches up to 80% 
after optimizing the MSN incubation concentration to 100 g/ml. Furthermore, in this study 
we demonstrated a novel protein delivery tracking approach in live cell imaging with good 
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temporal resolution, and disentangled the timing of protein uptake from that of sensor 
dynamics through the use of built-in chemically inducible components. 
Finally, in a collaborative project with Prof. Trauner (LMU), two types of photoswitchable 
supported lipid bilayers (SLBs) based on two different photo-sensitive lipids, AzoPC 
(azobenzene-containing phospholipid) and DC8,9PC (1,2-bis(10,12-tricosadiynoyl)-sn-
glycero-3-phosphocholine), were created on the surface of stellate MSNs. AzoPC and 
DC8,9PC exhibit distinct photochemical responses (photoisomerization for AzoPC and 
photopolymerization for DC8,9PC) and are sensitive to different wavelength ranges (320 – 
350 nm for AzoPC, 254 nm for DC8,9PC). Upon irradiation with the appropriate wavelengths, 
both AzoPC-SLB and DC8,9PC-SLB capped MSNs demonstrated photo-induced cargo 
release abilities.   
To summarize, we have established versatile large-pore multifunctional MSNs and 
demonstrated their stimuli-responsive controlled release abilities for several possible 
applications. Successful intracellular protein delivery using our large-pore multifunctional 
MSNs was also performed. We envision these large-pore multifunctional MSNs to provide a 
new platform for the facile delivery of biomacromolecules in future applications of 
nanomedicine. 
 
  
X 
 
  
XI 
 
Table of contents 
 
1 Introduction ........................................................................................................ 1 
1.1 Mesoporous Silica Materials ....................................................................................... 1 
1.1.1 Ordered Porous Materials .................................................................................... 1 
1.1.2 The Development of Mesoporous Silica Materials ............................................. 1 
1.1.3 Large-Pore Mesoporous Silica Nanoparticles ..................................................... 4 
1.1.4 Multifunctional Mesoporous Silica Nanoparticles for Drug Delivery ................ 8 
1.2 Intracellular Protein Delivery .................................................................................... 12 
1.2.1 Protein Therapy .................................................................................................. 12 
1.2.2 Intracellular Protein Delivery Strategies ............................................................ 14 
1.2.3 Endosomal Escape ............................................................................................. 18 
1.3 References ................................................................................................................. 24 
2 Characterization Techniques ..........................................................................33 
2.1 Nitrogen Physisorption .............................................................................................. 33 
2.2 Dynamic Light Scattering (DLS) .............................................................................. 38 
2.3 Zeta Potential Measurement ...................................................................................... 39 
2.4 Infrared (IR) and Raman Spectroscopy ..................................................................... 41 
2.5 UV-Vis Spectroscopy ................................................................................................ 43 
2.6 Thermogravimetric Analysis (TGA) ......................................................................... 43 
2.7 X-ray Diffraction (XRD) ........................................................................................... 44 
XII 
 
2.8 Fluorescence Spectroscopy ....................................................................................... 46 
2.9 Electron Microscopy ................................................................................................. 47 
2.9.1 Transmission Electron Microscopy (TEM) ....................................................... 48 
2.9.2 Scanning Electron Microscopy (SEM) .............................................................. 50 
2.9.3 Scanning Transmission Electron Microscopy (STEM) ..................................... 51 
2.10 Confocal Microscopy ............................................................................................ 52 
2.11 References ............................................................................................................. 55 
3 Synthesis and Functionalization of Ordered Large-Pore Mesoporous 
Silica Nanoparticles for Biomedical Applications ........................................57 
3.1 Introduction ............................................................................................................... 57 
3.2 Results and Discussion .............................................................................................. 60 
3.3 Conclusion ................................................................................................................. 69 
3.4 Experimental ............................................................................................................. 69 
3.5 Appendix ................................................................................................................... 77 
3.6 References ................................................................................................................. 79 
4 Clickable Multifunctional Large-Pore Mesoporous Silica Nanoparticles 
as Nanocarriers ................................................................................................83 
4.1 Introduction ............................................................................................................... 84 
4.2 Results and Discussion .............................................................................................. 86 
4.3 Conclusion ................................................................................................................. 96 
4.4 Experimental ............................................................................................................. 97 
4.5 Appendix ................................................................................................................. 103 
XIII 
 
4.6 References ............................................................................................................... 107 
5 Intracellular Chromobody Delivery by Mesoporous Silica 
Nanoparticles for Antigen Targeting and Visualization in Real Time ....111 
5.1 Introduction ............................................................................................................. 112 
5.2 Results ..................................................................................................................... 114 
5.3 Discussion ............................................................................................................... 127 
5.4 Experimental ........................................................................................................... 128 
5.5 Appendix ................................................................................................................. 136 
5.6 References ............................................................................................................... 142 
6 Optimisation and Live Cell Tracking of Nanoparticle Mediated Protein 
Delivery Through an Inducible Split Venus Based System .......................145 
6.1 Introduction ............................................................................................................. 146 
6.2 Results and Discussion ............................................................................................ 149 
6.3 Conclusion ............................................................................................................... 157 
6.4 Experimental ........................................................................................................... 158 
6.5 Appendix ................................................................................................................. 165 
6.6 References ............................................................................................................... 167 
7 Photoswitchable Supported Lipid Bilayers on Large-Pore Mesoporous 
Silica Nanoparticles For Controlled Release Applications ........................171 
7.1 Introduction ............................................................................................................. 171 
7.2 Results and Discussion ............................................................................................ 175 
7.3 Conclusions and Outlook ........................................................................................ 181 
XIV 
 
7.4 Experimental ........................................................................................................... 182 
7.5 Appendix ................................................................................................................. 186 
7.6 References ............................................................................................................... 187 
8 Conclusions and Outlook ..............................................................................189 
9 Curriculum Vitae ...........................................................................................193 
 
 
1 
 
1 Introduction  
1.1 Mesoporous Silica Materials 
1.1.1 Ordered Porous Materials  
Porous materials are of interest in scientific research because they contain unique surface and 
structural properties which can interact with atoms, ions and molecules.
1
 Before the early 
1990s, crystalline microporous zeolites (mainly composed of aluminosilicates) were regarded 
as the prototype of ordered porous materials. For decades, zeolites had shown great success in 
industrial applications such as catalysis, separation and ion exchange.
2,3
 Despite of these 
successes, the micropores of zeolites ranging from about 0.3 – 1.4 nm still restrict their uses 
to the adsorption and diffusion of small molecules. Offering to overcome the mass transfer 
bottleneck for large molecules as well as to broaden the application range of porous materials 
beyond the traditional uses as catalysts and adsorbents, a new type of silica-based molecular 
sieves containing ordered pore size larger than 2 nm has emerged in the 1990s.
4-6
 Motivated 
by these pioneering studies, the synthesis of mesoporous silica materials with different 
porous structures and dimensions has developed rapidly and has opened up a new perspective 
for the applications of porous materials. 
1.1.2 The Development of Mesoporous Silica Materials 
In the early 1990s, ordered mesoporous silica materials have been synthesized independently 
in the group of Kato in Japan
4
 and at the Mobil Research and Development Corporation.
5,7
 
Beck and co-workers at Mobil first proposed the “template” concept in the synthesis 
approach, using quaternary ammonium salts such as cetyltrimethylammonium bromide 
(CTAB) or cetyltrimethylammonium chloride (CTAC) as structure-directing agents to form 
liquid crystalline micelles in solution. Upon addition of silicate gels (dissolved in basic 
solution) to the surfactant solution, the mixture was reacted at elevated temperature (about 
100 – 150 °C) in order to attain ordered mesostructures. After template removal by 
calcination, the resulting materials featured long-range ordered mesopores surrounded by 
amorphous silica walls, high surface areas of about 1000 cm
2
/g, and narrow pore size 
distributions in the range of 3 – 5 nm. When incorporating auxiliary agents into the liquid 
crystalline micelles, the pore size could be expanded to 10 nm. This new type of mesoporous 
silica molecular sieves was named the M41S family.
5,7
 Representatives of the M41S 
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materials are hexagonal-pore-structured MCM-41 (MCM implies Mobil Composition of 
Matter), cubic-pore-structured MCM-48 and lamellar-structured MCM-50 (Figure 1.1). The 
alteration of porous structures can be achieved by adjusting the molar composition of the 
reaction solution.
8
   
 
 
Figure 1.1 Three mesoporous silica representatives in the M41S family.
8
 (a) MCM-41 
(2D hexagonal pore structure). (b) MCM-48 (3D cubic pore structure). (c) MCM-50 (1D 
lamellar structure). 
 
A few years later, another prominent type of mesoporous silica materials, designated as SBA 
(Santa Barbara Amorphous) materials, has been synthesized at the University of California, 
Santa Barbara.
6,9
 Stucky et al. employed non-ionic triblock-copolymers as structure-directing 
agents in an acidic synthesis condition, in which they obtained mesoporous silicas with large 
pores of 5 – 30 nm. The structure directing triblock-copolymers are composed of 
poly(ethylene oxide)x-poly(propylene oxide)y-poly(ethylene oxide)x (PEOx-PPOy-PEOx) units 
with variable x and y chain lengths. During the synthesis, the copolymers formed micellar 
aggregates where the hydrophobic PPO units aggregate into cores and the hydrophilic PEO 
units extend into water and associate with a silicate corona.
10,11
 The micelles then pack into 
large cylindrical domains followed by silica condensation around the micellar domains. 
Hydrothermal treatment at 100 °C is subsequently performed to gain an ordered porous 
structure. By applying different triblock copolymers that contain variable x and y 
compositions, distinct mesostructures can be obtained. The most well-known SBA-type 
materials are SBA-15 and SBA-16, the former is templated by Pluronic P123 and exhibits 2D 
hexagonal mesopores while the latter is templated by Pluronic F127 and contains a 3D cubic 
mesostructure (Figure 1.2). 
3 
 
 
Figure 1.2 Schematic illustration of the porous structures of (a) SBA-15 (channel-like) 
and (b) SBA-16 (nanocage-like).
12
 
Following the achievements of MCM-type and SBA-type mesoporous silica synthesis, the 
soft-templating technique has been widely expanded in the following years for the synthesis 
of diverse mesostructured silica materials. Several extended applications for mesoporous 
silica materials were subsequently accomplished, for example, high performance liquid 
chromatography for biomolecule separation,
13
 low dielectric constant films in microelectronic 
devices,
14,15
 and controlled release of drug molecules.
16
 Among the variety of applications, 
controlled release of drugs is of particular interest owing to the unique structural properties of 
mesoporous silica materials, including high surface area and large pore volume that enable a 
high level of guest molecule immobilization. 
Over the years, scientists spent great efforts on controlling the particle size and morphology 
of mesoporous silica materials to make them suitable for biomedical applications. It has been 
suggested to confine the particle size to smaller than 200 nm in order to achieve better 
cellular uptake efficiency.
17
 Therefore, the synthesis of nanosized mesoporous silicas with 
colloidal stability became prevalent in the last years of the 20
th
 century. Around 2003, Lin 
and his co-workers presented MCM-41-type mesoporous silica nanoparticles (MSNs) capped 
with chemically removable CdS nanoparticles for controlled drug release and applied the 
system in living cells.
18
 This research has prompted the rapid development of nanomedicine 
applications of MSNs. Since then, a large number of studies regarding MSNs for the delivery 
of a variety of therapeutics have been published.
19-21
 However, most of the drug delivery 
tasks have been achieved using small-pore (≤ 4 nm) MSNs. For sizable biomolecules such as 
siRNA, proteins and plasmid DNA, large-pore MSNs are required to achieve high loading 
and to encapsulate the cargos inside the mesopores for better protection from degradation in 
physiological environments.   
4 
 
1.1.3 Large-Pore Mesoporous Silica Nanoparticles 
In general, there are two major strategies to synthesize large-pore (> 5 nm) mesoporous silica 
materials: (i) using amphiphilic copolymers as structure-directing templates and (ii) 
incorporating organic pore-swelling agents into the surfactant micelles to increase the size of 
templates and thus the pores.
22
 In 2004, Ying et al. introduced a cationic fluorocarbon 
surfactant FC-4 (C3F7O(CFCF3CF2O)2CFCF3CONH(CH2)3N
+
(C2H5)2CH3I
-
) into the 
synthesis of mesoporous silica materials templated by nonionic triblock copolymers.
23
 In this 
study, FC-4 was used as co-surfactant in combination with different triblock copolymers 
including Pluronic F127, P123, P65 and F108, respectively. After a slow silica condensation 
process in mildly acidic solutions (pH 1.6-1.8) at a moderate temperature (35 °C), the 
nanosized (50 – 300 nm) silica particles featuring different mesostructures and pore sizes (5 –
 30 nm) were obtained (Figure 1.3 and Table 1.1). The authors proposed that the FC-4 
surfactant served as a particle growth inhibitor to confine the particle sizes in the synthesis 
process whereas the copolymers acted as structure-directing agents to enable ordered 
mesostructure formation. The resulting large-pore MSNs containing ordered mesopores and 
well-defined particle sizes were regarded as promising nanocarriers for encapsulation and 
delivery of sizable biomolecules. Thereafter, several research groups have adopted this 
synthetic strategy and applied the synthesized large-pore MSNs for different applications
24-27
 
(for a detailed review, please see Chapter 3). 
 
Figure 1.3 Mesoporous silica nanoparticles obtained in the fluorocarbon-surfactant-
mediated synthesis.
23
 (a) IBN-1, (b) IBN-2, (c) IBN-3, (d) IBN-4 and (e) IBN-5. 
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Table 1.1 Characteristics of mesoporous silica nanoparticles obtained in the 
fluorocarbon-surfactant-mediated synthesis.
23
 
Sample Mesostructure Template 
BET surface 
area (m
2
/g) 
Pore volume 
(cm
3
/g) 
Pore size 
(nm) 
IBN-1 3D cubic (Im3m) F127 779 0.73 5.8 
IBN-2 3D cubic (Im3m) F127+TMB 804 0.65 9.5 
IBN-3 Mesocellular foam P65+TMB 821 0.72 19.5 
IBN-4 2D hexagonal (p6m) P123 709 0.88 6.4 
IBN-5 Disordered F108 575 0.54 5.2 
 
Although the fluorocarbon-mediated synthesis strategy yields large-pore MSNs with highly 
ordered mesostructures, the as-synthesized materials often contain significant amounts of 
bulk silica showing some particle agglomeration, resulting in broad particle size distributions 
of the samples.
28
 The long synthesis process including 24 h of silica condensation and at least 
another 24 h for hydrothermal treatment also makes this approach somewhat less attractive.  
On the contrary, using cetyltrimethylammonium (CTA
+
) salts (e.g., CTAC or CTAB) for 
MSN synthesis under base-catalyzed conditions is more facile and produces more 
homogeneous particle sizes. By inclusion of organic auxiliary agents in the surfactant 
solutions, it is possible to enlarge the pore size of MSNs. Several organic molecules such as 
1,3,5-trimethylbenzene (TMB),
29
 decane,
30
 N,N-dimethylhexadecylamine (DMHA)
28
 and 
1,3,5-triisopropylbenzene (TiPB)
31,32
 were employed in the CTAC or CTAB templated MSN 
synthesis for pore size expansion. However, the pore expansion effect is limited in that the 
resulting pore sizes are only in the range of 5 – 6 nm. Nevertheless, our colleagues in the 
group have reported that these medium-pore MSNs are already sufficient for encapsulation of 
siRNA. The controlled loading and release of siRNA with these medium-pore MSNs are 
better than with the large-pore MSNs synthesized in the FC-4-mediated approach.
32
  
Inspired by the aforementioned cetyltrimethylammonium templating MSN synthesis 
approach, Zhang and coworkers established a facile route to synthesize monodispersed 
stellate MSNs (Figure 1.4) having ultra-large pores in the range of 10 – 20 nm and particle 
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size of about 100 nm.
33
 Impressively, they are able to produce MSNs at a kilogram scale. 
They used cetyltrimethylammonium tosylate (CTATos) as templating surfactant and 
triggered silicate condensation at near neutral conditions where the tosylate (Tos
-
) 
counterions compete with negative silicates in the surfactant-silicate self-assembly process, 
yielding more agglomeration of micelles and thus modifying the silica framework to create a 
stellate shape (Figure 1.5). The conical pore shape with large pore mouth is accessible for the 
mass transfer and the adsorption of large cargos. In this thesis, we also adopted this synthesis 
strategy in addition to surface functionalization to construct multifunctional large-pore MSNs 
for intracellular protein delivery (see Chapter 5 and Chapter 6).
34
 
Other significant synthesis methods for different types of large-pore MSN synthesis are also 
worth noting: (i) the amphiphilic block copolymer (polystyrene-b-poly (acrylic acid), PS-b-
PAA) and CTAB co-templated large-pore MSNs;
35,36
 (ii) modified swelling agent pore-
expansion synthesis strategy (using TMB and ethanol for pore etching at high temperature);
37
 
(iii) hollow silica nanospheres synthesized using a water-in-oil microemulsion as template,
38
 
etc. (Figure 1.6). 
 
 
Figure 1.4 SEM (top) and TEM (bottom) images of stellate MSNs synthesized using 
CTATos as templating surfactant.
33
 MSNs synthesized using triethyleneamine (a, b) or 
triethanolamine (c, d) or 2-amino-2-(hydroxymethyl)propane-1,3-diol (e, f) as catalytic small 
organic amines (SOAs) for silica condensation. 
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Figure 1.5 Proposed MSN synthesis mechanisms at low or high pH in solutions using 
CTATos or CTAB as templating surfactants.
33
 
 
Figure 1.6 Large-pore MSNs synthesized by different methods. (a) Core-shell structured 
dual-mesoporous silica nanosphere synthesized via PS-b-PAA and CTAB co-templated 
approach.
35
 (b) Large-pore silica nanosphere synthesized via PS-b-PAA and CTAB co-
templated approach with high ethanol content.
36
 (c) Irregular large-pore MSNs obtained from 
a modified swelling agent pore-expansion strategy.
39
 (d) Hollow silica nanospheres 
synthesized using a water-in-oil microemulsion as template.
38
 
8 
 
1.1.4 Multifunctional Mesoporous Silica Nanoparticles for Drug Delivery 
MSNs feature several advantageous properties including high surface area, large pore volume, 
tunable pore size, stable frameworks, ease of surface modification and good biocompatibility 
that renders them suitable for drug delivery applications. Specifically, the high surface area 
and large pore volume enables encapsulation of decent amounts of therapeutics; tunable pore 
size allows for immobilization of cargos in various sizes; the stable silica framework can 
protect cargos from enzymatic or chemical degradation; ease of surface modification enables 
the attachment of functional assemblies, e.g., targeting ligands and stimuli-responsive 
gatekeepers, etc.. MSNs have shown great success in the delivery of a variety of therapeutics 
including anti-cancer drugs,
40-44
 oligonucleotides
25,32,39,44,45
 and proteins
46-48
 either in vitro or 
in vivo for disease treatment or for biological research. In addition to drug delivery, MSNs 
can also be used for imaging purposes
49
 either at the cellular level for cell biology
34
 studies or 
for disease diagnosis such as magnetic resonance imaging (MRI)
50-52
 and positron emission 
tomography (PET).
53
 Figure 1.7 demonstrates a multifunctional MSN model as an 
autonomous nanoagent for different biomedical applications. The integrated functions ideally 
include a porous framework for cargo loading, a gate keeper system for controlled cargo 
release, tracking markers for particle tracing, spacer molecules (e.g., polyethylene glycol, 
PEG) to enhance the solubility and biocompatibility, targeting ligands to enable a specific 
targeting delivery, and endosomal escape agents to trigger cargo release from trapped 
endosomes.  
 
Figure 1.7 Schematic representation of a multifunctional mesoporous silica nanoparticle 
serving as an autonomous nanoagent in biomedical applications.
19
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In order to attach these functional features on the surface of the MSNs, incorporation of 
organic functional groups, e.g., amino groups, thiol groups, carboxylic groups, etc., into the 
silica framework to enable a subsequent chemical cross-linking process is required. The 
incorporation of functional groups can be achieved by either post-synthetic grafting or co-
condensation methods. In the post-synthetic grafting approach, functional silanes attach to the 
surface of MSNs after the particle structure is formed. This can be performed before or after 
surfactant extraction, hence resulting in only outer shell or entire surface functionalization. In 
the co-condensation synthesis process, organosilanes and tetraethoxysilane (TEOS) undergo 
hydrolysis and condensation simultaneously in solution, leading to the incorporation of 
functional groups in the silica framework during particle formation. By employing a delayed 
co-condensation strategy, site-selective core-shell bifunctional MSNs can be obtained.
54
 
Apart from the intention of performing cross-linking chemistry to attach functional ligands, 
surface functionalization also allows for the alteration of hydrophobic/hydrophilic properties 
of the MSNs that can strongly affect their cargo immobilization behavior. For example, 
several studies have shown that functionalization with positively charged moieties (e.g., 
amino groups or positively charged polymer) is required to enhance the loading/adsorbing 
efficiency for negatively charged siRNA or DNA.
24,25,32,55
 
When Lin and co-workers first initiated the idea of engineering MSNs as drug delivery 
systems in 2003, they also presented the concept of introducing stimuli-responsive 
gatekeepers in MSN systems for controlled cargo release.
18
 The original proposal of stimuli-
responsive drug delivery can be dated to the late 1970s with the use of thermosensitive 
liposomes for the local release of drugs through hyperthermia.
56
 Thanks to the development 
of materials chemistry and nanomedicine, the inclusion of stimuli-responsive moieties in the 
drug delivery system enables the delivery of payload in spatio-, temporal- and dosage-
controlled manners. For the MSN-based drug delivery system, capping the pores to prevent 
premature leakage of cargos and triggering the release at the targeted destination have also 
been suggested. Various stimuli-responsive gating systems have been successfully applied to 
MSNs for controlled cargo release.
19,57
 The response triggers of these strategies can be 
classified based on (i) exogenous stimuli: variations in temperature,
58
 light,
31,59
 magnetic 
field,
60
 ultrasound intensity
61
 and electric potential
62
 or (ii) endogenous stimuli: changes in 
pH,
34,41,63
 enzyme concentration
40,64,65
 and redox gradients
18,66
 (Figure 1.8).   
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Figure 1.8 Schematic representation of different stimuli triggers for drug controlled 
release.
67
 
Other surface coatings including PEG chains and supported lipid bilayers (SLBs) have been 
reported to enhance the dispersity, biocompatibility and in vivo circulation half-life of the 
MSNs.
19,68-70
 Different types of endosomal escape agents, for example, fusogenic peptides,
71
 
high buffering capacity dendrimers
72
 and cationic polymers
32
 have been incorporated into 
MSNs and demonstrated the endosomal destabilization ability in triggering cargo release. 
Although targeting-ligand-attached MSNs showed significant efficiency for cellular targeting 
in vitro,
31,71,73
 the in vivo targeting efficacy needs to be further investigated. For cancer 
targeting therapy, there are several in vivo barriers which can hinder the site-specific 
accumulation of nanocarriers.
68,74,75
 For instance, nanoparticles can be taken up by the liver, 
spleen or the macrophage system in the body depending on the sizes and surface 
characteristics of the nanocarriers. Choi et al. used quantum dots as model system to study 
the biodistribution of different sizes and surface charges of nanoparticles in rodents upon 
intravenous administration.
76
 The results indicated that particles with diameters < 5.5 nm 
rapidly undergo renal clearance. On the other hand, zwitterionic or neutral organic-coated 
particles with a hydrodynamic diameter expanded to > 15 nm can prevent the renal excretion 
as well as the adsorption of serum proteins. It has also been reported that particles with more 
hydrophobic surfaces tend to be captured by the liver, followed by spleen and lungs.
77
 
Moreover, in the blood stream nanoparticles are likely to be coated with some opsonin 
11 
 
proteins (e.g., fibronectin, thrombospondin, laminin, etc.). The adsorbed proteins can interact 
with specific plasma membrane receptors on phagocytic cells, leading to the internalization 
and clearance of the protein-nanoparticle complexes. The phagocytic clearance is the main 
clearance pathway for nanoparticles to be removed from the blood circulation.
68
 Therefore 
attachment of a hydrophilic PEG shell, “don’t eat-me” marker CD47, “self” peptides to create 
stealth nanoparticles, or coating particles with supported-lipid bilayers are beneficial 
strategies to enhance the circulation half-lives of nanocarriers.
75
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1.2 Intracellular Protein Delivery 
1.2.1 Protein Therapy 
Proteins perform the most dynamic and diverse functions of any large biomolecules within 
organisms, including catalyzing biochemical reactions, DNA replication, responding to 
stimuli, and transporting objects from one location to the other.
78
 This vast array of biological 
activities can also make proteins potent therapeutics. Protein therapy can have several 
advantages over treatments performed with small-molecule drugs,
78
 for example: (i) proteins 
exhibit a highly specific and complex set of functions that cannot be imitated by simple 
organic compounds; (ii) the highly specific action of proteins implies fewer interferences 
with other non-related biological processes, causing less adverse effects on normal cell 
behavior; (iii) proteins are naturally existent in the body, thus therapeutic proteins derived 
from natural proteins may be less likely to elicit immune responses. Furthermore, protein 
therapy is considered to be safer for the treatment of genetic disorders than gene therapy 
which has the potential risk of insertional mutagenesis.   
Thanks to the invention of recombinant DNA technology, protein production has become 
more facile and cost-effective, which has aided in the development of the modern 
biopharmaceutical industry. Recombinant technology for protein therapeutics manufacture 
allows for large-scale production, precise transcription and translation of human genes, which 
decreases the chances of immunological rejection, modification of proteins or selection of 
particular gene variants to improve protein function and specificity, and reduction of 
exposure to animal or human diseases during production.
78
 In 1982, the recombinant human 
insulin (Humulin

) developed by Genentech
79
 was approved by the US Food and Drug 
Administration (FDA) and became the first commercial protein therapeutic. Up to 2013, 
about 91 recombinant-protein-based new molecular entities in total have been approved by 
the FDA as therapeutics.
80
 Protein therapeutics can be classified into four major groups based 
on their pharmacological activities,
78
 the details are listed in Table 1.2.   
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Table 1.2 Functional classification of protein therapeautics.
78
 
Group I: Enzymes and regulatory proteins 
Pharmacological 
activities 
Ia. Replacing a protein that is deficient or abnormal 
Ib. Augmenting an existing pathway 
Ic. Providing a novel function or activity 
Examples of therapeutic 
application 
Ia. Insulin for diabetes treatment; pooled immunoglobulins for 
primary immunodeficiencies treatment 
Ib. Erythropoietin for haematopoietic defect treatment 
Ic. Collagenase for the digestion of collagen in the necrotic base of 
wounds 
Group II: Targeted proteins  
Pharmacological 
activities 
IIa. Interfering with a molecule or organism 
IIb. Delivering other compounds or proteins 
Examples of therapeutic 
application 
IIa. Cetuximab, a monoclonal antibody that binds epidermal 
growth factor receptor (EGFR) and impairs cancer cell growth 
and proliferation, for colorectal cancer and head and neck 
cancer treatment. 
IIb. Gemtuzumab ozogamicin, a monoclonal antibody (against 
CD33)-calicheamicin (a chemotherapeutic agent) complex, for 
CD33-positive acute myeloid leukaemia treatment. 
Group III: Protein vaccines 
Pharmacological 
activities 
IIIa. Protecting against a deleterious foreign agent 
IIIb. Treating an autoimmune disease 
IIIc. Treating cancer 
Examples of therapeutic 
application 
IIIa. Hepatitis B vaccine composed of recombinant hepatitis B 
surface antigen (HBsAg) proteins   
IIIb. Anti-Rhesus (Rh) immunoglobulin G for the protection of an 
Rh-negative mother at the time of delivery of an Rh-positive 
neonate 
IIIc. Sipuleucel-T (trade name: Provenge) for prostate cancer 
treatment 
Group IV: Protein diagnostics 
Pharmacological 
activities 
In vitro or in vivo medical diagnostics 
Examples of therapeutic 
application 
Natural and recombinant HIV antigens for HIV infection detection 
(by means of ELISA or western blot) 
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1.2.2 Intracellular Protein Delivery Strategies 
Intracellular delivery of therapeutic proteins is of great importance for the treatment of 
protein deficient/malfunction diseases as well as cancer. Besides the clinical applications, 
intracellular protein delivery is likewise of significance in scientific research for the 
investigation and manipulation of cellular processes. However, many constraints including 
instability and low cell-membrane permeability of proteins usually result in poor intracellular 
delivery efficiency.
81-83
 In order to overcome these challenges, substantial effort has been 
devoted to develop better techniques capable of packing proteins in a proper formulation, 
thus transporting proteins to cytosolic compartments in a more efficient manner.    
Cell-penetrating peptides (CPPs) are short peptides of less than 30 amino acids that feature 
the ability of penetrating through the cell membrane and translocating different cargos into 
cells. CPPs were the first tools used in protein transduction
84
 and to date are the best 
evaluated and widely used tools for intracellular macromolecule delivery.
85
 The well-known 
cell-penetrating peptides include the trans-activating transcriptional activator (TAT) peptide 
from HIV-1, penetratin peptide from Drosophila antennapedia homeoprotein, VP22 peptide 
from the herpes simplex virus VP22 protein and the synthetic polyarginine peptides, etc.. 
There are two major pathways for CPP-mediated cargo delivery: (i) direct translocation 
across cell membranes through an energy-independent mechanism and (ii) endocytosis.
86
 The 
uptake mechanism is highly dependent on the conjugated cargo. It was reported that certain 
CPPs can directly translocate across the plasma membrane when the attached cargos are 
small in size.
87
 However, when conjugated to macromolecules or when used at low 
concentrations, CPP-cargo complexes would be taken up by cells via an endocytic pathway.
88
 
In this case, most of the cargo would be trapped in endosomes. Many reports have indicated 
that the CPPs can subsequently induce an endosomal escape pathway and further promote the 
cargo release.
87
 Nevertheless, the endosomolytic activity of CPPs is still very poor comparing 
to the efficiency of internalization by cells. The CPP-mediated cellular delivery often requires 
covalent conjugation of CPPs with proteins via genetic encoding, which makes this approach 
difficult to be generalized, and sometimes the conjugation might alter the properties and 
functions of proteins. Recently Erazo-Oliveras et al. reported a highly efficient CPP-mediated 
protein delivery approach by simple co-incubation of dimeric fluorescent dye-labelled TAT 
(dfTAT) and targeted proteins in cell culture medium. They achieved cytosolic delivery in 
several cell lines and demonstrated simultaneous delivery of multiple molecules.
89
 Although 
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the CPP-based protein delivery strategy exhibits high efficiency in vitro, the toxicity and 
immunogenicity of CPPs are still concerns when exploited in vivo.
86
  
Alternatively, nanocarriers can be good candidates for transporting exogenous proteins 
intracellularly. Nanocarrier-based delivery systems offer the ability to tailor their physical 
and chemical properties through controlled synthesis for cargo accommodation, and can be 
modified with multiple functionalities for tuning the delivery processes. The potential 
benefits of employing nanocarriers in intracellular delivery include high molecular loading, 
packaging the cargos and protecting them from degradation, increasing the possibility of 
reaching the intended intracellular compartments, and controlling the cargo release with 
appropriate spatiotemporal dynamics.
90
 When applied in vivo, nanocarriers are capable of 
shielding proteins from eliciting immune responses of the body, and in addition, the bigger 
size of the packed nanocarrier-protein complexes can make it easier to escape rapid renal 
filtration.
91,92
 A variety of nanocarriers have been developed for drug delivery, including 
lipid-based nanocarriers, polymeric nanocarriers, inorganic nanocarriers and protein-
mediated nanocarriers (Figure 1.9(a)). The cargo loading can be achieved by facile routes 
such as direct conjugation via chemical crosslinking, physical adsorption on the 
external/internal surface or encapsulation in the framework of nanocarriers (Figure 1.9(b)).
92
 
 
Figure 1.9 Different types of nanocarriers (a) and cargo loading methods (b).
92
 
16 
 
In the following sections we will review some commonly used nanocarriers for applications 
in drug delivery.  
Liposomes: liposomes are a class of lipid-based vesicles capable of adhering to plasma 
membranes followed by entering cells through endocytosis or liposome-cell fusion.
93
 
Liposomes feature versatility in compositions and functions, and have shown great abilities in 
the delivery of various cargos like small molecules, siRNA, DNA and proteins.
93-95
 The 
advantages of using liposomes as drug delivery vehicles are their high loading capacity 
(strongly depending on cargo), the capability of delivering hydrophilic and hydrophobic 
drugs simultaneously, good biocompatibility and biodegradability, and high cellular uptake 
efficiency.
93
 There are various types of liposomes that can be classified either by their 
compositional character or the stimuli-responses, for example, conventional (neutral) 
liposomes, cationic liposomes, pH-sensitive liposomes, thermo-sensitive liposomes and long-
circulating liposomes.
93
 Among these types, pH-sensitive and cationic liposomes are the 
mostly used carriers for cellular delivery due to their ability of promoting endosomal release 
of the cargos (for details, see “Endosomal Escape” chapter).91,96 However, the stability is a 
major consideration of liposomes either for storage or during the delivery process.
93
 For 
instance, the fusion and breakage of liposomes may lead to drug leakage. 
Polymeric nanocarriers: polymers can be synthesized with defined composition and 
modified with various functionalities (e.g., conjugation with targeting ligand) that render 
them attractive vectors for protein delivery. The most famed and commonly used polymeric 
nanocarriers are polymeric micelles, which are normally comprised of amphiphilic block 
copolymers. The amphiphilic block copolymers form micelles (5 – 100 nm) in solution when 
the concentration of the polymer is above a critical micelle concentration (CMC),
97
 where the 
hydrophobic blocks of the polymer aggregate into a micellar core while the hydrophilic 
blocks associate with the surrounding water through hydrogen bonding thus forming a 
hydrophilic outer shell. The mostly used block copolymers usually contain PEG chains as the 
hydrophilic blocks and poly(propylene oxide)s, poly(L-amino acid)s or poly(ester)s as 
hydrophobic blocks.
98
 With the polymeric micelles, drugs or biologically active substances 
can be encapsulated in the hydrophobic core. For protein encapsulation, the hydrophobic core 
is made by complexing a section of polymer chain with protein molecules via electrostatic 
interactions, hydrophobic interactions, or other noncovalent interactions. However, the 
stability of the micellar complexes and the potential protein denaturation during 
17 
 
complexation are still problematic.
91
 The complexes may dissociate rapidly upon dilution or 
through the competitive binding of serum with polymers in vivo.
91
 To resolve this problem, 
introducing an additional cross linkage, for example, disulfide bridge, during micellar 
assembly may enhance the stability of the complexes. Inspired by this concept, Yan et al. 
developed an in-situ polymerization method to cross link neutral/positively charged 
monomers using non-degradable and degradable crosslinkers around the protein to form 
single protein nanocapsules for cellular delivery.
99
 Various stimuli-responsive polymers (also 
called smart polymers) are applicable for building up the polymeric drug delivery platform in 
a stimuli-responsive manner for controlled drug release.
100
 These include temperature-
sensitive polymers (e.g., poly(N-isopropylacrylamide)), pH-sensitive polymers (e.g., 
poly(vinylpyridine)), light-sensitive polymers (e.g., modified poly(acrylamide)), electric 
field-responsive polymers (e.g., poly(ethyloxazoline)) and ultrasound-responsive polymers 
(e.g., ethylenevinylacetate).
100
 
Although liposomes and polymeric nanocarriers feature several attractive advantages, their 
properties are highly dependent on the specific formulation. For example, changing one 
property like loading efficiency affects numerous other properties such as size, charge and 
stability.
69
 Therefore it is difficult to design a universal nanocarrier platform for different 
cargos based on one type of lipid or polymer component. 
Inorganic nanocarriers: inorganic nanocarriers such as gold nanoparticles, carbon 
nanotubes and mesoporous silica nanoparticles (MSNs) all have been reported to show 
successful intracellular protein delivery.
91
 Gold nanoparticles can be easily synthesized and 
functionalized, and feature low cytotoxicity, bioinertness and cellular imaging ability.
101
 
Proteins can assemble with gold nanoparticles into complexes and can be released from the 
complexes by the trigger of glutathione (GSH).
102
 Carbon nanotubes (CNTs) have attracted 
numerous biological studies recently due to their water-soluble and biocompatible nature. It 
has been revealed that single walled carbon nanotubes (SWNTs) possess the ability to shuttle 
various molecular cargos including proteins and nucleic acids into living cells.
91
 Pantarotto et 
al. reported that SWNTs were able to insert and diffuse through cell membranes via the 
energy-independent non-endocytic mechanism.
103
 Others have demonstrated that proteins 
(e.g. streptavidin, BSA, cytochrome c, etc.) were able to bind to the nanotube sidewalls 
through noncovalent and nonspecific adsorption, then the CNT-protein complexes were 
internalized by cells via energy-dependent endocytosis.
91
 Among the inorganic materials, 
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MSNs exhibit superior multiple functionalities (see Chapter 1.1.3) and have been used to 
deliver a variety of proteins for disease treatment, cellular function modification or bio-
imaging. The examples include human proteasome delivery to delay tau aggregation that 
leads to Alzheimer disease,
47
 superoxide dismutase delivery against external oxidative stress 
that leads to apoptosis,
46
 Cre protein delivery for gene editing,
48
 and chromobody delivery for 
cellular antigen visualization and targeting.
34
 
Other strategies like induced transduction by osmocytosis and propanebetaine (iTOP 
method)
104
 and commercially available cationic lipid mediated delivery of negatively 
supercharged GFP-fused proteins
105
 also showed high protein transduction efficiency in vitro 
and in vivo (only the latter).     
Despite the promising development of all kinds of delivery strategies that are capable of 
transporting protein into cells, efficient escape from endosomal entrapment of those 
internalized carrier-cargo complexes is still a great challenge. 
1.2.3 Endosomal Escape 
Cargos or nanocarriers internalized by cells via the endocytosis pathway are often trapped in 
the cytosolic vesicles where their ultimate fate will be to be degraded in acidic lysosomes or 
transported back to the cell surface by recycling endosomes (Figure 1.10),
92,96,106,107
 instead 
of reaching the cyotosol where they can perform their intended action. Hence, addressing 
endosomal escape is a significant step to achieve an appropriate therapeutic effect 
intracellularly. 
Understanding the endosomal escape mechanisms is important for constructing a cellular 
delivery system. Scientists have learned from viruses and bacteria on how to evade the 
entrapment of cellular vesicles during their infectious process in the host cells. These natural 
mechanisms are highly efficient and the best models to imitate when conducting cellular 
delivery by non-viral vectors. Based on the extensive studies performed during the past 
decades, several endosomal escape mechanisms have been proposed.
96,106,107
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Figure 1.10 Schematic representation of endocytic process for protein delivery 
vehicles.
92
 (a) Protein shuttled vehicles attach on cell membrane and enter the cell via 
endocytosis; (b) the internalized vehicles are trapped in endosomes; (c) the shuttled vehicle 
undergoes endosomal escape; (d) non-escaped vehicle and its payload are sorted to lysosome 
and degraded in the acidic milieu; (e) proteins are released from endosomes and diffuse 
through cytosol; (f) targeting proteins are transported to specific organelle; (g) cargos diffuse 
into nucleus and participate in cellular functions; (h) exocytosis of the shuttled vehicle by the 
recycling endosome.  
 
Membrane fusion:  
In nature, enveloped viruses can trigger endosomal escape by fusion of their viral envelope 
with the endosomal membrane in order to release the viral contents to the cytoplasm of the 
infected cells.
108
 Inspired by the natural pathway, scientists have identified some viral entry 
peptides, studied their membrane destabilization mechanisms and even modified their 
sequence to improve the endosomal escape efficiency as well as their biocompatibility. The 
viral entry peptides can be classified into three different categories based on their amino acid 
residues and the slightly different mechanism of action in endosomes.
96
 The first type is 
anionic amphiphilic peptides containing glutamate residues and hydrophobic segments. These 
peptides are capable of undergoing conformational changes from a random coil to an -helix 
under acidic conditions (pH 5 – 5.5). These -helical domains allow the envelope-bound 
peptides to induce membrane fusion with the endosomes, therefore these types of peptides are 
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also called fusogenic peptides. The haemagglutinin subunit HA2 of influenza virus and its 
derivatives INF7 and E5WYG are representatives of fusogenic peptides.  
The second type of viral entry peptides contains abundant histidine residues capable of being 
protonated in mildly acidic environments and destabilizing the endosomal membrane via 
cationic interactions and an osmotic buffering effect (see the section on “proton sponge 
effect”). H5WYG is a typical example of this type of peptides and has shown efficient 
transfection efficiency for nucleic acids and high endosomal escape efficiency when 
incorporated into supported lipid bilayer-coated mesoporous silica nanoparticles.
71,109
 Some 
peptides like GALA,
110
 consisting of both glutamate residues for pH-dependent 
conformational change and histidines for protonation buffering, are able to trigger different 
membrane destabilization mechanisms, consequently attaining high transfection efficiency. 
The third type is cationic amphiphilic peptides with copious lysine residues such as K5 and 
KALA. This type of peptides can induce pH-dependent membrane destabilization by cationic 
interactions (explained below) with the endosomal membrane.  
It was proposed that some lipid-based nanocarriers also possess the membrane fusion ability 
to release their payload to the cytoplasm. Cationic lipids such as 1,2-dioleyl-3-
trimethylammonium-propane (DOTAP) and 1,2-di-O-octadecenyl-3-trimethylammonium 
propane (DOTMA) are able to induce a “flip-flop” mechanism, inverting the negatively 
charged endosomal membrane (mainly the cytoplasm-facing leaflet) to attach on their 
positively charged phospholipids, thus creating a connection between the lipid enveloped 
milieu and the cytoplasm
96,106
 (Figure 1.11). The fusogenic lipid 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) is often incorporated into cationic lipoplexes as 
endosomolytic helper lipid to enhance the endosomolytic ability. DOPE is pH sensitive and 
will undergo a conformational transition from a lamellar structure to an inverted hexagonal 
liquid crystalline phase upon acidification. This conformational change allows for the 
destabilization of the endosomal membrane.
96
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Figure 1.11 Flip-flop mechanism induced by cationic lipid for endosomal membrane 
fusion.
96
 (a) A lipid-based nanocarrier was internalized by cell and trapped in the endosome. 
(b) The electrostatic attraction between cationic lipids on nanocarrier and anionic lipids 
presenting in the cytoplasmic-facing side of endosomal membrane facilitates the diffusion of 
endosomal lipids into cationic lipid compartment, forming charge-neutralized ion pairs. (c) 
The displacement of the endosomal lipid results in the flip-flop membrane fusion and 
therefore enables the release of the payload into the cytoplasm.       
Pore formation:   
Persistent membrane destabilization or insertion of peptides/pore forming proteins across the 
membrane can cause pore formation on the endosomal membrane, resulting in leakage of 
contents from the endosome to the cytoplasm. A well-known pore forming peptide is melittin, 
a major component of bee venom, which is characterized with the pore formation ability for 
membrane disruption and high cytotoxic activity.
107
 It is reported that
111
 the cationic melittin 
can form -helical structure in aqueous solution. The -helical structure in combination with 
the cationic character enables melittin to insert into lipid bilayers, subsequently leading to the 
membrane destabilization.    
Proton sponge effect (pH-buffering effect): the proton sponge effect
96,106,107,112
 is mediated 
by agents with high buffering capacity that can buffer endosomal acidification by adsorbing 
protons and eventually cause osmotic swelling and membrane rupture of endosomes. 
Molecules having protonable residues, such as secondary and tertiary amine groups with pKa 
close to endosomal/lysosomal pH, adsorb protons when exposed to the mildly acidic (~ pH 6) 
endosomal compartment, consequently resisting a further acidification of the endosomes. 
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Subsequently, more protons will be continuously pumped into endosomes with the attempt to 
acidify the compartment. The accumulation of positive charges inside endosomes induces a 
passive influx of chloride anions through ion channels to balance the transmembrane voltage 
differences. The increased ion concentration then causes an extensive inflow of water, 
leading to osmotic swelling and rupture of the endosomes (Figure 1.12). Various substances 
including cationic polymers (e.g., polyethylenimine, PEI), polyamidoamine (PAMAM) 
dendrimers, chloroquine and histidine-rich molecules feature the buffering ability.
106
 
Chloroquine, a lysosomotropic agent, is used in this study for endosomal destabilization. 
Chloroquine is able to diffuse through the cell membrane and will be accumulated in 
endosomes/lysosomes after being protonated. The effects of chloroquine on endosomal 
compartments are dosage-dependent. At low concentrations (< 100 M), chloroquine serves 
as an inhibitor for endosomal acidification and maturation. At high concentrations (> 100 
M), chloroquine is able to destabilize the endosomes and subsequently trigger cytosolic 
cargo release.
112
 In our study, chloroquine was used in high concentration (500 M) as a 
“shock” in the culture medium for cell incubation (at room temperature for 5 – 10 min), 
which induces an efficient endosomal release of proteins delivered by MSNs. 
 
Figure 1.12 Schematic representation of the proton sponge effect hypothesis.
96
 (a) The 
buffering agent (e.g., protonable polymer) is accumulated in the endosome. (b) The 
membrane-bound proton pump actively transports protons into endosome. The buffering 
agent is protonated and therefore resists the acidification of the endosome. (c) Continuous 
proton pumping leads to the influx of chloride anions and water, eventually causing osmotic 
swelling and rupture of the endosomal membrane.  
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Photochemically-induced membrane disruption: the technique based on photochemical-
induced membrane disruption for endosomal escape of trapping contents is designated as 
photochemical internalization (PCI).
96,107
 The PCI technique is mediated by photosensitizers 
that can be activated and generate singlet oxygen upon illumination with light. This singlet 
oxygen is highly reactive and is capable of destabilizing or destroying the 
endosomal/lysosomal membrane. Since the generated singlet oxygen has a short lifetime, the 
toxicity to the other organelles in the cell is limited while the impact on endosomal 
membrane rupture is sufficient for cargo release.
107
 A number of photosensitizers have been 
applied to trigger endosomal release of internalized contents, including meso-tetra-(para-sulfo 
phenyl) porphyrin (TPPS4), meso-tetraphenyl porphyrin disulphonate (TPPS2a), 
protoporphyrin-IX (PpIX), aluminum phthalocyaninedisulfonate (AIPcS2a) and dendrimer 
phthalocyanine (DPc).
31,41,59,107
 Among these substances, the red light photosensitizer 
AIPcS2a exhibits superior biocompatibility to the other photosensitizers owing to the lower 
phototoxicity and deeper tissue penetration when applying red light in the experiment.
31
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2 Characterization Techniques 
2.1 Nitrogen Physisorption 
Gas sorption measurement is an essential technique for the determination of the surface areas, 
pore size distributions and pore volumes of porous materials. The use of nitrogen in sorption 
analysis for pore size evaluation originates from the late 1940s. To date, nitrogen is still one 
of the most commonly used gaseous adsorptives in the sorption measurement.
1
 During the 
nitrogen sorption process, the gas adsorbs on the surface of a solid substrate (adsorbent) 
mainly via weak van-der-Waals forces where no chemical bond formation is involved. 
Therefore nitrogen sorption is classified as physisorption. The measurement is typically 
performed at a constant temperature at 77 K (the boiling point of nitrogen at 1 atm) where 
nitrogen is stepwise injected to the system. The equilibrium pressure at each nitrogen 
injection point is recorded. Thus, the amount of adsorbed nitrogen can be calculated. By 
plotting the adsorbed nitrogen volume against the equilibrium relative pressure p/p0 (p0 refers 
to the saturation pressure of the adsorptive), the isotherm is obtained. The isotherm curves are 
used to indicate the porous features of the adsorbents and their patterns were originally 
classified into six types according to IUPAC in 1985.
2
 In 2015, scientists refined the original 
IUPAC isotherms
3
 and the updated classification figures are shown in Figure 2.1. The 
material characteristics corresponding to different isotherm types are listed in Table 2.1.    
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Figure 2.1 Classification of isotherms defined in the new IUPAC physisorption report.
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Table 2.1 Types of isotherms classified by IUPAC and their corresponding materials.
3
 
Isotherm types Corresponding material characters 
I 
Microporous (pore size < 2 nm) materials having relatively small 
external surfaces. The limiting gas uptake is determined by the 
accessible micropore volume.  
Type I(a): materials containing mainly narrow micropores (< ~ 
1 nm). 
Type I(b): materials having broad pore size distributions including 
wider micropores and possibly narrow mesopores (~ 2.5 nm). 
II 
Nonporous or macroporous (pore size > 50 nm) materials. Gas 
adsorbed on the surfaces of the adsorbent from monolayer adsorption 
followed by unrestricted multilayer adsorption. 
III 
Nonporous or macroporous materials having weak interaction with 
the adsorbate, therefore the monolayer-multilayer adsorption 
transition point B is absent. 
IV 
Mesoporous (pore size between 2 nm and 50 nm) materials. The 
monolayer-multilayer adsorption followed by a capillary 
condensation in the mesopores. Adsorption reaches a final saturation 
plateau after capillary condensation. 
Type IV(a): Materials containing pore width wider than 4 nm where 
the capillary condensation is accompanied by a hysteresis. 
Type IV(b): Materials having mesopores of smaller width (< 4 nm) 
thereby the isotherms are completely reversible. Conical and 
cylindrical mesopores that are closed at the tapered end can also 
result in the reversible type IV(b) isotherm. 
V 
Materials exhibit weak interactions with adsorbate in the low p/p0 
range but undergo capillary condensation at higher p/p0. For 
example, using water for the sorption measurement on hydrophobic 
microporous and mesoporous adsorbents.  
VI 
Nonporous materials with highly uniform surfaces inducing layer-by-
layer adsorption. 
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Mesoporous silica materials typically show Type IV(a) isotherms in the nitrogen sorption 
analysis. During the adsorption measurement, capillary condensation, meaning the gas 
condenses to a liquid-like phase and fills out the pores completely, is observed.
4-6
 When 
desorption is performed, more energy (external pressure reduced) is needed to overcome the 
reversible liquid-vapor transition. Therefore the adsorption branch and desorption branch do 
not coincide and yield a hysteresis loop in the sorption isotherm. The hysteresis loops can be 
classified into several types (Figure 2.2) depending on the pore structures of the adsorbents. 
  
Figure 2.2 Hysteresis loops classified in the new IUPAC physisorption report.
3
 
There are several models that can be used to interpret isotherm curves such as Langmuir
7
 and 
Brunauer-Emmett-Teller (BET).
8
 The Langmuir model describes the adsorption process 
based on some simplified assumptions, for example, (i) the adsorption only occurs in a 
monolayer, (ii) the adsorbate behaves as ideal gas without interactions between adsorbed 
molecules and (iii) the adsorbent has an ideal solid surface where all the binding sites are 
equal. Brunauer, Emmett and Teller later extended the Langmuir theory to multilayer 
adsorption, in which they hypothesized (i) that the gas adsorbs on the adsorbent in unlimited 
layers, (ii) the interactions among the adsorbates are neglected and (iii) the Langmuir theory 
can be applied to each adsorption layer. The BET equation can be expressed as follow (Eq. 
2.1). 
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(Eq. 2.1) 
Equation 2.1 BET equation. n: the amount of the adsorbate at equilibrium pressure p, nm: 
monolayer capacity, C: BET constant, p: equilibrium pressure, p0: saturation vapor pressure 
of the adsorbate. 
By transforming the physisorption isotherm into a linear BET plot, the BET monolayer 
capacity nm can be evaluated, thereafter the BET surface area can be calculated (Eq. 2.2). 
                            
(Eq. 2.2) 
Equation 2.2 Formula for BET surface area calculation. as(BET): BET specific surface 
area of the adsorbent (of mass m), L: Avogadro constant, m: molecular cross-sectional area 
(0.162 nm
2
 for N2). 
For mesoporous materials containing no macropores, the pores are filled with the condensed 
adsorbate in the normal liquid state after capillary condensation. The total pore volume, Vp, is 
then derived from the amount of adsorbed gas at a relative pressure close to unity (e.g., p/p0 = 
0.95).
2
 The pore size distribution of the investigated sample is one of the most important 
pieces of information that we want to obtain from the sorption analysis. In early times, the 
pore size analysis of mesoporous materials was mostly based on the Kelvin equation. This 
model assumes that the pore width is related to the radius of the meniscus formed by 
condensed adsorbate. However, this model ignores the thickness of the adsorbate layers 
formed on the porous surface prior to condensation
9
. Also, this assumption is only applicable 
in cylindrical pores and in parallel-sided slits.
10
 Barrett, Joyner and Halenda (BJH) modified 
the Kelvin equation by combining a standard isotherm (the t-curve) to account for the pre-
adsorbed multilayer film.
11
 However, the standard t-curve is not properly accounting for the 
enhanced surface forces in narrow mesopores, therefore the BJH method (as well as the 
Kelvin equation) underestimates the pore size for narrow mesopores (for pore diameters 
< ~ 10 nm, the pore size will be underestimated by ~ 20 – 30%).3 To overcome the 
limitations of the Kelvin equation, several microscopic models including molecular 
simulation (Monte Carlo simulation) and density functional theory (DFT) can be applied for 
the proper calculation of the size of micropores and small mesopores. The DFT model takes 
𝑛
𝑛𝑚
=
𝑐 ∙
𝑝
𝑝0
 1 −
𝑝
𝑝0
  1 + 𝑐 −
𝑝
𝑝0
 
 
𝑎𝑠(BET) = 𝑛𝑚 ∙ 𝐿 ∙ 𝜎𝑚/𝑚 
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into consideration the interaction potentials for the fluid-adsorbent and fluid-fluid interactions 
and provides various methods for different pore structures which lead to a pore size 
distribution estimation that is more realistic and versatile compared to the Kevin equation.
5
 
The DFT method can be sub-categorized into local density functional theory (LDFT) and 
non-local density functional theory (NLDFT) based on their predictions regarding the 
adsorbed fluid density profiles on the adsorbent.
9
 The NLDFT approach is suitable for 
estimating the strongly interacting boundaries found for MSNs, therefore we applied this 
approach for the pore size distribution calculation of the mesoporous silica nanoparticles in 
this work. 
2.2 Dynamic Light Scattering (DLS)  
Dynamic light scattering (DLS) is a convenient and useful technique to determine the size 
distribution and colloidal stability of particles and polymers in suspensions.
12
 This technique 
is typically valuable for analyzing particles having sizes in the sub-micron range. DLS is also 
referred to as photon correlation spectroscopy, as the measurement applies the photon auto-
correlation function to analyze the intensity fluctuations of the scattered laser light from the 
particles in suspension. Upon illumination of the particles, the Brownian motion of the 
particles in solution leads to intensity fluctuations (resulting from the constructive and 
destructive interferences) of the scattered light which is then detected by the DLS instrument. 
Particle size is correlated to the speed of Brownian motion: the smaller the particle, the faster 
the Brownian motion is. Hence, the small particles cause the intensity to fluctuate more 
rapidly than the large ones. DLS measures the hydrodynamic particle size according to the 
translational diffusion coefficient D derived from the Stokes-Einstein equation (Eq. 2.3). The 
translational diffusion coefficient D depends on several factors, such as ionic strength in the 
solution, texture of particle surface and shape of particle. The hydrodynamic particle size was 
then obtained from a correlation function using various algorithms. 
                                                       
(Eq. 2.3) 
Equation 2.3 Stokes-Einstein equation. d(H): hydrodynamic diameter, D: translational 
diffusion coefficient, k: Boltzmann’s constant, T: absolute temperature, : viscosity. 
𝑑(𝐻) =
𝑘𝑇
3𝜋𝜂𝐷
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The size distribution obtained from the correlation function is based on scattering intensity. 
For small (particle size < 1/10 wavelength of the illuminating light) and monodispersed 
particles, the intensity-derived particle size distribution matches well with the real situation. 
The relation between particle size and the scattering intensity can be described by Rayleigh 
scattering (Eq. 2.4). 
                        
(Eq. 2.4) 
Equation 2.4 Rayleigh scattering. I: intensity of the scattered light, I0: intensity of the 
incoming light, : scattering angle, R: distance to the particle, : wavelength of the incoming 
light, n: refractive index of the particle, d: particle diameter. 
Since the scattering intensity is proportional to d
6
, a small portion of large particles or 
agglomerates in the solution would dominate the intensity-derived particle size distribution 
and thus compromise the result. Therefore, for large particles or samples containing broad 
particle size distributions, Mie theory has to be applied. Alternatively, a conversion to 
volume-weighted (proportional to d
3
) or number-weighted (proportional to d) size 
distribution is accessible to gain more accurate information.  
2.3 Zeta Potential Measurement 
Zeta potential, also known as electrokinetic potential, is the electric potential difference 
between the bulk fluid and the stationary layer of fluid adhered to the dispersed particle.
13
 
Zeta potential is positive if the potential increases from the bulk liquid phase towards the 
surface of the particle.
13
 This potential difference is also responsible for the electrokinetic 
phenomena of the particles.
14
 Particles in aqueous suspension often carry surface charges 
owing to the ionization of their surface groups, differential loss of ions from the particles, or 
adsorption of charged substances. The strength of the surface charge affects the distribution 
of ions in the surrounding solution, generating a counter ion double layer around the surface 
of the particle (Figure 2.3).
15
 The electric double layer consists of a dense inner layer (Stern 
layer) of bound ions and a slipping outer layer where the ions are more diffusive. While the 
surface-charged particle is undergoing a Brownian motion in the dispersing medium, the 
adhered electrical double layer moves accordingly. The potential at the interface between the 
drifting electrical double layer and the bulk medium is referred to as zeta potential. 
𝐼 = 𝐼0
1 + cos2 𝜃
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Figure 2.3 Scheme of the electric double layer surrounding a dispersed particle carrying 
negative surface charge and the corresponding potentials on the boundaries of different 
layers.
15
  
The zeta potential of particles is often highly dependent on the pH value of the dispersing 
solution that causes the protonation or deprotonation of the surface groups of the particles. 
Zeta potential is determined by measuring the electrophoretic mobility of particles in solution 
under an applied external electric field. By applying the Henry equation (Eq. 2.5), zeta 
potential can be calculated. As can be seen from the equation, the electrophoretic mobility of 
the particles not only depends on the zeta potential of the particles but also depends on the 
strength of the external electric field, the dielectric constant and the viscosity of the solution.  
                                            
(Eq. 2.5) 
Equation 2.5 Henry equation. UE: electrophoretic mobility, ε: dielectric constant of the 
sample, ζ: zeta potential, f(ka): Henry function, η: viscosity of the solution. 
𝑈𝐸 =
2𝜀𝜁𝑓(𝜅𝑎)
3𝜂
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For a zeta potential measurement, an electric field with known strength is applied to a 
capillary cell containing the particle suspension. The electrophoretic mobility of dispersed 
particles is obtained by measuring the particles’ velocity with Laser Doppler Velocimetry 
(LDV).
16
 When a laser beam strikes the sample, the scattering light from the moving particles 
interferes with a reference beam thereby causing a fluctuating signal due to the Doppler shift. 
The frequency shift of the fluctuating signal is used to determine the velocity of the drifting 
particles. The Henry function f(ka) measures the ratio of the particle radius to the electrical 
double layer thickness. For particles larger than 200 nm, a Smoluchowski approximation 
(f(ka) = 1.5) is applied. In this case, an aqueous solution with moderate electrolyte 
concentration is suitable for the measurement. For particles smaller than 200 nm, a Huckel 
approximation (f(ka) = 1.0) is fitting well. In this case, using a low dielectric constant solvent 
(e.g., non-aqueous medium) is suggested for the measurement. 
2.4 Infrared (IR) and Raman Spectroscopy  
Infrared (IR) and Raman spectroscopy are two common methods that can be used to identify 
the chemical bonding of molecules in a compound. The chemical bonding information of the 
functional groups is obtained by characterizing the vibrational modes in the system. For IR 
spectroscopy, the radiation in the mid-infrared (200 – 4000 cm-1) is mostly used to induce a 
vibrational excitation of the covalently bonded molecules and the intensity of the transmitted 
or scattered light from the samples are collected.
17
 Molecules undergo various vibrational 
motions such as stretching, bending, twisting, etc. when provided with energy. When the 
energy of the incident radiation matches energy differences of the vibrational states of the 
molecule, an absorption spectrum can be observed. An interferometer is used for the IR 
spectroscopy measurement and the resulting Fourier transformed frequency-dependent 
spectrum provides a fingerprint map which is used to identify the vibrational bands of 
specific functional groups.
18
  
For Raman spectroscopy, monochromatic light (usually generated from a laser in the visible, 
near infrared or near ultraviolet range) is applied for the measurement. The introduced 
electromagnetic radiation interacts with the electron clouds around chemical bonds and the 
resulting inelastic scattering is collected. Typically, when a sample is illuminated by 
electromagnetic radiation, most of the incident light is scattered and released without 
changing frequency, i.e. Rayleigh scattering (Figure 2.4). In Raman spectroscopy 
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measurements, the elastic Rayleigh scattering is filtered out and the inelastic scattering is 
detected. The inelastically scattered photon will either shift to a lower frequency (Stokes shift) 
or towards higher frequency (anti-Stokes shift) depending on the vibrational state of the 
excited molecules (Figure 2.4). The photon energy shifting indicates the vibrational modes of 
the chemical bonds in the system. Therefore the characteristics of the functional groups are 
obtained. 
 
Figure 2.4 Energy level diagram showing the scattering processes involved in Raman 
spectroscopy. 
Since IR and Raman spectroscopy rely on different physical processes, the general selection 
rules for observable vibrational states are different, but complementary. For IR-active 
samples, the dipole moment of the molecules has to change during the vibration. For Raman-
active samples, the polarizability of the chemical bonds in the sample has to change during 
vibration. 
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2.5 UV-Vis Spectroscopy 
Ultraviolet and visible (UV-Vis) absorption spectroscopy is widely used in analytical 
chemistry for quantitative (e.g., determination of protein concentration) or qualitative (e.g., 
detection of functional groups) analysis of samples.
17,18
 The analyte is irradiated by 
electromagnetic waves in the ultraviolet and visible range, and the attenuation of the incident 
light caused by absorption is measured. Photon energy in the UV-Vis range is able to excite 
the valence electrons from the ground state to an excited electronic state. When the photon 
energy of the incident light corresponds to the electronic transition energy, light absorption 
occurs at this specific wavelength. When the investigated substance is dispersed in solution, 
the concentration of the investigated substance (light absorbing species) can be quantified via 
the Beer-Lambert Law (Eq. 2.6) when measuring the sample in a fixed path length cell. 
                                            
(Eq. 2.6) 
Equation 2.6 Beer-Lambert Law. A: absorbance, I0: intensity of incident light, I: intensity 
of transmitted light, ε: molar extinction coefficient of the analyte, l: path length.  
2.6 Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis (TGA) measures the mass loss of a material with respect to 
increasing temperature.
19,20
 In this study, TGA is used to determine the content of organic 
functional groups in the mesoporous silica framework. The sample is heated up to 900 ºC 
with a constant heating rate in a furnace, and a constant gas flow consisting of inert gas or 
synthetic air is applied to remove the combusted or desorbed components from the sample. 
The mass loss of the sample is measured by a sensitive thermobalance during the heating 
process. The resulting decomposition pattern (mass loss as a function of temperature) 
provides information on the amount of the organic functional groups as well as the 
temperature stability of the investigated sample.  
 
 
 
𝐴 = 𝑙𝑜𝑔
𝐼0
𝐼
= 𝜀 ∙ 𝑐 ∙ 𝑙 
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2.7 X-ray Diffraction (XRD) 
X-rays are a form of electromagnetic radiation that has a wavelength in the range of 0.01 to 
10 nm. X-rays carry high photon energy (100 eV to 100 keV) and are capable of ionizing 
atoms, disrupting molecular bonds and passing through many materials without being much 
absorbed or scattered. X-rays are generated whenever highly energetic charged particles 
(electrons or ions) strike matter. In X-ray crystallography, usually a metal like copper or 
tungsten is used as the target to generate X-rays.
18,21,22
 An electron beam is produced by 
heating a metal filament (the cathode) while applying a high voltage in the vacuum tube to 
accelerate the electrons towards the metal target. During the collision, some electrons 
approach the nucleus of the metal atom due to the attraction between positive protons and 
negative electrons and then the electrons are deflected by the strong electric field near the 
nucleus. The deflection causes energy loss of the electrons where a small portion of the lost 
energy is emitted as X-rays in a continuous spectrum (Bremsstrahlung). On the other hand, 
some electrons with high energy can knock out an orbital electron from the inner electron 
shell of the metal atom resulting in an electron vacancy. Electrons from higher energy levels 
then drop to the vacancy thereafter producing a series of discrete X-rays. The discrete X-ray 
spectrum is corresponding to the electronic transition energies of the targeted metal (the 
anode) and thus called characteristic radiation. Copper is one of the most common materials 
used as an anode because it gives a wavelength suitable for many diffraction experiments. 
When using copper as an anode, the characteristic wavelength (Cu-K) is 1.54182 Å. 
Typically, monochromatic X-rays are used in an X-ray diffraction measurement. This can be 
achieved by introducing monochromators or blocking filters.
18
 
The monochromatic X-ray from the characteristic radiation has a wavelength in the Ångstrøm 
range, which is at the same order of magnitude as the distance of atoms in a solid material. 
When a solid sample is irradiated with X-rays, the radiation is scattered by the atoms of the 
investigated sample. If the sample contains regular structures, the scattered X-ray will 
experience constructive and destructive interference. This process is called diffraction (Figure 
2.5).   
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Figure 2.5 Illustration of the X-ray diffraction in a crystalline material. 
The diffraction pattern can be used to identify and characterize the crystalline structure of a 
material while the lattice distance of the material can be calculated using Bragg’s law (Eq. 
2.7). 
                                                             (Eq. 2.7) 
Equation 2.7 Bragg’s law. n: order of interference, : wavelength of incident X-rays, d: 
lattice spacing, : angle of incidence. 
In this study, X-ray diffraction was applied to characterize the ordered mesostructure of the 
MSNs where the ordered mesopores define the lattice planes of the sample. The X-ray 
scattering was performed in small angles (2 = 0.1 – 10°).   
  
𝑛𝜆 = 2dsin𝜃 
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2.8 Fluorescence Spectroscopy 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy used to measure the 
fluorescence of a sample. Some molecules, usually containing several combined aromatic 
groups or heterocycles with several  bonds, are able to absorb light energy of a specific 
wavelength in the UV or visible spectrum and re-emit light at a longer wavelength.
23,24
 This 
process is referred to as fluorescence, which is also a form of photoluminescence. The 
mechanism of fluorescence can be clarified in a Jablonski diagram (Figure 2.6).  
Generally, fluorescence undergoes three main processes: excitation, non-radiative relaxation 
and fluorescence emission. An incident light (generated by an incandescent lamp or a laser 
source) carrying photon energy hvex firstly hits the fluorescent material, and triggers an 
excitation of electrons from the ground state (S0) to an excited state (S1: the first, S2: the 
second excited singlet energy states). The excited molecules subsequently undergo 
vibrational relaxation upon collision with their environment and typically drop to the 
vibrational ground state of the electronic excited state. Ultimately, the electrons fall back to 
the ground state (S0), meanwhile releasing photon energy hvem that yields fluorescence 
emission. The released photon has a lower energy than the absorbed photon due to the 
vibrational relaxation of the electrons in the excited state. Therefore the fluorescence 
emission features a red-shift compared to the incident light. 
 
Figure 2.6 Jablonski diagram for the interpretation of fluorescence process.  
47 
 
Besides fluorescence emission, other electronic relaxation pathways such as quenching, 
fluorescence energy transfer, intersystem crossing (resulting in phosphorescence or delayed 
fluorescence) and non-radiative relaxation (energy dissipates in the form of heat) may also 
occur. 
2.9 Electron Microscopy  
Microscopes are instruments used to observe small objects or the microscopic structure of a 
material. The technique of using such an instrument to investigate a sample is called 
microscopy. Conventional optical microscopes using visible light (wavelength: 400 – 800 nm) 
for specimen illumination have a resolution limit in the range of 200 nm. Electron 
microscopes using a beam of highly accelerated electrons as illumination source are able to 
achieve high resolution images down to 0.05 – 0.1 nm, due to the shorter wavelength of the 
electron beam.
14
 This powerful technique can be used to characterize the structure of a 
material down to an atomic level, and is important for studies in nanotechnology. In a typical 
electron microscope the electrons are generated by a tungsten filament or a field emission gun 
and the emitted electrons are accelerated by a potential difference. Electrostatic and/or 
electromagnetic lenses are used to focus either the emitted electron beam on the investigated 
specimen or the transmitted electrons to form a magnified image. When the highly 
accelerated electrons hit matter, the electrons follow different pathways or undergo different 
conversions
25
 (Figure 2.7), for example, they transmit through the matter or they are scattered 
followed by energy loss. These various types of signals can be collected. The electron 
micrographs are then produced using a specialized digital camera and a frame grabber to 
capture the image. In order to reach high-resolution images, electron microscopes generally 
work under high vacuum conditions to avoid beam attenuation caused by electron collision 
with gas molecules. In general, electron microscopes can be classified into two major types: 
transmission electron microscopes and scanning electron microscopes, depending on the 
electron beam probing approach and the signal types being collected. 
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Figure 2.7 Schematic representation of electron beam interactions with matter and the 
corresponding scattering pathways. 
2.9.1 Transmission Electron Microscopy (TEM) 
The transmission electron microscope (Figure 2.8) is the original form of an electron 
microscope. The highly accelerated electron beam (40 to 400 keV) serving as an illumination 
source enables the imaging in high resolution down to an atomic level, where the wavelength 
of the electron beam is related to the accelerating voltage U (Eq. 2.8).
25
 Typically, the 
accelerating voltages between 80 kV and 200 kV are used in TEM where the wavelength 
produced under this voltage corresponds to 0.15 Å and 0.0251 Å, respectively. 
                             
(Eq. 2.8) 
Equation 2.8 The relation between the wavelength of an electron beam with its 
accelerating voltage.
26
 : wavelength of electrons, h: Planck constant, c: speed of light, m0: 
mass of electron, e: elementary charge of an electron, U: accelerating voltage. 
𝜆 =
ℎ𝑐
  2𝑚0𝐸  1 +
𝐸
2𝑚0𝑐2
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Figure 2.8 Scheme of a transmission electron microscope.
27
 
When the accelerated electron beam hits the specimen, a fraction of the electrons is 
transmitted through the specimen. The transmitted electrons are further focused by the 
electromagnetic lenses and the magnified electron image of the sample is then projected onto 
a phosphor-coated fluorescent viewing screen or a CCD (charge-coupled device) camera. The 
transmitted electrons carry the structure information such as crystallography, defects, spatial 
variation and composition of the investigated sample. In order to allow the electrons to pass 
through, the specimens for TEM analysis should be very thin (typically < 100 nm).   
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2.9.2 Scanning Electron Microscopy (SEM) 
In scanning electron microscopy (SEM), the specimen is probed by a focused electron beam 
scanning across a certain area (raster scanning) on the surface of the specimen.
28
 When the 
highly energetic electrons impinge the probing material, a portion of electrons transmits 
through the material while the other portions are scattered, accompanied by some energy loss. 
The energy loss of the electrons is converted into various forms such as heat, backscattered 
electrons, secondary electrons, and X-rays, all of which provide signals that carry the surface 
topography and composition information about the investigated material. In most of the 
SEMs, the secondary electrons emitted by the electron beam-excited atoms are collected and 
used to construct the final image. A schematic representation of a SEM setup is shown in 
Figure 2.9.  
 
Figure 2.9 Scheme of a scanning electron microscope setup.
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The accelerating voltage in SEMs is about 0.2 – 40 kV, which is lower than the accelerating 
voltage in TEM, hence the magnification of SEM is generally lower than that of TEMs. 
Nevertheless, owing to the surface probing mechanism, SEM is able to image bulk samples 
up to the size of many centimeters and create a great depth of field that results in a three-
dimensional image of the sample. SEM offers great good flexibility in the operating 
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conditions: the specimen can be investigated in high or low vacuum, in wet condition 
(environmental SEM), and at cryogenic or elevated temperatures. The specimen for SEM 
imaging should be somewhat electrically conductive on the surface to avoid the accumulation 
of electrostatic charge that causes scanning faults or image artifacts when using secondary 
electron detection mode. Non-conductive materials are usually surface-coated with an 
ultrathin electrically conducting film, for example Au or C, before performing SEM. 
Alternatively, non-conductive specimens without surface coating can be imaged using 
environmental SEM or a low-voltage mode of operation.   
2.9.3 Scanning Transmission Electron Microscopy (STEM) 
Scanning transmission electron microscopy (STEM) combines the working principles of 
SEM and TEM, and can be performed on either type of the above-mentioned instruments.
30
 
In STEM, the electron beam is highly focused into a small area and is scanned over the 
specimen, resembling the SEM operation. After probing the sample, the transmitted electrons 
are collected to produce a variety of transmission images such as brightfield images. Due to 
the interactions of the sample with the highly focused electron beam, some of the transmitted 
electrons are inelastically scattered. In classical STEM, few electrons emerging from the 
sample are being collected, resulting in low signal collection efficiency. Alternatively, using 
high angle annular dark field (HAADF) detectors to collect the transmitted beam electrons 
that are elastically scattered through a higher angle provide much better image contrast and 
higher resolution. Since the detected signal consists of the transmitted electrons, the specimen 
for STEM observation must be thin but can be thicker than the sample for TEM observation. 
STEM can also be carried out by adding transmission detectors to a scanning electron 
microscope. However, this approach limits the accelerating voltage of the electron beam to 
around 30 keV. Another option to carry out STEM is adding scanning coils to a transmission 
electron microscope. In addition to avoiding some of the imaging artefacts associated with 
TEM, the STEM mode also allows for spectroscopic analysis of samples at the nanoscale.  
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2.10 Confocal Microscopy 
Confocal microscopy is an optical imaging technique that is widely used in life sciences for 
subcellular structure visualization as well as in materials science for surface analysis.
31
 
Confocal microscopy features better optical resolution and contrast than the conventional 
widefield optical microscopy and is able to collect serial optical sections from thick 
specimens to reconstruct a three-dimensional image. In conventional widefield optical 
microscopy, the light stream used to excite fluorophores illuminates a large area of the 
investigated sample (Figure 2.10(a)). The fluorescence generated by the sample from the out-
of-focus region often interferes with the resolution of in-focus features. As the thickness of 
the specimen increases, the interference becomes more intense, therefore the resolution 
becomes worse. Confocal microscopy addresses the problem of the emission interference by 
adding a set of pinholes on the confocal plane of the lens to eliminate the out-of-focus light 
and thus improve the imaging resolution and contrast. The principal of light pathways in 
confocal microscopy is illustrated in Figure 2.11.    
 
Figure 2.10 Scheme of the illumination pattern of (a) conventional widefield microscopy, 
(b) laser scanning confocal microscopy and (c) spinning disc confocal microscopy.
32
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Figure 2.11 The principle of confocal microscopy.
33
 
A typical confocal microscope contains a set of light sources, a dichroic mirror, filters, 
objective lenses, a set of pinholes, a specimen stage and a photomultiplier detector. A light 
beam generated from the light source first passes through a pinhole aperture followed by a 
filter which selects the wavelength used to excite the fluorophores in the specimen. The light 
is subsequently reflected by a dichroic mirror and focused on a specimen through an 
objective lens. The excited fluorophores in the specimen then emit fluorescence that is 
collected by the objective, filtered by a dichroic mirror and filter, and then passes through 
another pinhole aperture before reaching the detector. The second pinhole placed on the focal 
plane selects only the fluorescence emitted from the focus point. The surface of the sample is 
scanned by either moving the specimen stage or the light beam. By imaging serial sections 
from different heights, a three-dimensional reconstitutive image can be obtained.   
The most common types of confocal microscopes are laser scanning confocal microscope and 
spinning disc confocal microscope. As illustrated in Figure 2.10(b), the laser beam in laser 
scanning confocal microscopy is focused on the sample in a single point and scans the sample 
point by point in a raster pattern. The signal is detected sequentially from each scanning point 
by a photomultiplier detector until the entire image is assembled. To reach a high-resolution 
image, many scanning points are required, thus a longer time is needed for creating an image 
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as compared to widefield microscopy. This leads to a time error in observing dynamic 
samples. Spinning disc confocal microscopy overcomes this problem by utilizing multiple 
pinholes or slits to project a series of parallel excitation light beams on the specimen in 
multiple points simultaneously (Figure 2.10(c)). The fluorescence emitted from the specimen 
passes through the same pinholes or slits, and the signal is subsequently collected. Spinning 
disc confocal microscopy generates a parallel area-array image, such that the specimen can be 
adequately illuminated with lower excitation intensity, and therefore the photobleaching and 
phototoxicity are reduced accordingly. This technique is highly suitable for live cell imaging. 
In this study, all the live cell images were recorded via spinning disc confocal microscopy. 
Figure 2.12 shows a schematic representation of the spinning disc confocal microscope 
configuration. 
 
Figure 2.12 Spinning disc confocal microscope configuration.
34
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3 Synthesis and Functionalization of Ordered Large-Pore 
Mesoporous Silica Nanoparticles for Biomedical Applications  
This chapter is based on the following publication: 
Hsin-Yi Chiu, Heinrich Leonhardt and Thomas Bein, Chemie Ingenieur Technik 2017, 89, 
876-886.  
Dedicated to Prof. Dr. Wilhelm Schwieger on the occasion of his 65
th
 birthday 
Abstract 
A dual surfactant synthetic approach was employed for the synthesis of large-pore 
mesoporous silica nanoparticles (MSNs). The as-synthesized mesoporous silica exhibited not 
only 2D hexagonal mesostructure with an average pore size of about 7 nm but also a 
spherical nanoparticulate morphology. A delayed co-condensation synthesis method was 
further employed to create site-specific core-shell bifunctional MSNs. These core-shell large-
pore MSNs are biocompatible and can be efficiently taken up by cells. They are therefore 
promising nanocarriers for cellular delivery purposes. 
3.1 Introduction 
Periodically ordered mesoporous silicas containing high surface area, large pore volume, and 
stable silica frameworks offer a good platform for adsorbing or hosting guest molecules and 
therefore are therefore widely used in separation, catalysis, and sensing.
1-4
 MCM-41 (Mobile 
Composition of Matter No. 41) discovered by Kresge et. al.
5
 and SBA-15 (Santa Barbara 
Amorphous No. 15) discovered by Stucky et. al.
6
 are two leading mesoporous silica materials 
used in the above-mentioned research fields. They both feature highly ordered 2D hexagonal 
mesostructures as well as narrow pore size distributions that are accessible for mass transfer 
of guest molecules and evaluation of cargo uptake and release kinetics.
7-9
 In 2003 a 
pioneering study described the synthesis of MCM-41-type mesoporous silica nanoparticles 
(MSNs) as a nanocarrier system.
10
 In this study, Lin and co-workers also addressed the 
possibility of functionalizing the 200-nm sized mesoporous silica particles with a stimuli-
responsive gatekeeper for the controlled release of drug molecules and neurotransmitters in 
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cells. Since then, the study of MSNs in biomedical applications has seen enormous growth. 
Apart from small drug molecules, a variety of biomolecules ranging from small-sized amino 
acids
11
 to massive proteins,
12,13
 oligonucleotides
14
 and plasmid DNAs
15
 were loaded into the 
pores or adsorbed on the external surfaces of MCM-41-type MSNs for drug and gene 
delivery purposes. However, these MCM-41-type MSNs containing an organized pore 
structure exhibit pore size limitations up to 6 nm.
16
 
In contrast, SBA-15-type mesoporous silica materials templated by the non-ionic triblock co-
polymer P123 or related copolymers exhibit large pore dimensions (ranging from 5 – 30 nm), 
thick walls (about 3 – 5 nm)17 and thermally stable frameworks that make them suitable for 
the encapsulation of biomolecules larger than 6 nm. Their rigid and stable silica frameworks 
provide better protection of cargos from denaturation in critical environments than MCM-41-
type silica materials.
18
 However, a major limitation of these SBA-15-type materials resides in 
their bulky particle sizes, which can restrict their use in intracellular delivery.  
In 2004 Ying et. al
19
. introduced the cationic fluorinated surfactant FC-4 to the nonionic 
triblock copolymer-templated mesoporous silica synthesis processes, where they obtained 
nanosized (50 – 300 nm) particles exhibiting various mesostructures including 3D cubic, 2D 
hexagonal, foamlike and disordered pores depending on the type of triblock copolymer used, 
and tunable pore sizes in the range of 5 – 30 nm. They proposed that the fluorocarbon 
surfactant acted as particle growth limiting agent to confine the particle sizes, whereas the 
triblock copolymers served as structure-directing templates to enable ordered mesostructure 
formation. For the first time, this work demonstrated the preparation of large, ordered 
mesostructured SBA-15-type silica particles with well-defined particle sizes (< 300 nm) 
suitable for drug delivery applications. Following up on this work, several research groups 
have adopted this fluorocarbon-mediated synthetic strategy to generate large-pore 
mesoporous silica nanoparticles containing ordered mesopores, and further functionalized 
their surfaces for encapsulation or delivery of large biomolecules.
20-23
 For example, Gao et. 
al.
20
 synthesized large, cubic mesostructured MSNs (with pore size around 17 nm and 
particle size in the range of 70 – 300 nm) templated by Pluronic F127 at low temperature 
(10 °C) and further post-synthetically grafted amino groups on the surface of the MSNs for 
plasmid DNA packaging. They demonstrated the large-pore MSNs to be capable of 
protecting DNA from degradation in the presence of enzymes in buffer. Qiao and coworkers 
grafted poly-L-lysine on the surface of similar MSNs (particle size about 100 – 200 nm) 
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containing a large pore (20 nm), cubic mesostructure for siRNA delivery in osteosarcoma 
cancer cells.
21
 Yu et al.
22
 introduced ethanol and KCl into a synthesis templated by Pluronic 
P123 and obtained highly ordered, bicontinuous cubic mesostructured large pore MSNs. 
After surface modification with octadecyl groups, they showed successful siRNA delivery 
into human colon cancer cells (HCT-116) with significant cell proliferation suppression. Kros 
and co-workers
23
 incorporated trimethylbenzene (TMB) into a Pluronic P123 templated silica 
synthesis which resulted in 10 nm-wide mesochannels in cuboidal-like nanoparticles 
90 ± 20 nm in length and 43 ± 7 nm in width. They modified the surfaces of these 
nanoparticles with amino groups and demonstrated that they enable the rapid encapsulation 
and release of several model proteins. All these studies indicate that using FC-4 in the 
triblock copolymer templated synthesis under mild acidic condition resulted in nanosized 
large-pore mesoporous silica particles. Furthermore, they also revealed that molecular surface 
modification of the MSNs can be an important factor for accommodating certain 
biomolecules in the mesopores.  
In this study, the fluorocarbon surfactant-mediated synthesis approach for the preparation of 
ordered, large-pore mesoporous silica particles with nanoparticulate morphology having a 
particle size about 100 – 200 nm was used. The as-synthesized mesoporous silica 
nanoparticles templated by Pluronic P123 exhibit 2D hexagonal mesopores with an average 
pore size of 7 nm and a wall thickness of about 3 nm, which resembles the mesostructure of 
SBA-15-type materials. Various contents of thiol groups were incorporated into the silica 
framework via a co-condensation synthesis procedure. The impact of thiol content in the 
silica co-condensation process on the final mesostructure morphology was also studied. 
Further, core-shell bifunctional SBA-15-like MSNs were synthesized using a delayed co-
condensation method. By applying two hydrothermal treatment steps, these core-shell MSNs 
retained ordered mesopores (2D hexagonal) and large pore size (8 nm).  
To evaluate the potential uses of these SBA-15-like MSNs in cellular delivery, polyethylene 
glycol (PEG) was attached to their external surface to enhance their colloidal stability and 
fluorescence dyes were grafted on the internal surface for microscopic tracking. The 
interaction of the multifunctional SBA-15-like MSNs with cells was also examined. The 
results indicate that the PEGylated SBA-15-like MSNs were efficiently taken up by HeLa 
cells and that they showed good biocompatibility up to the concentration of 200 g/ml. Using 
high-content optical microscopy, it was possible to quantify the cellular uptake efficiency of 
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the MSNs, being up to 98% after incubating HeLa cells with the MSNs for 24 h. Furthermore, 
the endosomal-binding protein RhoB (Ras homolog family member B
24,25
) was genetically 
encoded and conjugating with the fluorescent protein mCherry to HeLa cells for late 
endosome visualization. Using confocal microscopy, the co-localization of multifunctional 
MSNs and RhoB-labeled late endosomes could be tracked. Interestingly, it was found that 
most of the SBA-15-like MSNs were not co-localized with the RhoB-labeled late endosomes.   
3.2 Results and Discussion 
Synthesis of un-functionalized SBA-15 MSNs 
The MSNs we synthesized here exhibit features (mesostructured, pore size and wall thickness) 
similar to the typical SBA-15 materials; accordingly, these MSNs were named SBA-15 
MSNs. The SBA-15 MSNs were synthesized using 0.25 g of P123, 0.35 g of FC-4 and 1 g of 
TEOS in 40 ml of 0.02 M HCl at room temperature for 24 h, followed by a hydrothermal 
treatment at 140 °C for further 24 h. The as-synthesized powder was then template extracted, 
washed with ethanol and water, and re-dispersed in ethanol. After filtering out bulk 
precipitates, spherical particles with a size of about 100 nm remaining in the suspension can 
be observed in transmission and scanning electron microscopy (Figure 3-1a - b). Dynamic 
light scattering (DLS) (Figure 3-1c) indicated the hydrodynamic diameter of the particles in 
ethanol suspension to be around 150 nm. The X-ray diffraction data of the sample powder 
(Figure 3-1d) show three reflections indexed as (100), (110) and (200), which is associated 
with a 2D hexagonal mesostructure where the spacing between each pore center a0 
(calculated from the d(100) spacing, Table 3-1) is about 11 nm. This well-ordered pore 
structure can be further confirmed by the TEM image in Figure 1a. Nitrogen sorption analysis 
of the sample powder showed a type IV isotherm (Figure 3-1e) and a BET specific surface 
area of 185 m
2
/g. The pore size distribution calculated via a NLDFT equilibrium model 
resulted in an average pore size of 7 nm (Figure 3-1f).  
61 
 
 
Figure 3-1. Characterization of the un-functionalized SBA-15 MSNs. (a) TEM. (b) SEM, 
and (c) hydrodynamic particle size measured by DLS. Filtrated particles were measured in 
ethanol suspension. (d) XRD pattern. The reflections are attributed to the hexagonal pore 
structure of the SBA-15 MSNs. (e) N2 sorption isotherm. (f) N2 sorption pore size distribution 
calculated according to the NLDFT equilibrium model. 
According to the pore spacing a0 and the average pore size measured by N2 sorption, we 
estimate the wall thickness of the MSNs to be about 4 nm. The pore dimension (7 nm) of the 
as-synthesized SBA-15 MSNs is sufficient for adsorbing a large variety of important 
biomolecules.
1,2
 The narrow pore size distribution of the nanoparticles can also be favorable 
for adsorbing enzymes possessing a comparable size, as there appears to be evidence 
indicating that mesopores matching the size of encapsulated enzymes can enhance enzyme 
activity compared to hosts with pore sizes larger than the enzyme.
26-29
 In addition, 2D 
hexagonal pore systems confined in small particles result in short channel lengths, thus 
facilitating mass transfer in the mesostructure that can be favorable for immobilizing and 
releasing proteins.
23,30
 
 
 
62 
 
Table 3-1 Detailed characterization information of the SBA-15 MSNs.  
SH content in MSNs 
(mol %) 
Particle 
size
a
 (nm) 
XRD 2b 
(°) 
a0
c
 (nm) 
Pore size 
(nm) 
BET Surface 
area (m
2
/g) 
Pore volume
d
 
(cm
3
/g) 
0 (pure silica) 138 0.91 11.2 7 185 0.38 
2  195 0.95 10.7 6.6 297 0.42 
5  253 0.98 10.4 6 249 0.31 
7  276 1 10.2 6 421 0.57 
10  293 0.98 10.4 5.4 453 0.53 
a
 Filtrated samples were measured by DLS in ethanol suspension. 
b
 Referring to (1 0 0) reflection. 
c
 a0: spacing between each pore center, calculated based on the formula:     
d
 Calculated from p/p0 = 0.99. 
 
Synthesis of thiol-functionalized SBA-15 MSNs 
Thiol groups are widely used in cross-linking chemistry and can be easily applied for surface 
modifications. Hence, integrating thiol groups into the silica framework can enable further 
surface modifications of the MSNs. Here thiol-functionalized SBA-15 MSNs were 
synthesized via a co-condensation method. Various thiol contents were incorporated into the 
silica framework, and the as-synthesized thiol-functionalized SBA-15 MSNs were 
subsequently characterized (Table 3-1). According to the corresponding TEM micrographs 
(Figure 3-2a), all the thiol-functionalized SBA-15 MSNs exhibit spherical shapes and regular 
pore structures. However, as the thiol content increases, the 2D hexagonal porous structure 
becomes more irregular, which is also illustrated in the X-ray diffraction data (appendix 
Figure 3-6).  
𝑎0 = 𝑑100 ×
2
 3
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Figure 3-2. Characterization of the thiol-functionalized SBA-15 MSNs. (a) TEM images, 
(b) N2 sorption isotherms, and (c) NLDFT pore size distributions. (d) Thermogravimetric 
analysis. 
All the thiol-functionalized SBA-15 MSNs present type IV nitrogen sorption isotherms 
(Figure 3-2b) and have BET specific surface areas in the range of 200 – 500 m2/g (Table 3-1). 
Confirming the pore structure changes observed in the TEM images and the XRD data, the 
average pore size decreased from 7 nm to 5 nm when the thiol content in the MSNs increased 
from 0 mol% to 10 mol% (Figure 3-2c). The successful co-condensation of thiol groups into 
the silica framework can be observed with Raman spectroscopy, with an S-H vibration 
occurring at 2585 cm
-1 
(appendix Figure 3-7). The thermogravimetric analysis (TGA) of the 
mass loss of each sample correlates with the increasing thiol content in the silica framework 
(Figure 3-2d). Notably, the filtrated thiol-functionalized SBA-15 MSNs are smaller than 300 
nm (Table 3-1), which suggests applications in drug delivery. 
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Synthesis of core-shell bifunctional SBA-15 MSNs 
Following the successful co-condensation synthesis of thiol-functionalized SBA-15 MSNs, a 
delayed co-condensation synthesis method was employed to create site-specific core-shell 
bifunctional SBA-15 MSNs containing 5 mol% of SH groups in the core and 1 mol% of NH2 
groups on the external shell. To preserve the small particle size, we increased the amount of 
the particle growth inhibitor FC-4 from 0.35 g (for un-functionalized SBA-15 MSN synthesis) 
to 0.5 g for the synthesis of core-shell bifunctional SBA-15 MSNs. A second hydrothermal 
treatment in a 2 M HCl solution was employed in the synthesis process for pore expansion in 
order to balance the pore shrinking from the organosilane co-condensation. As illustrated in 
the TEM images (Figure 3-3a), the coreSH-shellNH2 SBA-15 MSNs present a well-defined 
close to spherical shape with a particle size of around 100 – 200 nm, as well as a highly 
ordered mesostructure. The average hydrodynamic particle size of the filtrated sample 
measured by DLS was about 150 nm (appendix Figure 3-8, Table 3-2). The presence of 
ordered mesopores in the coreSH-shellNH2 SBA-15 MSNs was substantiated by X-ray 
diffraction (Figure 3-3b), where the reflections could be indexed as (100), (110) and (200), 
referring to a 2D hexagonal mesostructure. Nitrogen sorption revealed a type IV isotherm 
(Figure 3-3c) and a BET surface area of 367 m
2
/g (Table 3-2). The pore size distribution 
obtained from the NLDFT equilibrium model showed an average pore size of 7.5 nm (Figure 
3-3d), where the pore expansion effect (compared to the 5 mol% thiol-functionalized 
particles) might be caused by the second hydrothermal treatment in an acidic environment. If 
the average pore size is substracted from the a0 (spacing between each pore center, calculated 
from the XRD d(100) spacing, see Table 2), the wall thickness of the coreSH-shellNH2 SBA-15 
MSNs is estimated to be 3 nm. The thinner wall thickness of the coreSH-shellNH2 SBA-15 
MSNs compared to the un-functionalized and thiol-functionalized samples suggests that the 
second hydrothermal treatment leads to a more condensed silica framework. 
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Figure 3-3. Characterization of the coreSH-shellNH2 bifunctional SBA-15 MSNs. (a) TEM 
images. (b) X-ray diffraction. (c) N2 sorption isotherm. (d) N2 sorption NLDFT pore size 
distribution. (e) Zeta Potential of the un-functionalized, thiol-functionalized, and coreSH-
shellNH2 bifunctional SBA-15 MSNs, respectively.  
The amino-functionalized external surface of the coreSH-shellNH2 SBA-15 MSNs displays a 
significantly higher zeta potential than the un-functionalized and thiol-functionalized SBA-15 
MSNs (Figure 3-3e). Summing up, here the successful synthesis of bifunctional core-shell 
SBA-15 MSNs was demonstrated by applying a delayed co-condensation strategy. These 
coreSH-shellNH2 SBA-15 MSNs offer the possibility to integrate several spatially defined 
molecular surface modifications, which renders them promising multifunctional nanocarriers. 
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Table 3-2. Detailed characterization information of the coreSH-shellNH2 SBA-15 MSNs 
Content of functional 
groups in core-shell MSNs 
Particle 
size
a
 (nm) 
XRD 2b 
(degree) 
a0
c
 (nm) 
Pore size 
(nm) 
Surface 
area (m
2
/g) 
Pore volume
d
 
(cm
3
/g) 
Core: 5 mol% SH 
Shell: 1 mol% NH2 
175 0.96 10.6 7.5 367 0.86 
a
 Filtrated samples were measured by DLS in ethanol suspension. 
b
 Referring to (1 0 0) reflection. 
c
 a0: spacing between each pore center, calculated based on the formula:     
d
 Calculated from p/p0 = 0.99. 
The interaction of the core-shell SBA-15 MSNs with cells 
To investigate the interactions of the core-shell SBA-15 MSNs with cells, hydrophilic 
polyethylene glycol (PEG) was attached on the external surface of the MSNs to enhance their 
colloidal dispersibility, while fluorescence dyes (ATTO 488) were grafted to the core of the 
particles to enable tracking of the particles in confocal microscopy. The coreATTO488-shellPEG 
SBA-15 MSNs were incubated with HeLa-k cells in a culture medium (25 g MSNs in 1 ml 
of cell culture medium) and the endocytosis of the MSNs was tracked by live cell confocal 
microscopy. It was observed that 4 h post particle incubation, the tracked particles were 
internalized by the cells and located near the nucleus in the cytoplasm (Figure 3-4a). In order 
to quantify the cellular uptake efficiency of the MSNs in a large cellular population (up to 10
3
 
cells per investigation), a high content imaging system (Operetta
®
, PerkinElmer) was used for 
the analysis. The MSN-treated (24 h) HeLa-k cells were fixed, DAPI and propidium iodide 
stained, and imaged by means of the high-content microscopy. After image segmentation 
through different fluorescence channels (DAPI for nuclei segmentation, propidium iodide for 
cytoplasm segmentation and ATTO 488 for MSN segmentation), the populations of the cells 
and the MSN-internalizing cells were evaluated (appendix Figure 3-9). The “cell” population 
implies the region containing nucleus and cytoplasm, while each cell that internalized more 
than two particles is referred to as “MSN-internalizing cell” (particles that locate in the cell 
areas were considered as being internalized by the cell). The cellular uptake efficiency was 
evaluated with the equation: 100% × number of the MSN-internalizing cells/number of the 
cells. Based on the evaluation of more than two thousands cells, the quantified cellular uptake 
𝑎0 = 𝑑100 ×
2
 3
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efficiency is 98%. This very high cellular uptake efficiency of the SBA-15 MSNs indicates 
their potential for carrying cargo across the cell membrane. Additionally, both the native 
core-shell MSNs and the PEGylated core-shell MSNs show good biocompatibility up to a 
concentration of 200 g/ml (the value of IC50) in the MTT assay (Figure 3-4b). 
 
Figure 3-4. Live cell imaging for cellular uptake tracking and cytotoxicity analysis of 
HeLa cells with respect to the core-shell SBA-15 MSNs. (a) The coreATTO488-shellPEG SBA-
15 MSNs (green dots) were internalized by HeLa cells after 4 h incubation. (b) MTT assay 
for cytotoxicity analysis after 24 h incubation of MSNs with HeLa cells. MSN: coreSH-
shellNH2 SBA-15 MSNs, MSN-PEG: coreSH-shellPEG SBA-15 MSNs.  
Endosomal trapping of internalized nanoparticles is a major barrier for cellular delivery of 
membrane impermeable cargos. To investigate whether the internalized SBA-15 MSNs are 
trapped in endosomes or not, a plasmid was constructed that expresses an endosomal-
localization protein – RhoB fused with red fluorescence protein mCherry – to genetically 
label the endosomes in HeLa-k cells and thereby being able to track the endosome locations 
in the cytoplasm. RhoB is a member of the GTPase family that was found to localize on the 
membrane of late endosomes, controlling cytokine trafficking and cell survival 
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regulation.
24,25
 24 h after transfection with plasmid pCAG-mCherry-hRhoB-IB, the 
coreATTO488-shellPEG SBA-15 MSNs were incubated with the endosome-labeled HeLa-k cells 
in the culture medium. After 24 h, the cells were washed, fixed, membrane-permeabilized, 
stained with DAPI and subsequently imaged by confocal microscopy.  
 
Figure 3-5. A 3D stacking confocal image of the MSN-internalized HeLa cells. (a) Top-
view of the image. (b)-(f) Different view angles of the image in (a) in the sequence of z 
direction (blue arrow in the images) rotation. White grid in the background: 1 unit = 51.4 m. 
Blue: DAPI stained nuclei, red: RhoB-mCherry-labeled late endosomes, green: coreATTO488-
shellPEG SBA-15 MSNs. 
Figure 3-5 illustrates a sequence of 3D stacking images (rotating along the z-axis) of the cells 
that have internalized SBA-15 MSNs. The images show that the SBA-15 MSNs (green) are 
located around the nucleus but that they are not co-localized with the RhoB-mCherry labeled 
late endosomes (red). In early studies of the endosomal escape of nanoparticles, researchers 
concluded that non-co-localization of particles and endosomes can serve as an indication for 
the endosomal escape of the particles.
13,31-33
 However, in the present study no endosomal 
escape agents were incorporated in the functional SBA-15 MSNs. Also, the RhoB-containing 
endosomes do not represent all vesicles in the cells. These findings warrant further studies 
into the endosomal escape mechanisms operating with our core-shell mesoporous silica 
nanoparticles.  
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3.3 Conclusion 
In this study, SBA-15-like mesoporous silica nanoparticles containing well-ordered 2D 
hexagonal mesopores and a small particle size around 100 – 200 nm were successfully 
synthesized by adopting the FC-4 and P123 co-surfactant synthesis strategy. An efficient co-
condensation synthesis was established to functionalize the nanoparticles with organic groups, 
and the method was further developed towards to a delayed co-condensation synthesis 
yielding spatially defined, core-shell bifunctional SBA-15 MSNs. The as-synthesized MSNs 
feature pore dimensions (around 7 nm) that are sufficient for the encapsulation of various 
biomolecules, and they could be decorated with multiple surface functionalizations. Their 
interactions with HeLa cells indicated that they are non-cytotoxic up to a concentration of 
200 g/ml, and that they can be efficiently taken up by the cells (cellular uptake efficiency is 
98% after 24 h of particle incubation). Concluding, we view these multifunctional SBA-15 
MSNs to be promising candidates for drug delivery vehicles and as nanocarriers for research 
on cellular delivery. 
3.4 Experimental 
Materials 
Pluronic P123 (P123, BASF), fluorocarbon surfactant FC-4 (FC-4, Yick-Vic Chemicals), 
tetraethyl orthosilicate (TEOS, Aldrich, ≥ 99%), 3-mercaptopropyl triethoxysilane (MPTES, 
ABCR, ≥ 92%), 3-aminopropyl triethoxysilane (APTES, Aldrich, ≥ 98%), oxalic acid 
dihydrate (Sigma), poly(ethylene glycol) bis(amine) (PEG-diamine, Aldrich, Mn = 2000), N-
(3-dimethylaminopropyl)-N-ethylcarbodiimide (EDC, Alfa-Aesar, 98 %), N-
hydroxysulfosuccinimide sodium salt (sulfo-NHS, Aldrich), absolute ethanol (EtOH, Aldrich, 
≥ 99.5%), conc. hydrochloric acid (HCl, Aldrich, 37 wt%), thiazolyl blue tetrazolium 
bromide (MTT, ≥ 97.5%, Sigma), dimethyl sulfoxide (DMSO, Applichem, molecular biology 
grade), Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma), Dulbecco’s Modified 
Eagle’s Medium – phenol red free (Sigma), Dulbecco’s Phosphate Buffered Saline (PBS, 
Sigma), Fetal Bovine Serum (FBS) Superior (Biochrom), gentamycin solution (50 mg/ml, 
SERVA), L-glutamine solution (200 mM, Sigma), HEPES solution (1 M, Sigma). 
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All reagents were used without further purification. Bi-distilled water obtained from a 
Millipore system (Milli-Q Academic A10) was used for all synthesis and washing steps. 2 M 
HCl and 0.02 M HCl were prepared using bi-distilled water and conc. hydrochloric acid. 
Methods 
Synthesis of un-functionalized and thiol-functionalized SBA-15 MSNs 
This synthesis procedure was adapted from a fluorocarbon-surfactant-mediated MSN 
synthesis method previously reported by Ying et al..
19
 In a typical un-functionalized SBA-15 
MSNs synthesis, 0.25 g of P123 and 0.35 g of FC-4 were dissolved in 40 ml of 0.02 M HCl at 
RT followed by the addition of TEOS (1 g, 4.8 mmol). For the co-condensation synthesis of 
thiol-functionalized SBA-15 MSNs, a portion of TEOS was replaced by MPTES (the detailed 
contents are listed in Table 3-3), and the mixture of TEOS and MPTES was added to the 
surfactant solution. The reaction solution was stirred (500 rpm) at RT for 20 h and then was 
transferred to a Parr autoclave for hydrothermal treatment at 140 C for 24 h under static 
conditions. After cooling down the autoclave in an ambient environment, the resulting white 
precipitate was collected by centrifugation (19000 rpm, 43146 rcf, 20 min), re-suspended in 
ethanol (~ 50 ml), and subsequently template-extracted, repectively. 
Table 3-3 Content of the silane precursors for the SBA-15 MSNs synthesis 
SH content in MSNs  TEOS MPTES 
(mol %) (g) (mmol) (g) (mmol) 
0 (pure silica) 1 g 4.8 ̶ ̶ 
2 0.98 g 4.704 0.023 g 0.096 
5 0.95 g 4.56 0.057 g 0.24 
7 0.93 g 4.464 0.080 g 0.336 
10 0.9 g 4.32 0.114 g 0.48 
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Synthesis of coreSH-shellNH2 bifunctional SBA-15 MSNs 
The core-shell bifunctional SBA-15 MSNs were synthesized through a delayed co-
condensation method where we included 5 mol% of MPTES in the core co-condensation and 
1 mol% of APTES in the shell co-condensation reactions, respectively. Briefly, 0.25 g of 
P123 and 0.5 g of FC-4 were dissolved in 40 ml of 0.02 M HCl at RT followed by the 
addition of silane precursors containing TEOS (0.85 g, 4.08 mmol) and MPTES (57.2 mg, 
0.24 mmol, 5 mol% of total silane content). The mixture was stirred (500 rpm) at RT for 2 h. 
0.1 g of TEOS (0.48 mmol) divided into 4 equal aliquots was added to the solution every 
3 min and the mixture was continuously stirred at RT for 2 h. Afterwards, a mixture of TEOS 
(10 mg, 0.048 mmol) and APTES (10.6 mg, 0.048 mmol, 1 mol% of total silane content) was 
added. The reaction solution was stirred at RT for 20 h and was then transferred to a Parr 
autoclave that was heated to 140 C for 24 h. The resulting white power was collected by 
centrifugation (19000 rpm, 43.146 rcf, 20 min), washed with EtOH and then H2O, and re-
suspended in 40 ml of 2 M HCl solution to perform a second hydrothermal treatment at 140 
C for 24 h. The solution was cooled down in ambient temperature. The resulting precipitates 
were collected by centrifugation (19000 rpm, 43146 rcf, 20 min), re-suspended in ethanol (~ 
50 ml) and were subsequently template-extracted. 
Template extraction and particle size separation 
To remove the organic surfactants from the mesopores, the as-synthesized particles were 
dispersed in an ethanolic solution containing 72 ml of ethanol and 8 ml of conc. HCl (37 wt%) 
and were subsequently heated to reflux for 1 h. Afterwards, the sample was collected by 
centrifugation (19000 rpm, 43146 rcf, 20 min) and washed with EtOH and H2O. The template 
extraction step was performed twice. The template-free sample was then dispersed in EtOH. 
Centrifugation (19000 rpm, 43146 rcf, 20 min) was applied after each reflux and washing 
step to collect the particles. The subsequent particle size separation was performed by two 
filtration steps using filter papers (Sartorius, Grade 393 and Grade 392) for different particle 
size cut-off. The resulting nanosized SBA-15 particles were preserved in EtOH for further 
characterization, modification and applications. 
PEGylation of the coreSH-shellNH2 SBA-15 MSNs 
Before PEGylation, the amino groups on the external surface of the particles were converted 
to carboxylic groups in order to covalently attach the PEG-diamine. 100 mg of the coreSH-
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shellNH2 SBA-15 MSNs (containing 4.8 µmol of -NH2 groups) was mixed with an excess 
amount of oxalic acid (5 mg, 55 µmol) and EDC (5 µL, 28 µmol) in 10 mL of EtOH and 
reacted overnight. The sample was collected by centrifugation (19000 rpm, 43146 rcf, 20 min) 
and washed with EtOH and H2O to remove the residual chemicals. The resulting coreSH-
shellCOOH particles were dispersed in 5 mL H2O for PEGylation. 1 mg (5 µmol) of PEG-
diamine was dissolved in 5 mL H2O, and mixed with a 5 mL aqueous solution containing 
EDC (3 µL, 16.8 µmol), sulfo-NHS (1.95 mg, 9 µmol) and 100 mg of the coreSH-shellCOOH 
particles. The mixture was stirred at RT for 2 h. The PEGylated particles were then collected 
and washed three times using H2O. Centrifugation (19000 rpm, 43146 rcf, 20 min) was 
applied after each reaction and washing step to collect the sample. The coreSH-shellPEG SBA-
15 MSNs were stored in sterilized H2O at a concentration of 10 mg/mL. 
Fluorescent dye labeling of the coreSH-shellPEG SBA-15 MSNs 
10 mg of coreSH-shellPEG SBA-15 MSNs was mixed with 5 g of maleimide-terminated 
ATTO 488 fluorescent dye in 1 mL H2O. The mixture was stirred at RT for 4 h followed by 
three washing steps with H2O to remove residual fluorescent dye. The obtained coreATTO488-
shellPEG particles were preserved in sterilized H2O at a concentration of 5 mg/mL. 
Centrifugation (14000 rpm, 16873 rcf, 5 min) was applied after each reaction and washing 
step to collect the sample. 
Characterization 
The samples for transmission electron microscopy (TEM) were prepared by drying diluted 
MSN suspensions (in ethanol) on a carbon-coated copper grid at room temperature several 
hours before imaging. The measurement was performed at 200 kV on a Jeol JEM-2010 
instrument with a CCD detection system. For scanning electron microscopy (SEM), a JEOL-
6500F scanning electron microscope equipped with a field-emission gun was used. Dried 
sample powder was prepared on a carbon paste for measurement. The SEM was operated at 
an acceleration voltage of 4 kV and a working distance of 6 mm. Nitrogen sorption analysis 
was performed on a Quantachrome Instrument NOVA 4000e at 77 K. The samples were 
degassed at 120 °C under vacuum (10 mTorr) 16h before the measurement. The BET model 
was applied in the range of 0.05 – 0.2 relative pressure (p/p0) to evaluate the specific surface 
area of the samples. Pore size distribution curves were calculated using a non-local density 
functional theory (NLDFT) analysis software provided by Quantachrome, using the 
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cylindrical pore equilibrium mode. X-ray diffraction (XRD) patterns were collected on solid 
samples at small angles on a Bruker D8 Discover with Ni-filtered Cu-Kα radiation (λ = 
1.5406 Å). Raman spectroscopy was performed on a LabRAM HR UV/VIS (HORIBA Jobin 
Yvon) Raman microscope (Olympus BX 41) equipped with a SYMPHONY CCD detection 
system. Dried sample powder was directly measured on a coverslip using a laser power of 10 
mW at a wavelength of 633 nm (HeNe laser). Dynamic light scattering (DLS) and zeta 
potential measurements were performed with a Malvern Zetasizer-Nano instrument equipped 
with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. For DLS measurements, 
the samples were diluted in ethanol to a concentration of 1 mg/ml and their hydrodynamic 
diameters were directly recorded by the instrument. For zeta potential measurements, 1 mg of 
the sample was prepared in 10 mL of bi-distilled water and the solution was titrated by an 
add-on Zetasizer titration system (MPT-2) with diluted NaOH (0.1 M and 0.01 M) and HCl 
(0.1 M) as titrants. Thermogravimetric analyses (TGA) of the bulk samples were recorded on 
a Netzsch STA 440 C TG/DSC from room temperature to 900 °C with a heating rate of 
10 °C/min in a stream of synthetic air of about 25 mL/min. 
Plasmid construction (pCAG-mCherry-hRhoB-IB) 
Human RhoB gene was amplified from HeLa cDNA with the forward primer RhoBfor 
(TAGCGATCGCATGGCGGCCATCCGC) containing an AsisI restriction site and reverse 
primer RhoBrev (GGGACTAGTGGCCCTCATAGCACCTTGC) containing a SpeI 
restriction site. The PCR products were digested with AsisI and SpeI restriction enzymes and 
cloned into the backbone plasmid pCAG-mCherry-IB digested with the same restriction 
enzymes. For the detailed plasmid map, please see appendix Figure 3-10.  
Cell culture  
HeLa Kyoto cells
34
 (HeLa-k, a genetically modified HeLa cell line characterized by little cell 
motility) were cultured in DMEM medium supplemented with 10% FBS and 50 µg/ml 
gentamycin under 5% CO2 at 37 °C. 
Live cell confocal microscopy 
For real time tracking of MSN cellular uptake, live cell imaging medium containing DMEM 
– phenol red free (Sigma), FBS (10 %), L-glutamine (200 M), HEPES (20 mM) and 
gentamycin (50 g/ml) was used for cell incubation. HeLa-k cells were plated on a 2-well -
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slide (ibidi, Germany) in 50% confluence for overnight incubation. The coreATTO488-shellPEG 
SBA-15 MSNs were dispersed in 1.5 mL of live cell imaging medium at a concentration of 
25 g/ml. The culture medium from the 2-well slide was replaced by the MSN-containing 
medium and the sample was incubated at 37°C for 4 h. Subsequently, the sample was placed 
in a closed live cell microscopy chamber (ACU control, Olympus, Japan) heated to 37 °C 
with 5 % CO2 and 60 % humidified atmosphere, mounted on a Nikon Ti microscope (Nikon, 
Japan) and the live cell imaging data were acquired with an UltraVIEW Vox spinning disc 
confocal system (PerkinElmer, UK). Image acquisition was performed using a 63x/1.4 NA 
Plan-Apochromat oil immersion objective lens and the images were obtained with a cooled 
14-bit EMCCD camera (C9100-50, CamLink) with a frame size of 1024 x 1024 pixels. The 
fluorophores on the MSNs were excited with 488 nm (10% laser output power) solid-state 
diode laser lines.  
High-content microscopy and image analysis 
HeLa-k cells (10
6
 cells) were seeded on an 18  18 mm coverslip in a 6-well plate containing 
2 mL of DMEM for overnight incubation. The cell culture medium was then replaced by the 
MSN-containing cell culture medium with the particle (coreATTO488-shellPEG SBA-15 MSN) 
concentration of 25 g/mL. After incubation (37 °C) for 24 h, the cells were washed with 
PBS (three times, 3 mL per wash), fixed with 3.7% of formaldehyde (in PBS, 1 mL), 
membrane-permeabilized with 0.5% Triton-X (in PBS, 3 mL) and DAPI (1 mL, 250 ng mL
-1
 
in PBS, Invitrogen, USA) stained followed by propidium iodide (1 mL, 10 g mL
-1
, 
Invitrogen, USA) staining. The coverslip was mounted in Vectashield anti-fading reagent 
(Vector Laboratories, USA) on an object slide. High-throughput images were acquired 
automatically with an Operetta
®
 High Content Imaging System (PerkinElmer, UK) using a 
40× air objective lens. DAPI, ATTO 488 and propidium iodide were excited and the 
emissions were recorded using standard filter sets. The exposure time was set at 400 ms, and 
35 different fields (approximately 2200 cells) were imaged. The images were then analyzed 
with the Harmony
®
 analysis software (PerkinElmer). Briefly, nuclei, cytoplasm and ATTO 
488-labeled MSNs were segmented from background based on DAPI, propidium iodide and 
ATTO 488 fluorescence and individually identified by setting area- and intensity-based 
thresholds, respectively. The internalized ATTO 488-labeled MSNs were visualized as spots 
within the cytoplasm area. The segmented results (nuclei, cytoplasm and MSN spots) were 
used to define populations. Population 1: cells = DAPI-stained nucleus plus its surrounding 
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cytoplasm region. Population 2: cells with internalized MSNs = cells that internalize more 
than two MSN spots in their cytoplasm region. The evaluation of cellular uptake efficiency of 
HeLa-k cells with respect to MSNs was based on the calculation: population 2/population 1  
100%.  
Laser scanning confocal microscopy 
HeLa-k cells (10
6
 cells) were plated on an 18  18 mm coverslip in a 6-well plate containing 
2 mL of DMEM for overnight incubation. The plasmid pCAG-mCherry-hRhoB-IB was 
transfected into the cells with Lipofectamine 2000 reagent (Invitrogen) according to a 
standard protocol provided by Invitrogen. 20 h post transfection, the MSN particles 
(coreATTO488-shellPEG SBA-15 MSNs) were added to the culture medium at a concentration of 
25 g/mL and incubated with the cells for 24 h. Subsequently, the cells were washed with 
PBS (three times, 3 mL per wash), fixed with 3.7% of formaldehyde (in PBS, 1 mL), 
membrane-permeabilized with 0.5% Triton-X (in PBS, 3 mL), and DAPI (1 mL, 250 ng mL
-1
 
in PBS, Invitrogen, USA) stained. The coverslip was mounted in Vectashield anti-fading 
reagent (Vector Laboratories, USA) on an object slide. The co-localization of coreATTO488-
shellPEG SBA-15 MSNs and RhoB-mCherry-labeled endosomes was analyzed using a Leica 
TCS SP5/AOBS confocal laser scanning microscope equipped with a UV-transmitting HCX 
PL 63/1.4 oil objective lens. Fluorophores were excited with a 405 nm diode laser (DAPI, 
10% output laser power), a 488 nm Ar laser line (ATTO 488, 10% output laser power) and a 
561 nm diode-pumped solid-state (DPSS, 20% output laser power) laser line (mCherry). 
Images were recorded with a frame size of 512  512 pixels, a pixel size of 50 nm, a z-step 
size of 250 nm and a pinhole opening of 1 Airy unit. A maximum intensity projection of 
several confocal z-sections was then performed using Fiji ImageJ. 
Cytotoxicity test 
The MTT assay was applied to evaluate the cytotoxicity of MSNs. HeLa-k cells were seeded 
on a 96-well microplate (5 × 10
3
 cells per well) in cell culture medium (100 l/well) and 
incubated at 37 °C one day before the MTT test. 1 mg of MSNs was dispersed in 1 mL of 
DMEM (serum free) and the MSN-DMEM solution was subsequently diluted to different 
particle concentrations. The culture medium was removed from the cells followed by adding 
100 l of MSN-DMEM solutions (with various particle concentrations) to each well. The 
control group was incubated with 100 l of serum-free DMEM. The cells were incubated 
76 
 
with MSN-DMEM solutions for 24 h, the residual particles were removed and the cells were 
washed with PBS three times. MTT solution (0.5 mg/ml in DMEM) was freshly prepared and 
added to the cells (100 l/well). After 4 h incubation (at 37 °C), the purple crystals 
metabolized from healthy cells can be observed. The MTT solution was removed and the 
purple crystals were dissolved in 200 l of DMSO. The resulting solutions were incubated at 
37 °C for 1 h and the absorbance was measured at 570 nm, together with the reference 
absorbance at 655 nm using a Microplate reader (Infinite® M1000 PRO, TECAN). 
Experiments were triplicated. Error bars represent the standard deviations. 
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3.5 Appendix 
 
Figure 3-6. XRD of the thiol-functionalized SBA-15 MSNs. Samples with (a) 2 mol%, (b) 
5 mol%, (c) 7 mol% and (d) 10 mol% of SH content in the SBA-15 MSNs. 
 
 
Figure 3-7. Raman spectroscopy of the thiol-functionalized (10 mol%) SBA-15 MSNs. 
The peak at 2585 cm
-1
 indicates the S-H stretching vibration.  
 
78 
 
 
Figure 3-8. DLS measurement of the coreSH-shellNH2 SBA-15 MSNs. The sample was 
measured in ethanolic suspension. 
 
Figure 3-9. High content imaging for cellular uptake analysis. A selected image from the 
imaging fields is presented. The coreATTO488-shellPEG SBA-15 MSNs (green) were incubated 
with HeLa cells (25 g MSNs/mL) for 24 h and the particles were washed away. The cells 
were fixed, membrane-permeabilized, and stained with DAPI (blue) and propidium iodide 
(red). 
 
Figure 3-10. Plasmid map of the pCAG-mCherry-hRhoB-IB. 
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4 Clickable Multifunctional Large-Pore Mesoporous Silica 
Nanoparticles as Nanocarriers  
This chapter is based on the following manuscript: 
Hsin-Yi Chiu and Thomas Bein, to be submitted. 
Abstract 
Large-pore mesoporous silica nanoparticles (LP-MSNs) with defined particle size (< 200 nm) 
are promising carrier systems for the cellular delivery of macromolecules. Ideal nanocarriers 
should be adaptable in their surface properties to optimize host-guest interactions, thus 
surface functionalization of the nano-vehicles is highly desirable. In this study, we 
synthesized various mono-functional LP-MSNs by incorporating different organic groups 
into the silica framework via a co-condensation approach. Further, we applied a delayed co-
condensation strategy to create spatially segregated core-shell bi-functional LP-MSNs. 
Diverse particle morphologies were obtained by adding different organosilanes to the silica 
precursor solution. The effect of organosilanes in the co-condensation process on particle size 
and pore structure formation is also discussed. Surface functional groups were then used for 
binding stimuli-responsive linkers. These were finally exploited for copper-free click 
chemistry for cargo conjugation to create a delivery system with controlled cargo release. 
Model cargo release experiments in buffers using these new multifunctional LP-MSNs 
demonstrate their ability in controlled cargo uptake and release and their potential for 
biomolecule delivery. 
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Scheme 4-1 Schematic illustration of the multifunctional large-pore MSNs established in 
this study for different applications. 
4.1 Introduction 
Since the discovery of periodically ordered mesoporous silica MCM-41 in 1992,
1,2
 scientists 
have spent great efforts on tailoring physical and chemical properties (i.e. particle size and 
morphology, pore size and structure, surface functionalities, etc.) of mesoporous silica 
materials and have accommodated a variety of cargos in the mesopores for the study of guest-
host interactions.
3-5
 Nanosized mesoporous silica materials (mesoporous silica nanoparticles, 
MSNs) feature several favorable properties, for example, high surface area and pore volume, 
ease of surface functionalization and biocompatibility, which make them suitable 
nanocarriers for biomedical applications.
6,7
 In the past decade, multifunctional MSNs have 
been developed for controlled release as well as targeted delivery of various therapeutics such 
as anti-cancer drugs, antibiotics, etc. either in vitro or in vivo.
6,8
 However, most of the drug 
delivery tasks have been achieved using small-pore (≤ 4 nm) MSNs. As the development of 
siRNA and protein therapies has dramatically advanced in recent years,
9-11
 the interest in 
developing MSNs for drug delivery purposes has turned towards synthesizing large pores for 
accommodating sizable biomolecules, while simultaneously retaining particle sizes smaller 
than 200 nm for better cellular uptake or an increased EPR (enhanced permeability and 
retention) effect.
12
 Numerous research articles regarding the synthesis of large-pore MSNs 
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with suitable particle sizes have been published in the past years. Recently, Zhang et al. 
reported a synthesis using cetyltrimethylammonium p-toluenesulfonate (CTATos) as 
surfactant in near-neutral precursor solutions resulting in wide-pore stellate MSNs.
13
 The 
pore size distribution of these stellate MSNs ranging from 10 – 20 nm and their defined 
particle size of around 100 nm present an ideal platform for the cellular delivery of large-
sized bio-macromolecules. One significant achievement of this synthesis method is that it can 
be used for large-scale production. Up to now, most of the reports regarding the synthesis of 
stellate MSNs have focused on the discussion of the pore-forming mechanism and particle 
size control. Only few studies have addressed the functionalization of these stellate MSNs 
(either by post-synthetic grafting or only shell functionalization) for optimized biomedical 
applications,
14,15
 while none of them has discussed the impact of different organosilanes in 
the precursor solution on particle morphology when undergoing silica co-condensation.  
To engineer MSNs suitable for nanomedicine, molecular surface modification offers several 
advantages: hydrophobicity or hydrophilicity as well as the surface charge can be adjusted 
towards the respective guest molecules thus ensuring optimal uptake and release properties. 
Furthermore, a site-specific surface decoration with functional groups allows for the 
independent attachment of diverse linker or targeting molecules, thus creating multifunctional 
delivery agents. Post-synthetic grafting and co-condensation are two common methods to 
implant functional groups into the framework of MSNs. Post-synthetic grafting is more 
commonly used for functionalizing large-pore stellate MSNs since grafting does not or only 
negligibly impair the particle morphology or pore structure. However, challenges of post-
synthetic grafting include (i) achieving site-specific localization of two or more different 
functional groups on the MSN surface and (ii) controlling the degree of functional groups 
incorporated into the silica framework. On the other hand, a co-condensation approach 
provides a facile route to attain a controlled degree and spatially selective functionalization in 
the MSN particles. In addition, the functional groups are more homogeneously distributed 
throughout the pore structure when performing a co-condensation synthesis. However, for 
this approach to result in well-defined MSNs, high concentrations and/or highly charged 
organosilanes are typically avoided with this approach.  
In this study, we first synthesized various mono-functionalized MSNs via the co-
condensation approach. We will discuss the prominent impact of 3-aminopropyl 
triethoxysilane (APTES) (when used together with tetraethyl orthosilicate (TEOS) as silica 
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precursors) on the final pore structure and the particle size of MSNs. We further employed 
our delayed co-condensation strategy
16,17
 to synthesize site-specific (spatially selective) core-
shell bi-functional LP-MSNs. Aza-dibenzocyclooctyne (DBCO)-derivatives were attached to 
the inner surface of MSNs to enable copper-free click chemistry reactions for the conjugation 
of azide-terminated cargos. In combination with different stimuli-responsive linkers (e.g., 
redox-sensitive disulfide bridged and pH-sensitive acetal linkers) between DBCO moieties 
and the MSN surface, we were able to control the cargo uptake and trigger the release in 
specific buffer solutions. We envision these multifunctional LP-MSNs (Scheme 4-1) to be 
promising nanocarriers for encapsulation and controlled release of various therapeutics in a 
spatiotemporal manner. 
4.2 Results and Discussion 
Synthesis of mono-functional MSNs via a co-condensation method 
We first chose three commonly used organosilanes carrying thiol, phenyl or amino groups for 
the functionalization of MSNs. Thiol and amino groups are frequently used in secondary 
cross-linking reactions while phenyl groups are capable of increasing the hydrophobicity of 
the silica surface. The three different organosilanes 3-mercaptopropyl triethoxysilane 
(MPTES), 3-aminopropyl triethoxysilane (APTES) and phenyltriethoxysilane (PTES) were 
mixed with tetraethyl orthosilicate (TEOS), respectively, and introduced as silica precursors 
in the co-condensation procedure. A fraction between 5% and 10% of the total amount of 
silica was substituted by the respective organosilane (see Table 4-2). Un-functionalized 
MSNs (pure silica, un-MSN) were also synthesized as control group (experimental details are 
described in the experimental section).  
According to the TEM micrographs (Figure 4-1a-c), the resulting samples un-MSN, thiol-
functionalized MSNs (MSN-SH) and phenyl-functionalized MSNs (MSN-Ph) all show a 
stellate silica framework with conical pore structure, with MSN-SH and MSN-Ph exhibiting a 
less dense central backbone and a smaller particle size than un-MSN. The SEM images 
(Figure 4-1e-g) further illustrate the flower-shaped morphologies of these stellate MSNs 
containing irregular pores. In contrast, amino-functionalized MSNs (MSN-NH2) present a 
very different particle morphology (Figure 4-1d, 4-1h), i.e. a denser silica structure with 
small pores and a large particle size of around 200 nm.  
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Figure 4-1 TEM and SEM micrographs of MSNs functionalized with different organic 
groups. (a), (e) Un-functionalized MSNs. (b), (f) Thiol-functionalized MSNs. (c), (g) Phenyl-
functionalized MSNs. (d), (h) Amino-functionalized MSNs. 
N2 sorption (Figure 4-2a, 4-2b) analysis indicates high surface areas (around 520 – 890 m
2
/g) 
and wide pore size distributions (3 – 30 nm) in samples un-MSN, MSN-SH and MSN-Ph (for 
detailed information, please see Table 4-1). In accordance with TEM images, N2 sorption 
analysis shows that both MSN-SH and MSN-Ph have wider pore size distributions and larger 
pore volumes than un-MSN. We note that the pore volume was evaluated at a relative 
pressure of p/p0 = 0.99 and includes a small contribution of textural porosity (inter-particle 
volume) due to the small particle size.  The results of the N2 sorption also reveal that the 
MSN-NH2 sample has a low surface area of only 285 m
2
/g, a low pore volume and a narrow 
pore size distribution (3 – 4 nm), correlating with the TEM picture. IR spectroscopy shows 
the typical Si-O-Si asymmetric stretching vibration at 1240 – 1050 cm-1 (full range spectra in 
appendix Figure 4-6a). Additionally, an absorption band at 1629 cm
-1
 of the bending mode of 
water adsorbed on the surface of MSNs clearly appears in un-MSN, MSN-SH and MSN-NH2 
indicating that these MSNs are hydrophilic. The signals of the ring C=C stretching mode at 
1431 cm
-1
 and two aromatic ring C-H stretching modes at 3059 cm
-1
 and 3079 cm
-1
 (indicated 
by *) can be observed in the MSN-Ph spectrum (Figure 4-2c, blue line). Sample MSN-NH2 
(Figure 4-2c, green line) shows the absorbance of the symmetric NH3
+
 vibration at 1532 cm
-1
 
and of saturated primary amines at 1627 cm
-1
 (indicated by *, this band overlaps with the 
physisorbed water in MSNs).  
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Figure 4-2 N2 sorption (a) isotherms, (b) pore size distributions and (c) IR spectra of 
MSNs. The signals of the ring C=C stretching mode at 1431 cm
-1
 and two aromatic ring C-H 
stretching modes at 3059 cm
-1
 and 3079 cm
-1
 (indicated by *) can be observed in the MSN-Ph 
spectrum (blue trace). The signal at 1627 cm
-1
 (indicated by *) in the MSN-NH2 spectrum 
(green trace) indicates the presence of saturated primary amines. For clarity, the pore size 
distribution curves in (b) are shifted along the y-axis by a value of 0.1 and the IR spectra in (c) 
are shifted along the y-axis by 0.05. 
Table 4-1 Characterization of MSN samples 
Sample 
DFT
1
 Pore size 
distribution (nm) 
Pore volume
2
 
(cm
3
/g) 
BET surface 
area (m
2
/g) 
Particle size
3
 
(nm) 
IEP 
(pH) 
Zeta Potential at 
pH 7 (mV) 
Un-MSN 4.5 - 22 1.6 521 135 ± 53 3.6 -35 
MSN-SH 6.0 - 30 3.2 671 117 ± 52 2.3 -30 
MSN-Ph 3.5 - 22 2.4 885 50 ± 10 3.3 -28 
MSN-NH2 3.0 - 4.5 0.3 285 216 ± 56 5.6 -31 
1
 Data were acquired from the adsorption branch of the isotherms. 
2
 The total pore volume was determined at p/p0 = 0.99. 
3
 Un-MSN, MSN-SH and MSN-NH2 were measured by DLS, MSN-Ph was analyzed by TEM. 
The amino groups in this sample also increased the isoelectric point (IEP) of the particles 
(IEP = pH 3.6 for un-MSN; IEP = pH 5.6 for MSN-NH2). Thiol groups of sample MSN-SH 
can be detected by Raman spectroscopy (appendix Figure 4-6) showing the S-H stretching 
mode at 2581 cm
-1
. Thermogravimetric analysis (TGA, appendix Figure 4-7) also 
demonstrates the inclusion and the different stability of the functional groups. The 
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decomposition of SH, Ph and NH2 groups can be observed in a dominant weight change at 
341 °C, 631 °C and 302 °C in the samples MSN-SH, MSN-Ph and MSN-NH2, respectively. 
The TGA mass losses and estimated degree of organic functionalizations of the samples are 
listed in appendix Table 4-3.  
These results show that organosilanes can be successfully introduced into the silica 
framework of large-pore stellate MSNs via a co-condensation synthesis. MPTES and PTES 
had only a moderate influence on the stellate formation while APTES strongly modified the 
co-condensation process resulting in a highly divergent silica structure. Factors that affect 
particle morphology and pore structure such as surfactants, catalyst agents, ratio between 
reactants, temperature, reaction time, stirring rate, etc. are well studied in the literature. In 
contrast, only few papers have discussed the influence of organosilanes on the MSN 
morphology.
18,19
 
The influence of organosilanes on pore structure formation 
To investigate the influence of organosilanes on the pore structure formation during co-
condensation, we measured the pH values (at room temperature) of the precursor solutions of 
all samples (Table 4-2).  
The surfactant solution containing CTATos, triethanolamine and water has a pH value of 
about 9.7. Upon addition of TEOS, the pH value dropped to 9.3. After stirring the reaction 
solution for 30 minutes, part of the silicon alkoxides are hydrolyzed and condensed, and the 
pH value dropped further down to 9.0. When 10 mol% of TEOS was replaced by MPTES or 
PTES, these pH values remained nearly unchanged. However, the addition of APTES led to a 
higher pH value (pH 10.06) in the reaction mixture due to the basic property of the amino 
groups. Zhang et al. proposed a mechanism for the large-pore stellate MSN synthesis: they 
propose that at near neutral conditions the counterions Tos
-
 (X
-
) compete with the negatively 
charged silicates (I
-
) for the positively charged surfactant micelles (S
+
). Consequently, more 
Tos
-
 ions are included in the silica structure resulting in  less dense silica particles and larger 
pores.
13
 Following this argument we propose that the increasing pH caused by the addition of 
APTES enhances the affinity between negatively charged silicates (I
-
) and positively charged 
surfactant micelles (S
+
) and thus results in expelling the counterion Tos
-
 (X
-
). Accordingly, a 
denser particle structure with smaller pores results. Similar observations were reported in a 
recently published paper from our group showing that CTATos does not influence the pore 
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radius in comparison to the commonly used CTAC template when the synthesis was 
performed at the high pH of about 12.
17
  
Table 4-2 pH values of synthetic precursor mixtures 
Sample Silica precursors
1
 (mol%) 
pH value of 
surfactant solution
2
 
pH value
3
 after 
silane addition 
pH value
4
 after 30 min 
of silane addition 
Un-MSN 100% TEOS 9.68 9.30 9.0 
MSN-SH 90% TEOS + 10% MPTES 9.70 9.28 9.01 
MSN-Ph 90% TEOS + 10% PhTES 9.65 9.31 9.03 
MSN-NH2 95% TEOS + 5% APTES 9.70 10.06 9.43 
1
 100 mol% = 9.6 mmol.  
2
 Surfactant solution: 13.7 g of H2O + 0.263 g of CTATos + 0.047 g of TEA. 
3
 All pH values were measured after 2 min of silane addition at room temperature. 
4
 All pH values were measured at room temperature. 
In a previous publication,
20
 we demonstrated the possibility to create multiply functionalized 
or even core-shell MSN particles, the latter by performing a time-delayed co-condensation 
with more than one organosilane (e.g., APTES + PTES) at high pH. Here, we applied a 
similar strategy for incorporating either PTES and APTES or PTES and MPTES 
simultaneously in the co-condensation processes to establish dual-functionalized stellate 
particles. According to appendix Figure 4-8, multiply functionalized MSNs were successfully 
synthesized. The aminogroup-containing dual functionalized MSN-Ph/NH2 particles 
resemble the mono-functionlized MSN-NH2 particles in that both of them consist of a 
comparably dense silica framework with a narrow pore size distribution. The reaction 
solution of the MSN-Ph/NH2 particles still has a high pH value of about 9.92 compared to 
10.06 in the mono-functionalized MSN-NH2
 
solution, containing only half of the amino 
concentration, likely causing again the dense silica structure. However, the smaller APTES 
concentration now results in almost twice the surface area of MSN-NH2. On the other hand, 
the mixed MSN-Ph/SH particles resemble their mono-functionalized parent samples MSN-Ph 
and MSN-SH, with pore size, pore volume and particle size of MSN-Ph/SH falling between 
those of MSN-Ph and MSN-SH. 
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Synthesis of core-shell bi-functional stellate MSNs using the delayed co-condensation 
approach 
To synthesize core-shell MSNs having two functional groups precisely localized at either the 
internal or the external surfaces, we applied the delayed co-condensation procedure. 3-
cyanopropyltriethoxysilane (CPTES, 5 mol% of total silane content) was used for co-
condensation with TEOS to generate a nitrile-containing particle core while MPTES (1 mol% 
of total silane content) and TEOS were used to generate thiol groups on the outer surface. A 
shell of pure TEOS was condensed in-between to create an interlayer between the cyano- and 
mercapto-regions. TEM and SEM micrographs (Figure 4-3a, 4-3b) of the resulting coreCN-
shellSH particles (MSN-CNin-SHout) show a similar stellate morphology, particle size and pore 
structure as the un-MSNs particles.  
According to N2 sorption analysis, MSN-CNin-SHout particles possess a high surface area of 
573 m
2
/g and a wide pore size distribution of about 2.5 – 12 nm (Figure 4-3c). The 
incorporated nitrile groups can be seen in the IR spectrum (Figure 4-3d, blue trace) at 
2256 cm
-1
 representing the stretching vibration of aliphatic nitriles. The nitrile groups in 
MSN-CNin-SHout could be converted into carboxylic groups by heating the sample in a 
hydrochloric acid solution (appendix Figure 4-9a). The obtained MSN-COOHin-SHout sample 
shows strong COO
-
 asymmetric stretching vibrations at 1556 cm
-1
 in the IR spectrum (Figure 
4-3d, magenta). To verify the presence of thiol groups on the outer surface, we applied a 
thiol-disulfide exchange reaction. Incubating MSN-CNin-SHout particles with cystamine in 
carbonate-bicarbonate buffer resulted in amino groups being anchored on the outer surface of 
the MSNs. This exchange reaction is evidenced by a dramatic increase in the zeta potential of 
the particles (Figure 4-3e). External mercapto-groups can be exploited for ligand attachment, 
e.g., PEGylation of the particles. PEG anchored to the external surface of MSNs has been 
reported to enhance the particle circulation time in the blood stream as well as to prevent 
particle degradation.
21,22
 To assemble the potential nanocarriers MSN-COOHin-PEGout for 
biomedical application, we attached PEG polymers to the outer surface of the MSN-COOHin-
SHout particles via a mercapto-reactive maleimide-PEG linker (appendix Figure 4-9b). The 
corresponding weight increase of the PEGylation can be seen in TGA measurements (Figure 
4-3f). 
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Figure 4-3 Characterization of core-shell MSNs. (a) TEM and (b) SEM images of MSN-
CNin-SHout particles. (c) N2 sorption-based pore size distribution obtained from the adsorption 
branch and calculated using NLDFT mode. (d) IR spectra. Blue: MSN-CNin-SHout, magenta: 
MSN-COOHin-SHout. (e) Zeta potential of MSN-CNin-SHout (blue) and MSN-CNin-NH2out 
(green). (f) Thermogravimetric analysis of MSN-CNin-SHout (blue), MSN-COOHin-SHout 
(magenta) and MSN-COOHin-PEGout (green). 
Copper-free click chemistry for cargo immobilization using stimuli-responsive linkers 
for controlled release 
Several strategies have been described to modify functional groups in MSNs for cargo 
immobilization and controlled release. Recently, we have reported on NTA (nitrilotriacetic 
acid)-modified MSNs chelating metal ions (Ni
2+
, Zn
2+
 and Ca
2+
) capable of a controlled 
binding and pH dependent release of His-tagged fluorescence nanobodies (chromobodies). 
These constructs enabled the direct transport of nanobodies into living cells for antigen-
visualization in real time.
23
 The MSNs used in the above study were similar to the 
multifunctional large-pore stellate MSNs discussed in this report. Here, we present an 
alternative strategy for ligand coupling with the functional groups in these particles. We 
couple aza-dibenzocyclooctynes (DBCO) to the interior surface of the MSNs to enable a 
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copper-free click chemistry for guest molecule conjugations. DBCO was developed 
independently by the van Delft group in 2009 and the Popik group in 2010 to enhance the 
reaction kinetics of strain-promoted azide-alkyne cycloaddition (also referred to as copper-
free click chemistry).
24,25
 Copper-free click chemistry mediated by DBCO derivatives 
became popular recently in bio-orthogonal conjugation applications for their high selectivity 
and reactivity toward azide-functionalized molecules under physiological conditions.
26-29
 The 
absence of metal catalysts in the reaction solutions also renders this type of click chemistry 
strategy more favorable for biological applications.  
In our study, two different DBCO derivatives (DBCO-NHS ester and DBCO-S-S-NHS ester) 
were used to functionalize the internal surface of MSN-COOHin-PEGout. After a series of 
surface modifications (Figure 4-4a), we fabricated two types of DBCO-modified MSNs in 
which MSN-(S-S-DBCO)in-PEGout contains redox-sensitive disulfide bridges between the 
mesopore surface and DBCO groups while MSN-DBCOin-PEGout contains no stimuli-
responsive linkers. Azide-terminated TAMRA dye was chosen as model cargo to carry out 
the copper-free click reaction with MSN-(S-S-DBCO)in-PEGout and MSN-DBCOin-PEGout. 
To evaluate the cargo immobilization efficacy of the DBCO-modified MSNs, time-based 
release experiments of the fluorescent TAMRA dye were performed in PBS at 37 °C. In brief, 
0.5 mg of TAMRA dye-coupled MSNs in 200 l PBS was loaded into a custom made Teflon 
cap fitting on a fluorescence cuvette. The cap was sealed with a dialysis membrane (MWCO 
14,000 g/mol) which was permeable for small dye molecules but not for MSNs. The released 
dye in the fluorescence cuvette (filled with 3 mL PBS) was recorded by a spectrofluorometer 
with ex = 545 nm and λem = 565 nm. According to Figure 4-4b, the two MSN samples 
showed no spontaneous release and thus an efficient coupling of the TAMRA dye to the 
MSN host during the first 5 hours. Upon adding the reducing agent glutathione at this point 
(GSH, 10 mM in the final solutions) to the particle solutions and incubating the samples at 
37 °C shortly for 5 min, the TAMRA dye was quickly released from the MSN-(S-S-
DBCO)in-PEGout sample, whereas no release was observed from the MSN-DBCOin-PEGout 
sample. This result demonstrates that DBCO-modified MSNs are capable of conjugating 
azide-terminated molecules and are able to immobilize them stably within the particle interior. 
By introducing a stimuli-responsive linker between the silica surface and the cargo 
conjugating moiety, a controlled release of the cargo from MSNs can be achieved. 
94 
 
 
Figure 4-4 (a) Preparation of DBCO-modified MSNs. (b) Time-based release of 
TAMRA dyes from DBCO-modified MSNs. Azide-terminated TAMRA dye served as 
model cargo to be immobilized into DBCO-modified MSNs via copper-free click chemistry. 
After 5 h of release experiment initiation, glutathione (10 mM in the final concentration) was 
introduced to the two samples, respectively. The glutathione-added samples were incubated 
at 37 °C under shaking (500 rmp) for 5 min before the continuous release experiment.   
As an alternative to the redox-sensitive disulfide bridge, we employed a pH-responsive linker 
between the MSN surface and the dye cargo to allow a stimuli-responsive cargo release. The 
pH-sensitive hydrolysis of the acetal linker 3,9-bis(3-aminopropyl)-2,4,8,10-
tetraoxaspiro[5.5]undecane (called AK linker) was previously reported in the literature.
30,31
 
We modified the MSN-COOHin-PEGout particles by attaching the amino terminus of the AK 
linker to the carboxy groups in the inner particle surface and then conjugated an amino-
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reactive NHS-DBCO moiety to the residual amino group of the AK-linker (Figure 4-5a). 
TAMRA dyes were then again coupled to these MSN-(AKL-DBCO)in-PEGout samples via 
copper-free click chemistry. The dye attachment and pH-sensitive release was studied with 
fluorescence spectroscopy as described above.  
 
Figure 4-5 (a) Preparation of DBCO-modified MSNs with pH-responsive acetal linker 
(AKL). (b) Time-based release of TAMRA dyes from AKL-DBCO-modified MSNs. 2 h 
after release of TAMRA dyes in a pH 7 buffer, the sample was collected by centrifugation 
and re-dispersed in a pH 5 buffer for the following release experiment.  
As illustrated in Figure 4-5b, TAMRA dyes were stably attached in the mesopores of MSN-
(AKL-DBCO)in-PEGout without premature leakage when kept in a buffer solution at pH 7. 
However, the subsequent exchange of the medium with a pH 5 buffer triggered the TAMRA 
dye release due to the AK linker hydrolysis. 
These release experiments demonstrate that DBCO derivatives are efficient elements for 
cargo conjugation on functionalized MSNs. Moreover, the sequential MSN modification with 
DBCO and stimuli-responsive linkers has no significant influence on the pore size 
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distribution of our large-pore nanoparticles (appendix Figure 4-10a). The successful 
modification with DBCO and the stimuli-responsive linker is seen in TGA results, which 
show an increasing mass loss after each reaction step (appendix Figure 4-10b). Detailed 
information about DBCO-modified MSNs is listed in appendix Figure 4-10c.  
4.3 Conclusion 
In summary, we were able to tailor the surface properties of large-pore stellate MSNs via co-
condensation and post-synthetic modification into multifunctional MSNs that render 
promising nanocarriers for potential biomolecule delivery. Various organic functional groups 
could be incorporated into the silica framework by co-condensing organosilanes with TEOS. 
We note that the acidity or basicity of an organosilane which might alter the pH value of 
reaction solution (e.g., ATPES) should be used with care since they can modify the large-
pore stellate particle morphology formation and result in different silica structures. A delayed 
co-condensation approach was used to spatially control the localization of functional groups 
in the mesoporous nanoparticle, hence creating a core-shell bi-functional stellate MSN 
structure. In addition, we demonstrated the feasibility of both external and internal MSN 
surface modification. DBCO derivatives were employed for copper-free click chemistry in 
combination with redox-sensitive disulfide bridged or pH-sensitive acetal linkers in our 
multifunctional MSN system to result in controlled cargo release. The synergy of surface 
adaptability and large pore radius in these stellate silica nanoparticles provides a promising 
outlook for applications in biomolecule delivery. This prospect was also demonstrated in our 
recent paper where similar large-pore stellate MSNs were used for the intracellular delivery 
of chromobodies.
23
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4.4 Experimental 
Materials 
Tetraethyl orthosilicate (TEOS, Aldrich, ≥ 99%), phenyltriethoxysilane (PTES, Aldrich, 
> 98%), (3-mercaptopropyl)triethoxysilane (MPTES, Aldrich, ≥ 80%), 3-
aminopropyltriethoxysilane (APTES, Aldrich, 99%),  3-cyanopropyltriethoxysilane (CPTES, 
ABCR, 97%), cetyltrimethylammonium p-toluenesulfonate (CTATos, Sigma), 
triethanolamine (TEA, Aldrich, 98%), cystamine dihydrochloride (Aldrich), ethanol (EtOH, 
Aldrich, absolute), hydrochloric acid (HCl, Aldrich, 37%), methoxypolyethylene glycol 
maleimide (PEG, MW 5000, Sigma), ethylenediamine dihydrochloride (Aldrich), 
dibenzocyclooctyne-S-S-N-hydroxysuccinimidylester (DBCO-S-S-NHS ester, Aldrich), 
dibenzocyclooctyne-N-hydroxysuccinimidyl ester (DBCO-NHS ester, Aldrich), 3,9-bis(3-
aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]undecane (AK linker, TCI), 5-
carboxytetramethylrhodamine azide (5-TAMRA Azide, Baseclick),  L-glutathione reduced 
(GSH, Sigma), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide (EDC, Alfa Aesar, 98%), 
saline-sodium citrate buffer (SSC buffer, Sigma), sodium carbonate (Sigma), sodium 
bicarbonate (Sigma), Dulbecco’s phosphate-buffered saline (PBS, Gibco). Bi-distilled water 
was obtained from a Millipore system (Milli-Q Academic A10).   
MSN synthesis  
Un-functionalized MSNs (un-MSN) were synthesized based on an adapted recipe reported in 
the literature.
13
 In brief, TEA (0.047 g, 0.32 mmol), CTATos (0.263 g, 0.58 mmol) and H2O 
(13.7 g, 0.77 mmol) were mixed in a 100 mL round bottom and stirred vigorously (1250 rpm) 
at 80 °C until the surfactant solution became homogeneous. TEOS (2.013 g, 9.6 mmol) was 
then added to the surfactant solution, and the mixture was continuously stirred at 80 °C for 
2 h. The molar ratio of the above-mentioned mixture is TEOS : CTATos : TEA : H2O = 1 : 
0.06 : 0.033 : 80. The as-synthesized particles were collected by centrifugation (7197 g, 
20 min) and were immediately template extracted (see below).  
For functionalized MSNs (MSN-R), TEOS and organosilanes (RTES) were mixed in molar 
ratios as described in Table 4-2 (the total silane content remained at 9.6 mmol) for silica co-
condensation. All other procedures were the same as in the un-MSN synthesis. 
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Core-shell bi-functional (MSN-CNin-SHout) MSNs were synthesized through a delayed co-
condensation approach. TEOS (1.71 g, 8.2 mmol) and CPTES (116 mg, 0.48 mmol; 5 mol%) 
were mixed and added to the surfactant solution (as described in the previous section), and 
the mixture was stirred (1250 rpm) at 80 °C for 1 h. Afterwards, 201 mg of TEOS 
(0.96 mmol) was separated into 4 aliquots and added to the mixture every 3 minutes. The 
solution was further stirred for 1 h at 80 °C. A mixture of TEOS (20.1 mg, 0.096 mmol) and 
MPTES (28.6 mg, 0.096 mmol, 1 mol%) was then added to the solution to generate the outer 
shell of MSNs. The resulting solution was continuously stirred at 80 °C for 1 h. The as-
synthesized particles were collected by centrifugation (7197 g, 20 min) and were 
subsequently template extracted. 
Template extraction 
To remove the organic surfactant from MSNs, 1 g of the as-synthesized particles were heated 
in an ethanolic solution (150 mL) containing 3 g of ammonium nitrate at 90 °C under reflux 
for 1 h, cooled and collected by centrifugation (7197 g, 20 min) and extracted by a second 
reflux at 90 °C using a 2 M HCl/ethanolic solution (150 mL) for 1 h. Afterwards, samples 
were washed in the sequence of EtOH, H2O, EtOH (100 mL per wash) and were finally kept 
in 20 mL of EtOH. Particles were collected by centrifugation (7197 g, 20 min) after each 
template extraction and washing step.  
Buffer preparation  
a. Carbonate-bicarbonate buffer, pH 9 
2 mL of 200 mM of sodium carbonate (2.2 g of sodium carbonate was dissolved in 100 mL 
H2O) was slowly added to 23 mL of 200 mM of sodium bicarbonate (1.68 g of sodium 
bicarbonate was dissolved in 100 mL H2O) to adjust the pH value to 9.0. By filling the buffer 
volume to 50 mL with H2O the final carbonate-bicarbonate concentration of 100 mM was 
obtained. 
b. 0.1 M MES buffer, pH 4.7 
4-Morpholineethanesulfonic acid (1.95 g, 10 mmol) was dissolved in 100 mL of H2O. 2 M 
NaOH was added dropwise to adjust the pH value to 4.7. 
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Modification of core-shell bi-functional MSNs 
a. Hydrolysis of MSN-CNin-SHout  
200 mg of MSN-CNin-SHout was dispersed in 20 mL of H2O, and 60 mL of HCl (37 %) was 
added carefully. The sample was heated to reflux (90 °C) for 3 h and then cooled down in 
ambient environment. Afterwards 40 mL H2O was added and the solution was stirred at RT 
overnight. 100 mL of H2O was added to further dilute the solution before centrifugation 
(7197 g, 20 min) for particle collection. The resulting MSN-COOHin-SHout particles were 
washed with SSC buffer (pH 7), H2O and EtOH (50 mL per wash), and were kept in EtOH 
(10 mL). Centrifugation (7197 g, 20 min) was applied after each washing step for particle 
collection. 
b. Modification of MSN-CNin-SHout with cystamine 
The thiol groups on the outer shell of MSN-CNin-SHout could be converted to amino groups 
by disulfide exchange of MSN-CNin-SHout with cystamine. In brief, cystamine 
dihydrochloride (22.5 mg, 0.1 mmol) was dissolved in 1 mL of H2O as cystamine coupling 
solution. 10 mg of MSN-CNin-SHout was dispersed in 900 L of H2O and then mixed with 
100 L of 100 mM carbonate-bicarbonate buffer and 1 mL of cystamine coupling solution. 
The mixture was stirred at RT for 2 h followed by washing steps (twice with H2O and twice 
with EtOH (5 mL per wash), followed by centrifugation (16873 g, 5 min) to remove excess of 
cystamine and the side product 2-mercaptoethylamine. The resulting MSN-CNin-NH2out 
particles were suspended in 5 mL EtOH. During the modification processes, particles were 
collected by centrifugation (16873 g, 5 min) in 1.5 mL Eppendorf tubes after reaction and 
each washing step. 
c. PEGylation of MSN-COOHin-SHout  
10 mg of MSN-COOHin-SHout and 10 mg of maleimide-terminated PEG were mixed in 6 mL 
of SSC buffer in a 10 mL-glass bottle. The mixture was stirred at RT overnight. The resulting 
MSN-COOHin-PEGout particles were washed with 10 mL of H2O three times to remove 
excess free PEG molecules and were kept in 10 mL of H2O. Centrifugation (16873 g, 5 min) 
was used to collect the particles after reaction and after each washing step. 
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d. Modification of MSN-COOHin-PEGout to MSN-DBCOin-PEGout/MSN-(S-S-DBCO)in-PEGout 
To modify MSN-COOHin-PEGout with DBCO-S-S-NHS ester or DBCO-NHS ester, 
conversion of MSN-COOHin-PEGout to MSN-NH2in-PEGout was required. Ethylenediamine 
was used to convert COOH groups to NH2 groups, the procedure was following the protocol 
described in the literature.
32
 Briefly, ethylenediamine dihydrochloride (1.33 g, 10 mmol) was 
dissolved in 10 mL of 0.1 M MES buffer (pH 4.7) to generate 1 M ethylenediamine coupling 
buffer in a 30 mL-glass bottle. The amount of 4 mg of MSN-COOHin-PEGout was dispersed 
in the ethylenediamine coupling buffer (10 mL) followed by addition of EDC (20 mg, 
128.8 mol, 2 mg/ml in the reaction solution) and the mixture was stirred at RT overnight. 
The resulting MSN-NH2in-PEGout particles were collected by centrifugation (16873 g, 5 min) 
and were washed with 4 mL H2O three times to remove residual chemicals. 
DBCO-S-S-NHS ester and DBCO-NHS ester were dissolved in DMSO in the concentration 
of 10 mM to serve as stock solutions, respectively. 2 mg of MSN-NH2in-PEGout particles were 
mixed with 1 mg of DBCO-S-S-NHS ester (170 l from stock solution) or 1 mg of DBCO-
NHS ester (240 l from stock solution) in 1 mL PBS. The mixtures were shaken at RT for 3 h 
followed by washing steps (washed with 2 mL H2O, 2 mL EtOH and 2 mL DMSO). 
Centrifugation (16873 g, 5 min) was performed for particle collection after each washing step. 
The resulting MSN-DBCOin-PEGout and MSN-(S-S-DBCO)in-PEGout particles were stored in 
DMSO at the concentration of 1 mg/ml. 
e. Conversion of MSN-COOHin-PEGout to MSN-(AKL-DBCO)in-PEGout 
A mixture of 4 mg of MSN-COOHin-PEGout, 5 mg of AK linker (18 mol) and 5 l of EDC 
(4.3 mg, 28 mol) were dispersed in 1 mL SSC buffer in a 10 mL-glass bottle and were 
stirred at room temperature overnight. The resulting MSN-AKLin-PEGout particles were 
collected by centrifugation (16873 g, 5 min), washed with 10 mL SSC buffer and dispersed in 
4 mL EtOH. 2 mg of MSN-AKLin-PEGout particles in 1 mL EtOH were mixed with 1 mg of 
DBCO-NHS ester (240 l from stock solution) in a 1.5 mL- Eppendorf tube and the sample 
was shaken at RT for 2 h. The resulting MSN-(AKL-DBCO)in-PEGout particles were washed 
with 2 mL EtOH three times and stored in DMSO in the concentration of 1 mg/ml. 
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MSN Characterization 
For transmission electron microscopy (TEM), samples were prepared by drying a diluted 
MSN suspension (in ethanol) on a carbon-coated copper grid at room temperature for several 
hours. The measurement was performed at 200 kV on a Jeol JEM-2010 instrument with a 
CCD detection system. Scanning electron microscopy (SEM) was performed at 30 kV on a 
Helios NanoLab G3 UC instrument (FEI, USA) equipped with a TLD detector. Diluted MSN 
suspensions (in ethanol) were dried on a carbon-coated copper grid at room temperature for 
several hours. Nitrogen sorption analyses were performed on a Quantachrome Instrument 
NOVA 4000e at 77 K. Sample outgassing was performed at 120 °C under vacuum (10 mTorr) 
16 h before measurement. Pore size distribution curves were calculated by non-local density 
functional theory (NLDFT) procedures provided by Quantachrome based on the adsorption 
branch of N2 on silica. A Thermo Scientific Nicolet iN10 IR-microscope was used to record 
infrared spectra of dried sample powders in reflection-absorption mode with a liquid-N2 
cooled MCT-A detector. Raman spectroscopy was performed on a Bruker Equinox 55 with a 
Nd:YAG laser having a wavelength of 1064 nm at a laser power of 100 mW and 3000 scans. 
Dynamic light scattering (DLS) and zeta potential measurements were performed on a 
Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser (633 nm) and an 
avalanche photodiode. DLS measurements were directly recorded in diluted suspensions of 
the particles at a concentration of 1 mg/ml in ethanol. Zeta potential measurements were 
performed with an add-on Zetasizer titration system (MPT-2) based on diluted NaOH and 
HCl as titrants, and the samples were prepared by adding 1 mg of the particles to 10 mL bi-
distilled water. Thermogravimetric analyses (TGA) of the powder samples (20 mg) were 
recorded on a Netzsch STA 440 C TG/DSC with a heating rate of 10 °C/min up to 900 °C in 
a stream of synthetic air of about 25 mL/min. 
Release experiments 
MSNs modified with DBCO-functional groups in the inner surface (MSN-DBCOin-PEGout / 
MSN-(S-S-DBCO)in-PEGout / MSN-(AKL-DBCO)in-PEGout) were used in the release 
experiments. 5-TAMRA azide was used as model cargo to carry out the copper-free click 
chemistry conjugation with DBCO modified MSNs. For dye loading, 0.5 mg of MSNs and 
200 g of 5-TAMRA azide (5 mg/ml in DMSO) were mixed in 1 mL PBS in an 1.5 mL-
Eppendorf tube. The samples were incubated at 37 °C under shaking. After 2 h, TAMRA dye 
conjugated MSN samples were washed with 1 mL PBS three times to remove free dyes in the 
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solution. Centrifugation (16873 g, 5 min) was applied after each washing step for particle 
collection. MSN-TAMRA particles were re-dispersed in 200 l PBS and were transferred to 
a custom made Teflon cap fitting on a fluorescence cuvette. The cap was sealed with a 
dialysis membrane (ROTH Visking type 8/32, MWCO 14,000 g/mol) and placed on the top 
of a fluorescence cuvette filled with 3 mL PBS. Time-based fluorescence release experiments 
were performed at 37 °C on a PTI spectrofluorometer equipped with a xenon short arc lamp 
(UXL-75XE USHIO) and a photomultiplier detection system (Model 810/814). The 
excitation wavelength was set to λ = 545 nm and the emission fluorescence intensity was 
recorded at λ = 565 nm. All slits were adjusted to 2.0 mm. To trigger the stimuli-responsive 
dye release, 22 l of 100 mM GSH in PBS was added to MSN-DBCO-TAMRA and MSN-S-
S-DBCO-TAMRA samples (each sample contains 200 l volume), respectively to achieve a 
final GSH concentration of 10 mM. The samples were incubated at 37 °C under shaking (500 
rpm) for 5 min. The MSN-AKL-DBCO-TAMRA sample was transferred to an Eppendorf 
tube and the particles were collected by centrifugation (16873 g, 5 min). Afterwards, the 
sample was re-dispersed in 200 l of acetate buffer (pH 5) and was transferred back to the 
Teflon cap for the release experiment. All samples were sealed with the dialysis membranes 
and the release setups were reassembled. The fluorescence cuvettes for MSN-DBCO-
TAMRA and MSN-S-S-DBCO-TAMRA samples were filled up with PBS containing 10 mM 
of GSH, while the fluorescence cuvette for MSN-AKL-DBCO-TAMRA sample was filled 
with acetate buffer (pH 5). Fluorescence spectra (λex = 545 nm, λem = 565 nm) were recorded 
continuously overnight. 
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4.5 Appendix 
 
Figure 4-6 (a) Full range infrared spectra of MSNs. All curves are shifted along the y-
axis by 0.1 units for clarity. (b) Raman spectrum of MSN-SH. The spectrum was obtained 
with a Nd:YAG laser ( = 1064 nm) at a laser power of 100 mW and 3000 scans. 
 
Figure 4-7 Thermogravimetric analysis of MSNs functionalized with different organic 
groups. 
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Table 4-3 TGA mass losses and estimated degree of organic functionalizations of the 
functionalized MSNs. 
Sample Formulation of 
functional group (R) 
Molecular weight of 
functional group (MWR) 
TGA mass loss
a
 
(%) 
Estimated degree of 
organic functionalization
b
 
(%) 
MSN-SH C3H6SH 75.2 18.6 15.4 
MSN-Ph C6H5 77.1 13.1 10.5 
MSN-NH2 C3H6NH2 58.1 15.0 15.4 
a
 Calculated based on the mass differences between 150 °C and 900 °C. 
b
 Calculated based on the formulation:   
  ,x (%) = degree of organic functional groups. 
 
Figure 4-8 Characterization of (a) MSN-Ph/NH2 and (b) MSN-Ph/SH. From left to right: 
TEM images, N2 sorption isotherms and NLDFT pore size distributions obtained from 
adsorption branches.  
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Table 4-4 Synthesis and characterization information of MSN-Ph/NH2 and MSN-Ph/SH. 
Sample Precursors 
DFT Pore size 
distribution (nm) 
Pore volume 
(cm3/g) 
BET surface 
area (m2/g) 
Particle size 
(nm) 
pH value after 
silane addition 
MSN-Ph/NH2 
95 mol% TEOS 
2.5 mol% PTES 
2.5 mol% APTES 
2.5-5.0 0.9 496 190 ± 54 9.92 
MSN-Ph/SH 
90 mol% TEOS 
5 mol% PTES 
5 mol% MPTES 
3.5-22 2.6 712 73 ± 15 9.33 
 
 
Figure 4-9 Surface modification of core-shell MSNs. (a) Hydrolysis of MSN-CNin-SHout 
particles in acidic condition at 90 °C. (b) PEGylation of MSN-COOHin-SHout. 
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Figure 4-10 Characterization of core-shell MSNs. (a) NLDFT pore size distribution of 
core-shell MSNs calculated from adsorption branches of N2 sorption isotherms. (b) 
Thermogravimetric analysis. (c) Summary of the core-shell MSN characterization. The TGA 
mass loss was calculated based on the mass differences between 100 °C and 900 °C.  
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5 Intracellular Chromobody Delivery by Mesoporous Silica 
Nanoparticles for Antigen Targeting and Visualization in Real 
Time  
This chapter is based on the following publication: 
Hsin-Yi Chiu, Wen Deng, Hanna Engelke, Jonas Helma, Heinrich Leonhardt, and Thomas 
Bein, Scientific Reports 2016, 6, 25019 
Abstract 
Chromobodies have recently drawn great attention as bioimaging nanotools. They offer high 
antigen binding specificity and affinity comparable to conventional antibodies, but much 
smaller size and higher stability. Chromobodies can be used in live cell imaging for specific 
spatio-temporal visualization of cellular processes. To date, functional application of 
chromobodies requires lengthy genetic manipulation of the target cell. Here, we develop 
multifunctional large-pore mesoporous silica nanoparticles (MSNs) as nanocarriers to 
directly transport chromobodies into living cells for antigen-visualization in real time. The 
multifunctional large-pore MSNs feature high loading capacity for chromobodies, and are 
efficiently taken up by cells. By functionalizing the internal MSN surface with nitrilotriacetic 
acid-metal ion complexes, we can control the release of His6-tagged chromobodies from 
MSNs in acidified endosomes and observe successful chromobody-antigen binding in the 
cytosol. Hence, by combining the two nanotools, chromobodies and MSNs, we establish a 
new powerful approach for chromobody applications in living cells. 
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5.1 Introduction 
Today, antibodies are considered to be the most powerful tools for specific visualization of 
cellular compartments at the molecular level aimed at the study of cellular processes. They 
are indispensable for proteomic analyses, protein localization and detection of post-
translational modifications. However, the application of full-length antibodies is restricted to 
fixed cells, meaning dead cells, since the massive sizes (~ 150 kD) and complex folding 
structures, including intermolecular disulphide bridges, limit their use in living cells via the 
transient expression approach or via direct delivery. As a result, the idea of engineering 
recombinant small antibodies for real time dynamic protein tracing in living cells has 
received much attention. A variety of recombinant small antibodies including 
immunoglobulin (Ig) derived Fab (~ 50 kD) and scFv (~ 25 kD), as well as non-Ig derived 
monobody (~ 10 kD) and affibody (~ 6.5 kD) protein scaffolds have been generated in the 
last decades for this purpose.
1
 Nanobodies (~ 14 kD) are the single-domain antigen-binding 
fragments derived from camelid’s single-chain IgG.2 They have a binding affinity and 
specificity similar to conventional antibodies, but are much smaller in size and exhibit higher 
stability. When conjugated with fluorescent proteins or organic dyes, the fluorescent 
nanobodies, named chromobodies, become molecular probes that can trace the dynamics of 
endogenous cellular structures in living cells. Chromobodies have successfully shown their 
antigen detection efficacy on cytoskeleton, histone protein and DNA replication complexes, 
and have revealed the spatio-temporal protein changes during cell cycles.
3
 In our previous 
report,
4
 HIV-specific chromobodies have been generated and used for real time visualization 
of HIV assembly in living cells. These studies demonstrate that chromobodies are promising 
protein reporters for the study of cellular processes in living cells. However, to date the 
application of chromobodies for live cell imaging was limited due to the need to introduce 
them genetically, followed by subsequent cytosolic expression. To broaden the flexibility and 
use of chromobodies in biomedical applications (e.g., manipulation of cell function for 
disease treatment), direct intracellular delivery of the molecular probes would be highly 
desirable. However, intracellular protein delivery is challenging firstly because the large size 
of proteins leads to difficulties with passive diffusion through the cell membrane or with 
endocytosis. The following endosomal trapping of internalized proteins further limits the 
protein functions in cells. A few studies of non-carrier intracellular protein delivery aimed to 
enhance the cellular uptake efficiency in combination with endosomolytic agents and 
therefore to increase the protein delivery efficacy.
5,6
 For example, Erazo-Oliveras et al. co-
113 
 
incubated dimerized cell-penetrating peptide TAT (dfTAT) with proteins (EGFP and Cre 
recombinase, etc.) in culture media, the results show that proteins were successfully crossing 
the cell membrane with the help of dfTAT and presenting their functions in cytosols
5
; 
D’Astolfo et al. used hyperosmolality NaCl buffer to induce the highly efficient 
micropinocytosis of proteins. In combination with a transduction compound (a 
propanebetaine), intracellular protein release was achieved.
6
 Alternatively, using carriers such 
as cationic polyplexes with high cellular uptake efficiency for proteins may improve the 
generally low efficiency of protein uptake. However, the complex structures and wide variety 
of surface charges of proteins make it difficult to design a general carrier for universal protein 
delivery.
7
 The second challenge of protein delivery is that proteins are susceptible to 
proteolytic cleavage. Proteins must maintain their tertiary structure to preserve their 
functionality during the delivery process.   
To address these bottlenecks, we surmised that mesoporous silica nanoparticles (MSNs) 
could be promising candidates for serving as efficient and versatile protein delivery vehicles. 
For example, their surface can be modified with different functionalities and charges to 
accommodate different proteins; their pore sizes are tunable to fit different cargo sizes; their 
frameworks are stable and can effectively protect cargos from environmental degradation, 
and they can be efficiently taken up by cells. In the past years, the development of MSNs for 
biomedical applications has greatly increased. The achievements include delivery of 
chemotherapeutic agents for cancer therapy,
8
 intracellular protein delivery for manipulation 
of cell function,
9,10
 and oligonucleotide delivery for gene therapy.
11,12
 These studies 
demonstrate that MSNs can efficiently control the release of cargos in the target tissue/cells 
as well as effectively protect cargos from degradation. Importantly, MSNs were found to be 
biocompatible within certain concentration ranges.
13
 
In this study, we synthesize multifunctional large-pore MSNs for intracellular chromobody 
delivery. Metal chelate complexes are covalently attached on the internal silica surface and 
used for pH-responsive coordination binding of His6-tagged chromobodies. The binding 
affinity and pH-stimulated release of various metal ions (Fe
2+
, Co
2+
, Ni
2+
, Cu
2+
, Zn
2+
 and 
Ca
2+
) with His6-tagged chromobodies are examined by colorimetric measurements in vitro. 
Mouse embryonic fibroblasts (MEFs) expressing EGFP fused to LMNA (an inner nuclear 
membrane protein) (MEF-G-LMNA) are generated for the detection of GFP-specific 
chromobody release and function in intracellular delivery experiments. The successful 
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chromobody delivery, release from the endosomes and binding to the target structures can be 
confirmed by the fluorescence co-localization signals of EGFP and chromobodies on the 
LMNA structure. 
5.2 Results  
Synthesis and characterization of large-pore MSNs 
Mercapto-functionalized MSNs (MSN-SH) were synthesized using a sol-gel templating 
approach in a neutral pH reactive solution according to a modified protocol from the 
literature.
14
 During the synthesis process (Figure 5-1a) the structure directing agent 
cetyltrimethylammonium (CTA
+
) formed micelles in the initial solution, silica precursors 
tetraethyl orthosilicate (TEOS) and (3-mercaptopropyl)triethoxysilane (MPTES) were then 
adsorbed and co-condensed around the micelles because of the electrostatic attraction 
between CTA
+
 and negatively charged silica. In this neutral pH synthesis solution, the 
counter ions Tos
-
 compete with the silicate oligomers for association with the positively 
charged micelles, which results in sparse silica condensation and consequently the large 
stellate pore structure formation (Figure 5-1b).
14
 Mercapto-functional groups were introduced 
homogeneously into the silica framework via co-condensation for the purpose of further 
functionalization. According to the N2 sorption analysis (Figure 5-1c), MSN-SH has a fairly 
wide pore size distribution from 10 nm to 20 nm, a BET surface area of 670 m
2
 g
-1
 and a 
large pore volume of 3.06 cm
3
 g
-1
. With these pore dimensions, chromobodies featuring a 
size of 2 nm x 4 nm
15
 are expected to be efficiently loaded into the mesopores. The 
hydrodynamic particle size (Figure 5-1d) measured by dynamic light scattering (DLS) was 
100 – 200 nm. This particle size range is considered to be favorable for endocytosis.16 
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Figure 5-1 Synthesis and characterization of MSN-SH. (a) MSN-SH was synthesized 
through a modified protocol described earlier in the literature.
14
 MSN-SH was synthesized by 
co-condensation of oligosilicates (from TEOS) and mercapto-functionalized oligosilicates 
(from MPTES) in a neutral pH reaction mixture. (b) TEM image of MSN-SH. The high 
contrast areas indicate the dense silica backbones whereas the low contrast areas indicate the 
pore structure. The average particle size is about 100 nm according to the TEM image. Scale 
bar: 60 nm. (c) Nitrogen sorption isotherm (outer figure) of MSN-SH and its corresponding 
pore size distribution (inner figure) calculated by the NLDFT mode based on the adsorption 
branch of N2 on silica. (d) Dynamic light scattering (DLS) of hydrodynamic particle size of 
MSN-SH in EtOH. The average hydrodynamic particle size is around 160 nm. 
MSN-M
2+
 for controlled uptake and release of chromobodies 
To control chromobody loading and release from the silica framework, nitrilotriacetic acid -
metal ion complexes (NTA-M
2+
) were attached to the MSN surface as pH-responsive linkers. 
The recombinant GFP-specific chromobody possesses a built-in His6-tag on its C-terminus 
for purification purposes. This His6-tag can be used as a tether to conjugate chromobodies 
onto NTA-M
2+
 complexes because there are three potential coordination sites on the histidine 
molecule: the carboxyl group (pKa = 1.9), the imidazole nitrogen (pKa = 6.1) and the amino 
nitrogen (pKa = 9.1). Among these coordination sites, the imidazole nitrogen is considered to 
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be the primary site for the conjugation with metal ions. The conjugation can be separated by 
high imidazole concentration buffer elution (free imidazole substitutes the coordination 
binding of histidine on the NTA-M
2+
 complexes). Alternatively, low pH buffer can also be 
used for elution since the imidazole nitrogen is protonated under acidic conditions (pH < 6) 
and therefore acidification results in the detachment of His6-tagged chromobodies from NTA-
M
2+
 complexes. 
To carry out the MSN modification, MSN-SH was converted to carboxyl-functionalized 
MSN (MSN-COOH) by reacting MSN-SH with 6-maleimidohexanoic acid in ethanol. The 
MSN-COOH was then conjugated with N,N-bis(carboxymethyl)-L-lysine hydrate (NTA-
lysine) via an EDC-sulfo NHS coupling approach (Figure 5-2a). The 1700 cm
-1
 peak 
attributed to a C=O vibration in the IR spectrum (Figure 5-2b, red line) indicated the 
successful coupling of 6-maleimidohexanoic acid with MSN-SH, while the conjugation of 
MSN-COOH and NTA-lysine was verified by the increased secondary amide bond signal at 
1650 cm
-1 
in the IR spectrum (Figure 5-2b, blue line). After this two-step modification, the 
final NTA-conjugated MSNs (MSN-NTA) still exhibit the desired large-pore structure as 
well as colloidal stability (appendix Figure 5-6). To compare the effect of different NTA-M
2+
 
complexes for His6-tagged chromobody conjugation, various metal ions: Fe
2+
, Co
2+
, Ni
2+
, 
Cu
2+
, Zn
2+
 and Ca
2+
 were immobilized onto MSN-NTA, yielding NTA-M
2+
-complex-
modified MSNs (MSN-M
2+
) (Figure 5-2c). Chromobodies were then loaded on the MSN-M
2+
 
carriers (MSN-Fe
2+
, MSN-Co
2+
, MSN-Ni
2+
, MSN-Cu
2+
, MSN-Zn
2+
 and MSN-Ca
2+
) as well 
as MSN-SH (as control group) in 0.05 M Tris-acetate buffer (pH 8). Subsequently, 
chromobody loading and release tests were performed via measurements of the fluorescence 
intensity (emission at 669 nm) of the loading/release supernatants. The fluorescent intensity 
of a dilution series of pure chromobodies was measured as standard curve for the following 
quantification. Based on the results shown in Figure 5-2d, all samples (MSN-Fe
2+
, MSN-Co
2+
, 
MSN-Ni
2+
, MSN-Cu
2+
, MSN-Zn
2+
, MSN-Ca
2+
 and MSN-SH; for the latter, see discussion 
below) exhibited a similarly high chromobody loading capacity of approximately 70 g per 
mg MSN. This loading capacity corresponds to about 600 chromobody molecules per MSN 
(for the detailed calculation, please see appendix 5-12). After incubation of the chromobody-
loaded MSNs (MSN-M-Cb) in pH 7 buffer for 16 h, all the samples showed on average only 
5 % release of the loaded chromobodies (Figure 5-2e). However, performing the chromobody 
release in pH 5 buffer, MSN-Ni
2+
, MSN-Cu
2+
, MSN-Zn
2+
 and MSN-Ca
2+
 exhibited 
significantly higher chromobody release efficiency than in pH 7 (Figure 5-2e).  
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Figure 5-2 Surface modification of MSN and chromobody controlled release test in vitro. 
(a) Modification process of MSN-SH to yield MSN-NTA. (b) IR spetra of the functionalized 
MSNs during each modification step. MSN-SH (black), MSN-COOH (red) and MSN-NTA 
(blue). (c) MSN-NTA particles were treated with different metal ion solutions (50 mM), 
respectively, at room temperature for 6 h. The free metal ions were then washed away with 
water, and the resulting metal-immobilized MSNs (MSN-M
2+
) were incubated with 
chromobody (ATTO 647N labelled) loading buffers (100 g chromobody ml-1 in Tris-acetate 
buffer, pH 8) at 4 °C for 2 h to bind the chromobodies to MSNs. (d) Chromobody loading 
capacity of different metal-immobilized MSNs. MSN-SH served as control group in the in 
vitro controlled release test. (e) Chromobody loaded MSN particles (MSN-M-Cb) were 
dispersed in PBS buffer (with pH 7 or pH 5) at 37 °C for 16 h. Afterwards, the supernatants 
were collected and the amounts of chromobody released were measured using colorimetric 
analysis. Pure chromobodies were diluted in PBS buffer at different concentrations for 
creating the standard curve. Experiments were triplicated. Error bars were calculated as s.e.m. 
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In general, the extent of release of His6-tagged proteins from the NTA-M
2+
 moieties is 
determined by two factors: (i) the stability of the metal chelation by NTA, and (ii) the 
stability of the coordination between metal ions and histidine molecules. The general stability 
order of NTA-metal ion and histidine-metal ion complexes is: 
Cu
2+
 > Ni
2+
 > Zn
2+
 > Co
2+
 > Fe
2+
 > Ca
2+
.
17,18
 The results shown here indicate that 
Cu
2+
, Ni
2+
, Zn
2+
 and Ca
2+
 are able to allow for the chromobody release in an acidic 
environment at pH 5, while Cu
2+
, Ni
2+
 and Zn
2+
 show a rather high stability when 
incorporating to the MSN-NTA system. By contrast, Co
2+
 and Fe
2+
 showed no significant 
differences of chromobody controlled release in pH 7 and pH 5 buffers due to their weak 
complexing stability with either NTA or histidine. Interestingly, although the theoretical 
coordination stability of NTA-Ca
2+
 is low, His6-tagged chromobodies still bind sufficiently to 
MSN-Ca
2+
 in pH 7 buffer. Practically, MSN-Ca
2+
 is favored for chromobody delivery 
because the decomposition of the NTA-Ca-chromobody complex starts already at pH 6 (data 
not shown), therefore more chromobodies can be released in the early endosome stage. 
Moreover, small amounts of Ca
2+
 are considered to be biocompatible and non-toxic.  
The control group MSN-SH particles showed high chromobody loading capacity and low 
chromobody release in both pH 7 and pH 5 even without any capping system or chemical 
conjugation. This indicates that the negatively charged silica framework (zeta potential: -13.7 
mV at pH 5, -30.8 mV at pH 7) exhibits non-specific binding to chromobodies. The MSN-
M
2+
 carriers we developed here are not only useful for His6-tagged chromobody controlled 
release, but also promising for universal His-tagged protein delivery to living cells. Several 
groups have previously shown the successful binding and release of His-tagged proteins on 
NTA-Ni
2+
-complex-modified silica substrates either for protein delivery or for biosensor 
detection.
9,10,19
 Similarly, these proteins could be attached to the large internal surface of our 
MSN-M
2+
 carrier system. 
MSN-Ni
2+
, MSN-Zn
2+
 and MSN-Ca
2+
 (primary carrier) were used for the following 
intracellular chromobody delivery study in MEF-G-LMNA cells. To address possible 
concerns of cytotoxicity of the dissociated metal ions after uptake of the particles into the 
cells, we performed MTT assays after incubation of MSN-Ni
2+
, MSN-Zn
2+
 and MSN-Ca
2+
 
particles with the MEF cells (wild type) for 24 h. The results (appendix Figure 5-7) indicate 
that these three metal-immobilized MSNs, as well as un-functionalized MSNs are non-toxic 
to MEF cells below a concentration of 100 g ml-1. 
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Cellular uptake of MSNs 
After the study of chromobody loading and release from NTA-M
2+
-complex-modified MSNs, 
we further investigated the interactions between cells and MSNs. There are numerous studies 
about the cellular uptake of nanoparticles (e.g. liposomes, polyplexes and silica nanoparticles, 
etc.).
16,20-28
 These studies reveal that electrostatic surface charge of nanoparticles, 
functionalization, particle shape and particle size are key factors that can affect the 
endocytosis mechanisms. For example, positively charged nanoparticles are favored for 
cellular uptake because the negatively charged cell membrane tends to attract the positively 
charged particles on its surface; particle sizes below 200 nm are considered the most 
favorable size for cellular internalization. In addition, the endocytosis behavior for different 
nanoparticles is also dependent on cell-type.
29,30
 In this study, the MSN size used for 
intracellular chromobody delivery is about 100 – 200 nm. The endocytosis pathways are 
mostly clathrin-mediated or caveolin-mediated endocytosis.
16,27
 The confocal images in 
Figure 5-3a reveal the kinetics of cellular uptake of chromobody loaded-MSNs (MSN-Ca-
Cbs) by MEF-G-LMNA cells. MSN-Ca-Cbs were added to the cells in serum free medium at 
a concentration of 5 g ml-1, and real-time live cell images at the indicated time points were 
acquired. As the incubation time increased, the number of MSN-Ca-Cbs co-localized with 
cells also increased. After 2 h of co-incubation with MSN-Ca-Cbs, almost all cells in the 
imaging frame co-localized with more than two MSN-Ca-Cb spots. High content statistics of 
cellular uptake of MSN-Ca-Cbs for different time points and concentrations were examined 
with a high throughput imaging system (Operetta
®
, PerkinElmer). Different concentrations of 
MSN-Ca-Cb (5 g ml-1, 10 g ml-1 and 20 g ml-1) were added to each sample in a 24-well 
plate. At the indicated time points, cells were washed to remove free MSN-Ca-Cbs, and were 
then imaged by Operetta immediately. On average 600 cells were imaged and analyzed per 
sample. The evaluation sequence is shown in the supplementary information (appendix 
Figure 5-8). The results (Figure 5-3b and 5-3c) from the high content analysis illustrate that 
cellular uptake of MSN-Ca-Cbs is time and dose dependent. After 10 min of incubation, more 
than 30 % of the cells have taken up MSN-Ca-Cbs already (cells with more than two MSN-
Ca-Cb spots within their cytosols and nuclear region are defined as MSN-uptake cells; each 
MSN-Ca-Cb spot might contain more than one MSN-Ca-Cb) both for low particle 
concentration (5 g ml-1) and for high particle concentration (20 g ml-1). After 2 h of 
incubation with MSN-Ca-Cbs, more than 90 % of the cells have taken up MSN-Ca-Cbs. This 
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result demonstrates the high cellular uptake efficiency of MSN-Ca-Cbs by MEF-G-LMNA 
cells. 
To further visualize the MSN locations in the cytosol we used super-resolution microscopy 
(3D SIM). A stable MEF cell line (MEF-mEGFP) that expresses endogenous membrane co-
localizing EGFP protein was developed to label the cell boundary. Cy3 labeled MSNs (MSN-
Cy3s) at the concentration 10 g ml-1 were incubated with MEF-mEGFP cells on a glass 
coverslip in culture medium for 2 h. Afterwards, cells were washed to remove free MSNs and 
were fixed. DAPI counterstaining was performed after cell fixation. The super resolution 
microscope image (Figure 5-3d, XY view and XZ cross-section view) visually confirms that 
MSNs were internalized by MEF-mEGFP cells. The image clearly shows that the internalized 
MSN-Cy3s were equally distributed in the cytosol, and single particles can be seen in the 
magnified images. 
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Figure 5-3 Cellular uptake of MSNs. (a) Real-time live cell imaging of the MSN-Ca-Cb 
uptake process by MEF-G-LMNA cells. Images were taken at the indicated time points after 
incubation with MSN-Ca-Cb (5 g ml-1) on MEF-G-LMNA cells in a 2-well ibidi cell culture 
slide. Scar bar: 20 m. (b), (c) Time-based analyses of cellular uptake of MSN-Ca-Cb using 
a high-throughput imaging system (Operetta
®
, PerkinElmer). Cells were seeded on 24-well 
plates at the concentration of 3 × 10
4
 cells per well and incubated at 37 C overnight. Cell 
culture medium was removed and different concentrations of MSN-Ca-Cb particles in serum 
free live cell imaging medium (LCIM) were then added to each well. After incubation of 
MSN-Ca-Cb particles with cells for the indicated time intervals, free particles were removed 
by washing with PBS, and high-throughput live cell imaging was performed.  Experiments 
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were triplicated. An average of 600 cells were imaged in each experiment. Error bars were 
calculated as s.d. (d) Super-resolution microscopy (3D SIM) image of a cell after MSN 
internalization. Cy3-labeled MSNs (10 g ml-1) were incubated with MEF-mEGFP cells  
(3 × 10
5
 cells per well) on a glass coverslip in a 6-well plate for 2 h. Afterwards, free MSNs 
were removed by washing with PBS. Cells were then fixed with 3.7 % formaldehyde and 
counterstained with DAPI (1 g ml-1 in PBS). Green: EGFP, red: Cy3 labeled MSNs, 
magenta: DAPI counterstaining. Scale bars: 5 m (main figure and XZ cross-section figure) 
and 1 m (magnified figures). 
Intracellular chromobody delivery  
In the intracellular chromobody delivery experiment we used MSN-Ca
2+
 as the main 
chromobody carrier. Above we have shown that the average chromobody loading capacity in 
MSN-M
2+
 is 70 g per mg MSN (Figure 5-2c). Here we added the MSN-Ca-Cbs to the cell 
culture slide (-Slide 2-well, ibidi) at a concentration of 5 g ml-1 (1 ml of culture medium 
per well), which yields a chromobody concentration for the intracellular delivery of 
approximately 25 nM. Importantly, compared to the recently published papers of direct 
protein delivery that use micromolar protein concentrations in each experiment, the amount 
of cargo we used in this work is 200 times less.
5,6
 MEF-G-LMNA cells were used to detect 
the release and function of GFP-specific chromobodies. When Atto 647N labeled GFP-
specific chromobodies are delivered to and subsequently released from endosomes, they 
passively diffuse through the nuclear envelope and bind to GFP molecules on the LMNA 
structure. Therefore, a distinct microscopic co-localization signal from EGFP-LMNA and 
GFP-specific chromobodies can be observed. Figure 5-4 illustrates the successful delivery of 
GFP-specific chromobodies to MEF-G-LMNA cells.  After 24 h of incubation with MSN-Ca-
Cbs, several cells can be observed with chromobody release. In fact, chromobody release can 
already be seen after 4 h incubation of MSN-Ca-Cbs in some cells, and the chromobody 
staining remained on the EGFP-LMNA structure until 96 h after incubation (appendix Figure 
5-9). We also examined two other carriers: MSN-Ni
2+
 and MSN-Zn
2+
, and both of them 
allowed for intracellular chromobody delivery (appendix Figure 5-9). The application of 
MSNs for intracellular chromobody delivery allows for directly and efficiently transporting 
chromobodies into living cells. In comparison, incubation of free chromobodies with cells 
without carriers does not lead to any significant uptake (appendix Figure 5-10).    
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Figure 5-4 Live cell confocal imaging of intracellular chromobody delivery. 24 h post 
incubation of MSN-Ca-Cbs (5 g ml-1) with MEF-G-LMNA cells. Scale bar: 10 m. 
Representative images are presented. 
To systematically quantify the efficiency of chromobody delivery via MSNs, we then used a 
high-throughput imaging system to image a large quantity of cells and further calculate the 
chromobody release efficiency (chromobody release efficiency % = chromobody stained 
cells/GFP-LMNA-positive cells x 100 %). The result (Figure 5-5a, the control group) showed 
only 1 – 2 % chromobody release efficiency after 24 h post MSN-Ca-Cbs incubation. We 
attribute the low release efficiency to endosomal trapping of most of the internalized particles, 
whereas the limited observed endosomal escape of chromobodies might result from the 
proton sponge effect generated by the His6-tag on chromobodies.   
To enhance endosomal release, we investigated 4 different endosomal escape triggers: 
fusogenic peptide INF7, acid shock, DMSO and chloroquine. 
Fusogenic peptide INF7 is a peptide derivative from influenza virus hemagglutinin HA2 
protein. Wagner et al. first reported in 1994 that the 23 N-terminal amino acid sequence of 
HA2 has liposome disruption ability and erythrocyte lysis activity.
31
 The derivative INF7 
peptide exhibits more pH specificity with membrane disruption ability and erythrocyte lysis 
activity than HA2 due to its conformation change in acidic environment. Therefore, this pH-
dependent conformation change and membrane-disruptive fusogenic peptide is promising for 
endosomal escape since the late endosomes feature an acidic environment at ~ pH 5. Here, 
we conjugated the INF7 peptide to MSNs using a pH-responsive acetal linker
32
 (appendix 
Figure 5-11), then co-incubated MSN-INF7s with MSN-Ca-Cbs to MEF-G-LMNA cells for 
2 h. However, the result (Figure 5-5a) showed that INF7 has no enhancement for the 
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chromobody delivery efficiency. The second endosomal release trigger we used here is acid 
shock, that is, extracellular acidification of cells. The purpose of using acid shock is to 
generate external stress on cells and to investigate if the cellular stress response is to increase 
the endosomal leakage. However, the acid shock applied in this experiment had no effect on 
the chromobody delivery efficiency. Moreover, the acidic buffer incubation leads to 60% cell 
death (Figure 5-5b). The third endosomal release trigger DMSO has been reported to be 
capable of enhancing membrane permeability.
33-36
 A molecular dynamics simulation 
demonstrated that DMSO molecules can cause fluctuations on the two hydrophilic sides of 
the lipid bilayer followed by the formation of a water-permeable pore in the lipid bilayer.
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Wang et al. used it to enhance the penetration efficiency of the cell-penetration peptide TAT 
fusion protein.
36
 In our study a short incubation (5 – 10 min) with 7% DMSO indeed 
enhances the release of chromobodies from the endosomes. The chromobody release 
efficiency increased from 1% (control group) to 12% after this short incubation with DMSO 
(Figure 5-5a). Furthermore, the increased endosomal release of chromobodies can be detected 
right after the DMSO treatment (data not shown).  
The most effective endosomal release trigger studied in this work is chloroquine. 
Chloroquine is a well-known lysosomotropic agent (and anti-malaria drug) that preferentially 
accumulates in lysosomes and destabilizes the lysosomal membrane. When chloroquine is 
used at low concentration, it increases the pH of the acidic endosomes.
37
 When applied at 
high concentration (> 100 M), chloroquine can generate a strong proton sponge effect and 
therefore destabilize the endosomal membrane.
37,38
 Our study shows that a short incubation 
of high concentration (500 M) chloroquine facilitates endosomal release. In contrast to the 
DMSO treatment, the proton-sponge effect for increased endosomal release becomes obvious 
24 h after the chloroquine treatment. To sum up the endosomal escape experiments, INF7 and 
acid shock showed no increase of chromobody release efficiency (same as the control group, 
1 – 2%) while cells treated with DMSO or chloroquine showed 12 – 18 fold increase in 
efficiency. The corresponding live cell images of increased chromobody release efficiency 
after treatment with DMSO and chloroquine are shown in Figure 5-5d. 
Since the introduction of endosomal triggers might induce cytotoxicity, we analyzed cell 
viability after each endosomal trigger treatment. The cultured cells were imaged before 
MSN-Ca-Cbs incubation, and the numbers of GFP-LMNA-positive cells were counted. After 
2 h incubation of MSN-Ca-Cbs in serum-free medium and following the treatment with 
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endosomal release triggers, cells were imaged and counted again. The blank group refers to 
cells incubated in serum-free medium for 2 h without MSN-Ca-Cb treatment and no 
endosomal trigger treatment. Cell viability was calculated based on: GFP-LMNA-positive 
cells after drug treatment/GFP-LMNA-positive cells before MSN-Ca-Cb treatment x 100%. 
The cell viability analysis shown in Figure 5-5b indicates that, compared to the blank group 
and the control group, the short exposure to 7% DMSO or 500 M chloroquine has almost no 
effect on cell viability. The slight decrease in cell viability of the blank group, control group, 
DMSO-treated cells and chloroquine-treated cells might result from the serum free medium 
incubation. Cell proliferation was also studied after endosomal trigger treatment to ensure the 
drug treatment has no effect on cell proliferation. The result in figure 5-5c indicated that 
DMSO and chloroquine treated cells proliferate normally in the following days. 
126 
 
 
Figure 5-5 Comparison of different endosomal release triggers for chromobody delivery 
efficiency. High-throughput imaging system (Operetta
®
, PerkinElmer) was used for 
chromobody delivery efficiency (a), cell viability (b) and cell proliferation (c) studies. (a) 
Chromobody delivery efficiency after treatment with different endosomal release triggers. 
24 h after MSN-Ca-Cb incubation and endosomal release trigger treatment, cells were 
imaged by Operetta. GFP-positive cells were counted by Harmony software, and 
chromobody-stained cells were counted visually. Chromobody delivery efficiency % = 
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chromobody-stained cells/GFP-positive cells x 100 %. (b) Cell viabilities after treatment with 
different endosomal release triggers. Cells were imaged by Operetta before MSN-Ca-Cbs 
incubation. After 2 h incubation of MSN-Ca-Cbs and short treatment with different 
endosomal release triggers, cells in the same region of each plate were then imaged with 
Operetta again. Cell viability % = GFP-positive cells after drug treatment/ GFP-positive cells 
before drug treatment x 100 %. (c) Cell proliferations after treatment with different 
endosomal release triggers. The cell number immediately after drug treatment of each sample 
is defined as 1-fold. Cell numbers were then counted every 24 h by Operetta. (a), (b), (c) 
Experiments were triplicated. Error bars were calculated as s.d. (d) Live cell confocal images 
of intracellular chromobody delivery after non-treatment (control), DMSO-, and chloroquine-
treated MEF-G-LMNA cells. Scale bar: 20 m. 
5.3   Discussion 
In this work, we successfully developed NTA-M
2+
-complex-modified MSNs as carriers for 
intracellular chromobody delivery. We systematically studied (1) the interactions between 
His6-tagged chromobodies and NTA-M
2+
-complex-modified MSNs; (2) cellular uptake of 
MSNs, and (3) endosomal release triggers for the enhancement of chromobody release 
efficiency. MSN-Ca
2+
, MSN-Ni
2+
 and MSN-Zn
2+
 carriers all are applicable for successful 
intracellular chromobody delivery, while DMSO and chloroquine are effective triggers for 
drastically increased chromobody release efficiency. We could clearly demonstrate the 
functionality of the delivered chromobodies based on their specific binding to GFP-LMNA. 
Thus, the mesoporous MSN-M
2+
 carriers can now enable the direct delivery of chromobodies 
into cells to image and understand biological processes. Moreover, we envision that the novel 
delivery strategy based upon the MSN-M
2+
 carriers can be generalized toward the cellular 
delivery of other His-tagged proteins aimed at various biological applications.  
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5.4 Experimental 
Materials 
Tetraethyl orthosilicate (TEOS, Aldrich, ≥ 99%), (3-mercaptopropyl)triethoxysilane 
(MPTES, Aldrich, ≥ 80%), cetyltrimethylammonium p-toluenesulfonate (CTATos, Sigma), 
triethanolamine (TEA, Aldrich, 98%), bi-distilled water is obtained from a Millipore system 
(Milli-Q Academic A10). 6-Maleimidohexanoic acid (Aldrich), N(alpha),N(alpha)-
bis(carboxymethyl)-L-lysine hydrate (NTA-lysine, Aldrich), N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide (EDC, Alfa-Aesar, 98%), N-hydroxysulfosuccinimide sodium salt (sulfo-
NHS, Aldrich), iron (II) chloride tetrahydrate (Sigma Aldrich), cobalt (II) chloride 
hexahydrate (Aldrich), nickel chloride hexahydrate (Riedel-de Haen), copper chloride 
dihydrate (LMU, Germany), zinc chloride (Aldrich), calcium chloride dihydrate (LMU, 
Germany), magnesium chloride (Aldrich), tris(hydroxymethyl)-aminomethane (TRIS, ≥ 99%, 
ROTH), acetic acid (99% - 100%, ROTH), thiazolyl blue tetrazolium bromide (MTT, 
≥ 97.5%, Sigma), dimethyl sulfoxide molecular biology grade (DMSO, Applichem), 3-
Maleimidopropionic acid N-hydroxysuccinimide ester (99%, Sigma Aldrich), 3,9-Bis(3-
aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]undecane (AK linker, Tokyo Chemical Industry), 
formaldehyde solution (37 %, Applichem), SSC buffer 20x (Sigma), Dulbecco’s Modified 
Eagle’s Medium (DMEM, Sigma), Dulbecco’s Phosphate Buffered Saline (PBS, Sigma), 
FBS Superior (Biochrom, S0615), Gentamycin solution (SERVA, 50 mg ml
-1
), trypsin-
EDTA solution (Sigma, T3924), Dulbecco’s Modified Eagle’s Medium – phenol red free 
(DMEM, Sigma), L-glutamine solution (200 mM, Sigma), HEPES solution (1 M, Sigma). 
MSN synthesis and modification 
The MSN-SH was synthesized following a modified recipe reported earlier.
14
 In brief, TEA 
(47 mg, 0.32 mmol), CTATos (0.263 g, 0.58 mmol) and H2O (13.7 g, 0.77 mmol) were 
mixed in a 100 ml glass flask and vigorously stirred (1250 rpm) at 80 ⁰C until the solution 
became homogeneous. A mixture of TEOS (1.8 g, 8.64 mmol) and MPTES (0.23 g, 
0.96 mmol) was then added and the solution was continuously stirred (1250 rpm) at 80 ⁰C for 
2 h. Afterwards the reaction solution was cooled down to room temperature under ambient 
conditions, and the particles were collected by centrifugation (43146 x g, 20 min). The 
organic template extraction was carried out right after the particle collection. The particle 
pellet was re-suspended in an ethanolic solution (100 mL) containing 2 g of ammonium 
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nitrate, and the solution was heated to 90 ⁰C under reflux for 1 h. The second template 
extraction step was subsequently performed by heating the particles under reflux at 90 ⁰C in 
an ethanolic solution (100 mL) containing 10 mL of hydrochloric acid (37 %). The MSN-SH 
was collected by centrifugation (43146 x g, 20 min) and was washed with water and EtOH 
after each extraction step.  
The template-extracted MSN-SH was then modified to yield NTA-functionalized MSN 
(MSN-NTA). 60 mg of MSN-SH and 30 mg (0.142 mmol) of 6-maleimidohexanoic acid 
were mixed in 12 ml of EtOH. The mixture was stirred at room temperature overnight. The 
resulting MSN-COOH particles were collected by centrifugation (43146 x g, 20 min), washed 
twice with EtOH and re-dispersed in 12 ml of EtOH. The amount of 40 mg of MSN-COOH 
in 8 ml of EtOH was then mixed with EDC (15 l, 67.5 mol) at room temperature for 
10 min. Sulfo-NHS (14.6 mg, 67.5 mol) and NTA-lysine (17.5 mg, 67.5mol) were mixed 
in 1 ml of H2O and afterwards added to the MSN solution. The mixture was stirred at room 
temperature for 2 h, and the resulting MSN-NTA particles were washed twice with H2O and 
EtOH to remove the residual chemicals. 20 mg each of MSN-SH, MSN-COOH and MSN-
NTA were dried for further characterization. 
Characterization of MSN 
Transmission electron microscopy (TEM) was performed at 200 kV on a Jeol JEM-2010 
instrument with a CCD detection system. A drop of diluted MSN suspension was dried on a 
carbon-coated copper grid at room temperature for several hours before TEM observation. 
Nitrogen sorption measurements were performed on a Quantachrome Instrument NOVA 
4000e at 77 K. Samples (about 15 mg) were degassed at 120 ⁰C under vacuum (10 mTorr) for 
12 h before measurement. The pore volume and pore size distribution were calculated based 
on non-local NLDFT procedures provided by Quantachrome, using the adsorption branch of 
N2 on silica. The hydrodynamic sizes of MSNs were measured by dynamic light scattering 
(DLS) analysis using a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne 
laser (633 nm). Infrared spectra of different organic functional groups on MSNs were 
recorded on a Thermo Scientific Nicolet iN10 IR-microscope in reflection-absorption mode 
with a liquid-N2 cooled MCT-A detector.  
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Generation of GFP-specific chromobody 
GFP-specific nanobody
39
 expression was performed in E. coli (JM109). Expression was 
induced with 0.5 mM of isopropyl beta-D-1-thiogalactopyranoside (IPTG, ROTH), and cells 
were incubated at 37 °C for 24 h. Cells were lysed in the presence of Lysozyme (100 g ml-1; 
Serva, Germany), DNase (25 μg ml-1; Applichem, Germany) and phenylmethanesulfonyl 
fluoride (2 mM, PMSF, Sigma) followed by sonication (Branson
®
 Sonifier; 16 x 8 sec, 20% 
Amplitude) and debris centrifugation at 20000 x g for 30 min. Protein purification was 
performed with an Äkta FPLC system (GE Healthcare, USA) using a 5 mL His-Trap  column 
(GE Healthcare, USA); peak fractions were concentrated to 2 ml using Amicon filter columns 
(cut-off 10 kDa, Merck Millipore, Germany) followed by size exclusion chromatography 
using a Superdex 75 column (GE Healthcare, USA). Peak fractions were pooled and protein 
aliquots were shock-frozen and stored at -80 °C. 1 mg purified nanobody protein was then 
labeled with ATTO 647N (ATTO-TEC, Germany) with a theoretical DOL (degree of 
labeling) of 3, according to the manufacturers’ instructions. Unbound dye was removed by 
gel filtration in PD10 columns (GE Healthcare, USA). The final ATTO 647N labelled GFP-
specific chromobody was obtained and preserved in PBS in the concentration of 1 mg ml
-1
. 
Chromobody loading and release in vitro test 
MSN-NTA (200 g per vial, 6 vials) was treated with 50 mM solutions of different metal 
ions (0.5 mL each) (FeCl2, CoCl2, NiCl2, CuCl2, ZnCl2 or CaCl2) at room temperature for 6 h. 
After metal ion immobilization, the excess un-bound metal ions were washed out with 3 ml 
of H2O. 200 g of each NTA-M
2+
-complex-modified MSNs (MSN-M
2+
) was then suspended 
in 150 l of chromobody loading buffer where the concentration of chromobody was 
100 g ml-1 in 0.05 M Tris-acetate buffer (pH 8.0), and incubated at 4 °C for 2 h. The un-
bound chromobodies were then removed by centrifugation (4218 x g, 3 min) and the 
chromobody-loaded MSNs (MSN-M-Cbs) were washed 3 times (1 ml per wash) with 0.05 M 
Tris-acetate buffer (pH 8.0). Centrifugation (4218 x g, 3 min) was applied in every wash step 
to separate the supernatant and particles. Before the buffer release experiments, each type of 
MSN-M-Cbs was separated into two vials holding equal amounts (100 g MSN per vial). 
Subsequently, 150 l of PBS having different pH values (pH 7 and pH 5) were added to 
suspend the MSN-M-Cbs (100 g). The in vitro chromobody release experiments were 
performed at 37 °C for 16 h. The solutions with released chromobody were centrifuged 
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(4218 x g, 3 min) and then the supernatants were collected. The final chromobody release 
supernatants were quantified via their fluorescence intensity at 669 nm (excitation 644 nm) in 
a 96-well plate (Greiner Bio-One, Germany) by a microplate reader (Infinite® M1000 PRO, 
TECAN, Switzerland). The quantification was based on a calibration curve with a series of 
diluted pure chromobody solutions. 
Cell culture and stable cell lines 
MEF cells were cultured in DMEM medium supplemented with 10 % FBS and 50 g ml-1 
gentamycin (cell culture medium) under 5 % CO2 at 37 °C. 
The plasmid construction for stable cell line generation was performed as follows. The 
plasmid pmEGFP-N1 was constructed by cloning of membrane EGFP
40
 into pEGFP-N1 
vector (Clontech) with AgeI and BsrGI endonucleases (Thermo Fisher Scientific) to 
substitute the EGFP with mEGFP. To prepare the pCAG-eG-LMNA-IB plasmid, the mouse 
LmnA/C gene was amplified with primers (forward primer: 5’-GGG CGA TCG CAT GGA 
GAC CCC GCT ACA and reverse primer: 5’-AGT CGC GGC CGC TTT ACA TGA TGC 
TGC) by PCR and cloned into plasmid under a CAG promoter with AsisI and NotI restriction 
sites. 
To make the GFP-LMNA expression cell line, pCAG-eG-LMNA-IB was transfected into 
MEF cells with Lipofectamine 2000 reagent (Invitrogen), and positive cells (MEF-G-LMNA) 
were selected with 6 µg ml
-1
 blasticidin (Sigma) for two weeks then sorted with a 
fluorescence-activated cell sorting (FACS) Aria II (Becton Dickinson) instrument. For the 
mEGFP expression cell line, pmEGFP-N1 was transfected into MEFs, and mEGFP stable 
expression cells (MEF-mEGFP) were purified by FACS two weeks after transfection. 
Sample preparation for cellular uptake experiments of MSNs  
Live cell imaging medium (LCIM) containing DMEM – phenol red free, FBS (10%), L-
glutamine (200 M), HEPES (20 mM) and gentamycin (50 g ml-1) was used for cell 
incubation in all live cell microscopy experiments. 
For real-time tracing of cellular uptake of MSN-Ca-Cbs, MEF-G-LMNA cells were seeded 
on a 2-well -Slide (ibidi, Germany) in 50% confluence (the proportion of the culture slide 
surface which is covered by cells) for overnight incubation. In each culture well, 1 ml of 
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culture medium or LCIM was used for either cell culture or microscopy. 5 g ml-1 of MSN-
Ca-Cb in serum-free LCIM was added to cells and images were acquired at 10 min, 20 min, 
30 min, 1 h and 2 h after the addition of MSN-Ca-Cbs.  
For the high content live cell imaging, MEF-G-LMNA cells were plated on 24-well plates 
(Corning, USA) in 70 % confluence. The working volume for all kinds of solution (cell 
culture medium, PBS, etc.) in the 24-well plate is 0.5 ml per well.  MSN-Ca-Cb with 
different concentrations (5 g ml-1, 10 g ml-1 and 20 g ml-1) in serum-free cell culture 
medium were added to cells. At indicated time points (10 min, 20 min, 30 min, 1 h and 2 h), 
cells were washed with PBS three times to remove residual MSN-Ca-Cbs in the medium. 
CellMask
TM
 orange (Thermo Fisher Scientific) (5 mg ml
-1
 in DMSO) was diluted 1000x in 
LCIM and incubated with cells at 37 ⁰C for 10 min for plasma membrane staining. After the 
plasma membrane staining, the CellMask solution was removed. LCIM was then added to the 
sample and high content imaging was performed immediately. 
For the super-resolution microscopy (3D SIM), MEF-mEGFP cells were cultured on an 
18 x 18 mm coverslip in a 6-well plate (Corning, USA) (3 × 10
5
 cells per well). 10 g ml-1 of 
Cy3 (Lumiprobe, Germany) -labelled MSNs (MSN-Cy3) in 2 ml of serum free cell culture 
medium were added to cells and incubated for 2 h. Cells were then washed with PBS three 
times to remove residual MSNs, followed by fixation using 3.7% of formaldehyde in PBS 
(10 min in room temperature). DAPI (1 g ml-1 in PBS) counterstaining (10 min in room 
temperature) was performed after cell fixation. The sample was then mounted in Vectashield 
antifade mounting medium (Vector Laboratories, USA) to a glass slide.  
Intracellular chromobody delivery - sample preparation 
MEF-G-LMNA cells in cell culture medium were seeded on either a 2-well-Slide (1 ml per 
well) or a 24-well plate (0.5 ml per well) in 50% confluence one day before the intracellular 
chromobody delivery experiment. The applied culture medium or LCIM volume in each well 
(1 ml per well for 2-well-Slide; 0.5 ml per well for 24-well plate) is the same for all 
following intracellular delivery experiment. MSN-Ca-Cbs, MSN-Ni-Cbs and MSN-Zn-Cbs 
were prepared in serum-free cell culture media at a concentration of 5 g ml-1, respectively. 
The cell culture medium was removed from the pre-seeded cells followed by the addition of 
pre-mixed MSN-M-Cb containing medium. The MSN-M-Cbs were incubated with cells at 
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37 °C for 2 h. Afterwards, the residual particles in the medium were washed out by PBS, and 
the cells were incubated in LCIM for the following live cell imaging processes.   
Experiments with samples treated with endosomal triggers were carried out according to two 
different approaches. MSN-Ca
2+
 was the main carrier used in the following experiments. For 
the INF7 treatment, INF7 peptide (Biosyntan GmbH) was conjugated on MSNs with pH-
responsive acetal linkers as indicated in Figure S5. In brief, 10 mg (37 mol) of 3-
(Maleimido)propionic acid N-hydroxy succinimide (dissolved in 100 l of DMSO) and 6 mg 
(22 mol) of AK linker (dissolved in 1 ml of 1x SSC buffer, pH 7.4) were mixed at room 
temperature and stirred for 1 h. 5 mg of MSN-SH in stock solution (20 mg ml
-1
 in EtOH) was 
collected by centrifugation (16837 x g, 5 min) and re-suspended in previous solution. The 
mixture was stirred at room temperature overnight. The resulting MSN-AK-linker particles 
was collected by centrifugation (16837 x g, 5 min) and washed by H2O (10 ml per wash, 3 
times wash).  INF7 peptide consisting cysteine on its C-terminus was conjugated to 1 mg of 
MSN-AK-linker particle with a content of 10 INF7 molecules per MSN in 1 ml of DMSO. 
The mixture was stirred at room temperature for 1 h and the final MSN-INF7 particles were 
washed with 1 ml of DMSO two times. MSN-INF7s (1 g ml-1) and MSN-Ca-Cbs (5 g ml-1) 
were co-incubated with MEF-G-LMNA cells in serum-free cell culture medium for 2 h. The 
residual particles in the incubation medium were afterwards washed out by PBS (1 ml per 
well). The MSN-INF7 and MSN-Ca-Cb treated cells were then incubated in LCIM for live 
cell imaging. For the acid shock treatment, DMSO and chloroquine release trigger tests, PBS 
(pH 6), 7% DMSO in LCIM and 500 M chloroquine in LCIM were introduced to MSN-Ca-
Cb-treated cells and incubated at room temperature for 5 – 10 min. The release trigger 
solutions were then removed from the cells, and cells were then incubated in LCIM for live 
cell imaging. 
Optical microscopy 
Spinning Disc 
MSN-M-Cb-treated cells plated on 2-well -Slide were selected and imaged in LCIM. 3D 
stacks were acquired with an UltraVIEW Vox spinning disc confocal system (PerkinElmer, 
UK) in a closed live cell microscopy chamber (ACU control, Olympus, Japan) heated to 
37 °C, with 5% CO2 and 60% humidified atmosphere, mounted on a Nikon Ti microscope 
(Nikon, Japan). Image acquisition was performed using either 63x/1.4 NA or 40x/1.3 NA 
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Plan-Apochromat oil immersion objective lenses. Images were obtained with a cooled 14-bit 
EMCCD camera (C9100-50, CamLink) with a frame size of 1024 x 1024 pixels. GFP and 
fluorophores were excited with 488 nm (10% power density), 561 nm (5% power density) or 
647 nm (30% power density) solid-state diode laser lines.  
High-throughput microscopy and analysis 
High-throughput images of living cells on a 24-well plate (3 × 10
4
 cells per well) were 
acquired automatically with an Operetta
®
 High Content Imaging System (PerkinElmer, UK). 
Imaging was performed using a 40× air objective lens. GFP, CellMask and chromobody- 
ATTO 647N were excited and the emissions were recorded using standard filters. The 
exposure time was controlled at 200 – 400 ms to avoid pixel saturation, and 50 different 
fields were imaged in each well. In the cellular uptake experiment, on average 600 cells were 
imaged. The images were then analyzed by the Harmony
®
 analysis software (PerkinElmer) 
with a sequence as described in Figure S3. In the endosomal release trigger, cell viability and 
cell proliferation analyses, MEF-G-LMNA cells before any treatment were first imaged and 
counted. After addition of MSNs and the following endosomal release triggers treatment, 
cells were imaged and counted again. The definition of cell viability % is: GFP-LMNA-
positive cells after endosomal release trigger treatment/GFP-LMNA-positive cells before any 
treatment × 100%. The blank group refers to the cells incubated in serum-free DMEM culture 
medium for 2 h without MSN and endosomal release trigger treatment. Control group refers 
to the cells incubated with MSN-Ca-Cbs for 2 h, but no endosomal release trigger treatment 
afterwards. Chromobody release efficiency was recorded 24 h after MSN-Ca-Cbs 
introduction. Cells exhibiting a chromobody release signal were counted visually. The 
chromobody release efficiency is defined as: chromobody-LMNA-positive cells/GFP-
LMNA-positive cells × 100%. Cells with different treatments were imaged and counted every 
24 h for the cell proliferation calculation. 400 to 10000 cells were imaged in the endosomal 
release trigger, cell viability and cell proliferation tests depending on the recording time point.        
Super-resolution microscopy (3D-SIM) 
Super-resolution microscopy (3D-SIM) was performed with a Delta Vision OMX v3 
(Applied Precision, GE Healthcare) instrument equipped with 405 nm, 488 nm and 593 nm 
laser diodes, a 100×/1.4 NA Plan-Apochromat oil immersion objective lens (Olympus) and 
Cascade II:512 EMCCD cameras (Photometrics). The image stacks were acquired with a z-
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step of 125 nm and with 15 images per plane (five phases, three angles). The raw data were 
computationally reconstructed by using the SoftWorx 5.1.0 software.  
MTT assay 
MEF cells (wild type) were first seeded on 96-well microplates with the concentration of 
5 × 10
3
 cells per well in cell culture medium (100 l per well), and incubated at 37 °C for 
16 h. MSNs (un-MSNs, MSN-Ni
2+
, MSN-Zn
2+
, MSN-Ca
2+
) (2 mg from stock solution) in 
EtOH were centrifuged down (16873 x g, 5 min), and re-suspended in cell culture medium at 
the concentration of 1 mg ml
-1
. The MSN solutions were then series diluted to the desired 
particle concentrations. After removal of the culture medium, 100 l of MSN solution with 
different concentrations was added to each well. Also, 100 l of cell culture medium was 
added to cells to serve as control group. The wells with 100 l of cell culture medium but 
without cells were referred to as blank groups. MSN solutions and cells were then co-
incubated at 37 °C overnight. Afterwards, the MSN-treated cells were washed with PBS 
buffer three times to remove the residual particles. MTT was diluted in cell culture medium at 
the concentration of 0.5 mg ml
-1
 and then added to the cells (100 l per well). After 
incubating the MTT solution and cells for 4 h, purple crystals metabolized by healthy cells 
were observed. Subsequently, 100 l of pure DMSO was added to each well and the samples 
were incubated at 37 °C for 1 h until the purple crystals were dissolved. The absorbance at 
570 nm and the reference absorbance at 655 nm were measured on each sample using a 
Microplate reader (Infinite® M1000 PRO, TECAN). 
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5.5 Appendix 
 
Figure 5-6 Characterization of NTA-conjugated MSNs (MSN-NTA).  (a) Nitrogen 
sorption isotherm, (b) pore size distribution and (c) DLS analysis (particles suspended in 
EtOH) indicated that MSN-NTA preserved the large-pore mesoporosity and colloidal 
stability after surface modification. 
 
 
Figure 5-7 Cytotoxicity tests (MTT assay) of different metal-treated MSN-NTA samples 
(MSN-Ni
2+
, MSN-Zn
2+
 and MSN-Ca
2+
) and un-functionalized MSN (un-MSN) on MEF 
cells (wild type). All the particle types show no significant cytotoxicity below the particle 
concentration of 100 g ml-1. 
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Figure 5-8 High-throughput imaging evaluation of cellular uptake of MSN-Ca-Cbs. 
MEF-G-LMNA living cells were stained with CellMask orange and imaged at indicated time 
points after the addition of MSN-Ca-Cbs. Fluorescence from GFP, CellMask orange, and 
ATTO 647N (labeled on chromobodies) were recorded separately with Operetta high content 
image analysis system using standard filter for 488 nm, 546 nm and 647 nm emission. Images 
were analyzed with Harmony
®
 analysis software as the following sequence. (a) The nuclear 
region is segmented from the background according to GFP-LMNA signal where the GFP-
LMNA signal is shown in grey and the circular color lines stand for the segmentation results. 
Most of the recognized nuclear region fit the GFP-LMNA signal, which indicates a correct 
segmentation. (b) The cytoplasm region was recognized via CellMask signal segmentation. 
The cytoplasm region is obtained by subtraction of nuclear region obtained from step (a). The 
border of the segmented cell region was shown as closed color lines around the nuclear 
region. (c) Recognition of MSN-Ca-Cbs taken up by the cells. Internalized MSN-Ca-Cbs 
were visualized as spots within the cytoplasm region, and the spots recognition was presented 
as color dots in the image. The segmented results (nuclei, cytoplasm and MSN-Ca-Cb spots) 
were used to define populations. Population 1: Cell = GFP-LMNA nucleus plus its 
surrounding cytoplasm region. Population 2: MSN-uptake cell = cell with more than two 
MSN-Ca-Cb spots in its cytoplasm and nucleus region. The evaluation results were based on 
the calculation: (i) % cell take up MSN-Ca-Cbs = MSN-uptake cells/total cells; (ii) average 
MSN-Ca-Cb spots per MSN-uptake cell = total spots number in all MSN-uptake cells/MSN-
uptake cells. 
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Figure 5-9 Intracellular delivery of chromobodies via different metal-treated MSNs. (a) 
4 h after MSN-Ni-Cb/MSN-Zn-Cb/MSN-Ca-Cb incubation. (b) 96 h after MSN-Ni-Cb/MSN-
Zn-Cb/MSN-Ca-Cb incubation. 
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Figure 5-10 Delivery of free chromobodies into MEF-G-LMNA cell. 25 nM free 
chromobodies was incubated with MEF-G-LMNA. 2 h after incubation, the residual free 
chromobodies in the medium were washed out by PBS, and the cells were incubated in Live 
Cell Imaging Medium for the following live cell imaging process. LysoTracker was used for 
lysosomes tracking during the imaging process. 
 
 
Figure 5-11 Conjugation of INF7 peptide to MSNs via pH-responsive acetal linker. 
MSN-SH was conjugated with pH-responsive acetal linker (3,9-bis(3-aminopropyl)-2,4,8,10-
tetraoxaspiro-[5,5]-undecane) (AK linker) via the maleimide-NHS heterobifunctional 
crosslinker (3-Maleimidopropionic acid NHS ester) yielding MSN-AK-linker. INF7 peptide 
consisting of cysteine on its C-terminus was covalently attached to MSN-AK-linker through 
the maleimide-thiol reaction. 
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Appendix 5-12 
The calculation of chromobody loading capacity in MSNs 
 The radius of a MSN= 50 𝑛𝑚  
 Particle volume (sphere) =
4
3
𝜋𝑟3 = 5.236 × 105 𝑛𝑚3 = 5.236 × 10−16 𝑐𝑚3 
 Pore volume of MSNs (measured by N2 sorption): 2.3 𝑐𝑚3/𝑔 
 Pure silica density: 2.648 𝑔/𝑐𝑚3 
 1 g silica has: 
1𝑔
2.648
𝑔
𝑐𝑚3
= 0.38 𝑐𝑚3 
 1 g MSN has: 0.38 𝑐𝑚3 + 2.3 𝑐𝑚3 = 2.68 𝑐𝑚3  
 MSN density assumption: 
1𝑔
2.68 𝑐𝑚3
= 0.37 𝑔/𝑐𝑚3 
 Single particle weight = 5.236 × 10−16 𝑐𝑚3 × 0.37 𝑔/𝑐𝑚3 = 1.94 × 10−16𝑔 
 1 mg MSN has 
10−3𝑔
1.94×10−16𝑔
= 𝟓 × 𝟏𝟎𝟏𝟐 particles 
 Molecular weight of chromobody: 14000 𝑔/𝑚𝑜𝑙 
 Chromobody loading capacity: 𝟕𝟎 𝝁𝒈 𝒄𝒉𝒓𝒐𝒎𝒐𝒃𝒐𝒅𝒚/𝒎𝒈 𝑴𝑺𝑵 
 𝟕𝟎 𝝁𝒈 𝒄𝒉𝒓𝒐𝒎𝒐𝒃𝒐𝒅𝒚 =
70×10−6𝑔
14000
𝑔
𝑚𝑜𝑙
= 5 × 10−9𝑚𝑜𝑙 
= 5 × 10−9𝑚𝑜𝑙 × 6.02 × 1023
 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙
= 𝟑 × 𝟏𝟎𝟏𝟓 𝒄𝒉𝒓𝒐𝒎𝒐𝒃𝒐𝒅𝒚 𝒎𝒐𝒍𝒆𝒄𝒖𝒍𝒆𝒔 
 Chromobody loading capacity 
=
3×1015 𝑐ℎ𝑟𝑜𝑚𝑜𝑏𝑜𝑑𝑦 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
5×1012 𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
=
𝟔𝟎𝟎 𝒄𝒉𝒓𝒐𝒎𝒐𝒃𝒐𝒅𝒚 𝒎𝒐𝒍𝒆𝒄𝒖𝒍𝒆𝒔 
𝑴𝑺𝑵
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Table 5-1 
Sample Element mg
[1]
 mmol
[1]
 Molar ratio 
 Si 563.3 ± 91.3 20.1 1 
MSN-Ca
2+
 S 10.07 ± 0.34 0.31 0.016 
 Ca 0.29 ± 0.09 0.007 0.0004 
 Si 476.8 ± 9.97 17.0 1 
MSN-Ca-Cb S 9.11 ± 1.15 0.28 0.017 
 Ca 0.17 ± 0.03 0.004 0.0003 
 Si 532.0 ± 47.73 19.0 1 
MSN-Ni
2+
 S 9.8 ± 0.32 0.31 0.016 
 Ni 0.44 ± 0.01 0.007 0.0004 
 Si 507.8 ± 4.45 18.1 1 
MSN-Zn
2+
 S 10.12 ± 0.55 0.32 0.017 
 Zn 1.49 ± 0.03 0.023 0.0013 
Notes: [1] The element amount is relative to 1 g of the measured sample. 
           [2] Triplicate experiments were performed in each sample. 
Table 5-1. Elemental analysis of MSN-M
2+
 and MSN-M-Cb samples via ICP-OES 
approach. 
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6 Optimisation and Live Cell Tracking of Nanoparticle 
Mediated Protein Delivery Through an Inducible Split Venus 
Based System  
This chapter is based on the following manuscript: 
Hsin-Yi Chiu, Jack Bates, Jonas Helma, Hanna Engelke, Hartmann Harz, Thomas Bein and 
Heinrich Leonhardt, to be submitted. 
Abstract 
Mesoporous silica nanoparticles (MSNs) are promising nanocarriers for intracellular protein 
delivery with potential applications in disease treatment as well as cell research. To optimize 
and investigate their use we have developed a convenient, background free, live-cell Venus 
complementation based molecular sensor that exclusively detects delivered protein that is 
both functionally viable and bioavailable. We have applied this sensor in parallel with the 
MTT assay to maximize the protein delivery and biocompatibility of our large-pore 
multifunctional MSNs and have shown highly efficient protein transfection rates of about 
80%. Furthermore, we have demonstrated tracking of live cell protein delivery with good 
temporal resolution and disentangled the timing of protein uptake from that of sensor 
dynamics through the use of built-in chemically inducible components. We believe that the 
sensor will be suitable for application with a wide range of protein nanocarriers enabling 
simple multi-parameter optimization as well as comparison between nanocarriers. 
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6.1 Introduction 
Despite the increasing promise of protein therapeutics,
1,2
 their cellular delivery remains a 
major barrier to successful in vivo and medical implementation. Any technology addressing 
this challenge must tackle complications including short protein serum half-life, cellular 
uptake and endosomal entrapment. Mesoporous silica nanoparticles (MSNs) feature 
properties that make it possible to overcome these challenges. Specifically, a stable 
framework to shelter cargo from proteases and the immune machinery in addition to high 
cellular uptake efficiency and flexible surface functionalization for controlled drug release
3-6
 
make them particularly promising candidates. This versatility of MSNs has been utilized for 
the delivery of chemotherapeutic agents,
7,8
 proteins,
9-11
 oligonucleotides,
12,13
 and 
chromobodies.
14
 Having previously delivered bioactive proteins using MSNs,
10,11,14
 
researchers have also sought to maximize the protein delivery efficiency whilst retaining 
good biocompatibility. For the determination of the delivery efficiency it is important to take 
into account that successfully delivered proteins must have both undergone endosomal escape 
and retained their function.
15
.   
An array of techniques has been developed to quantify efficiencies of cellular protein 
delivery. The methods often exploit pre-existing cytoplasm/endosome differences such as 
pH,
16
 enzyme content,
17
 access to DNA,
18
 redox status,
19,20
 or localization,
21
 others still have 
utilized the physical separation of the compartments to create exploitable distinctions 
between the two environments.
22,23
 However, despite the advantages of each of these methods, 
many of these techniques do not provide a real-time readout, give a non-linear output due to 
amplification, transcription or recombination, give no indication of post-endosome protein 
functionality, or require more complex image analysis. Quantifying delivery efficiencies of 
functional proteins in real-time still remains challenging. 
Recently GFP-based bimolecular fluorescence complementation (BiFC) assays have been 
developed, consisting of two proteins derived from genetic splitting of a fluorescent protein 
that fluoresce after dimerisation only. With one protein already present in the cell and the 
other being delivered, they produce direct fluorescent readouts for endosomal escape whilst 
retaining a functional element demonstrative of at least partial protein integrity.
24-26
 These 
assays have been successfully employed for the comparison of cell penetrating peptide (CPP) 
function as well as assessment of antibody internalization. Unfortunately, fluorescent tracking 
of protein uptake using these systems is complicated by the absence of a mechanism to 
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distinguish the timing of protein release from that of system complementation. It is therefore 
not possible to determine if, for example, a gradual increase in fluorescence is indicative of 
slow protein release or simply of a delay due to fluorescent protein formation and fluorophore 
maturation timing. 
When designing a method to quantify the efficiency of our protein delivery system, we 
reasoned that an understanding of system dynamics and efficacy could be attained with a 
BiFC sensor if it could be inducibly controlled. To this end, here the chemically induced 
dimerisation (CID) components FKBP/FRB
27
 are utilized and serve to strongly 
heterodimerise the complex exclusively in the presence of rapamycin
28
. The two CID units 
are genetically fused to BiFC protein halves. The split Venus fluorescent protein (split 
154/155) was selected for its high fluorescence signal, rapid maturation at 37 °C and low 
auto-complementation.
29,30
 
In our study, the complete BiFC/CID system is divided onto two constructs. A mammalian 
expression cassette is used for stable cell line production (Scheme 6-1a) and features the N-
terminal portion of Venus (VN) fused C-terminally to FKBP via a flexible linker 
(GGGSx3). The protein expressed also contains an N-terminal c-myc nuclear localization 
signal (NLS)
31
 which serves to concentrate fluorescence in the nucleus of the cell enabling 
nuclear/cytoplasm fluorescence comparison and easy visual cell segregation. Furthermore, 
an mRFP follows VN which detaches via a T2A peptide
32
 and acts as an expression 
reporter used during stable cell line production. Moreover, it serves as calibration marker of 
the sensor intensity. Using HeLa Kyoto cells
33
 we produced a monoclonal stable cell line 
(HeLa-FKBP-VN) that expresses the cassette at a high level using the CAG promoter.
34,35
 
The complementary half of the BiFC/CID complex (Scheme 6-1b) consisting of His-tagged 
FRB domain fused N-terminally to the C-terminal half of Venus (VC) is expressed and 
purified using E. coli and affinity chromatography. The protein can thereafter be loaded 
into the MSNs for cellular delivery (Scheme 6-1c).  
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Scheme 6-1 Two-component cytosolic protein delivery detection system. (a) Layout of the 
mammalian expression cassette used to generate the HeLa-FKBP-VN stable cell line. (b) 
Layout of the bacterial expression cassette. (c) MSN-mediated application of the cytosolic 
protein delivery detection system. 1 Purified His-tagged FRB-VC proteins are loaded into 
MSNs via interaction with Ni-NTA groups on the surface of the MSN pore system. 2 
Charged MSN-FRB-VC complexes bind to the cell surface and are 3 endocytosed into the 
cell. Lower pH in the endosomal system causes accelerated FRB-VC dissociation from the 
MSN. 4 Chloroquine shock (0.5 mM in the medium, RT, 5 min) triggers endosomal protein 
release followed by 5 free protein diffusion in the cytoplasm and further into the nucleus. 6 
Addition of rapamycin leads to the formation of FRB/rapamycin/FKBP ternary complexes 
subsequently driving Venus complementation and fluorophore maturation. 
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Following cellular internalization of FRB-VC loaded MSNs (MSN-FRB-VC) via 
endocytosis,
36
 the MSN carrier with cargo proceeds through the endosomal system where a 
decrease in pH causes dissociation of His-tagged FRB-VC from the MSN. An endosomal 
release trigger (chloroquine shock) is then applied to prompt endosomal rupture and 
cytosolic release of FRB-VC. FRB-VC can then diffuse to the nucleus and interact with 
FKBP-VN which is primed with rapamycin at saturation levels. FKBP-rapamycin-FRB 
forms a ternary complex which approximates the Venus halves thus facilitating 
complementation and chromophore maturation. Successful protein delivery can then be 
observed in a rapid and non-amplifying manner through visualization and measurement of 
Venus fluorescence in the nucleus.  The fluorescent protein requires reconstitution prior to 
chromophore formation and thus only protein that has either evaded or escaped the endosome 
system and remains functional is able to produce signal in the nucleus.  
6.2 Results and Discussion 
Large-pore MSNs were surface-functionalized with NTA-Ni complexes (MSN-Ni) through 
a series of post-modifications (Figure 6-1a) to accommodate pH dependent binding and 
release of the His-tagged FRB-VC.
11,14,37
 STEM and SEM images (Figure 6-1b) indicated 
that the resulting nitrilotriacetic acid-modified MSNs (MSN-NTAs) exhibit uniform 
particle size, coral surface morphology consisting of irregular pore shape (pore size ranging 
from 10 – 40 nm) consistent with the structure of the un-functionalized form (appendix 
Figure 6-6). DLS measurements (Figure 6-1c) and N2 sorption analyses (Figure 6-1d-e) 
further confirmed these findings. Appendix Table 1 summarizes the characterization results 
of MSNs before and after NTA modification.    
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Figure 6-1 Synthesis and characterization of MSNs for His-tagged protein controlled 
binding and release.  (a) Surface modification series of un-functionalized MSNs (un-MSNs) 
to MSN-Ni. (b) STEM (left) and SEM (right) images of MSN-NTA, scale bar: 50 nm. 
Characterization of un-MSN and MSN-NTA: (c) dynamic light scattering, (d) N2 sorption 
isotherms and (e) pore size distribution calculated via NLDFT mode. 
We applied our protein delivery sensor in parallel with MTT assays to optimize MSN 
dosage for protein delivery and biocompatibility. As expected, the HeLa-FKBP-VN cell 
line exhibits no increased fluorescence in the Venus channel (Venus fluorescence was 
visualized in the GFP channel) (Figure 6-2).  
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Figure 6-2 Live cell confocal imaging of MSN-mediated intracellular protein delivery in 
the cytosolic protein delivery detection system. Different MSN-FRB-VC concentrations 
were incubated with HeLa-FKBP-VN cells. Images were taken 20 h post endosomal release 
trigger (chloroquine shock). Scale bar: 10 m. 
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Introduction of unloaded MSNs to the cells also did not increase Venus fluorescence 
(Figure 6-2, 6-3a, 6-3b). In contrast, application of MSN-FRB-VC complexes at all 
examined concentrations generated nuclear Venus signal in the cells (Figure 6-2). To 
quantify the gross Venus signal present in the cell populations we used microplate 
fluorometry. Whilst a significant increase in protein delivery is seen between the 50 µg/ml 
and 100 g/ml concentrations, the fluorescent signal saturated thereafter (Figure 6-3a). 
When we quantified the percentage of Venus positive cells via flow cytometry we saw a 
similar pattern (Figure 6-3b). A significant increase in protein transfection percentage was 
seen between the 50 g/ml and 100 g/ml concentrations indicating some dose dependency, 
with higher concentrations having no further positive effect on uptake efficiency.  
In parallel with protein delivery experiments, MTT assays were performed to evaluate 
cytotoxicity at different MSN concentrations. No significant difference in cell viability was 
seen at concentrations of 50 µg/ml and 100 µg/ml when compared to the no-MSN control 
population. However, concentrations of 150 µg/ml and 200 µg/ml were shown to be 
significantly more cytotoxic than the control. The cytotoxicity displayed at higher levels of 
MSN concentration may explain the plateau in the Venus signal we see in the protein 
delivery experiments, as damage to the cells may impair protein uptake. Further, it might 
explain the slight decrease in delivery efficiency measured with microplate fluorometry 
above 100 µg/ml. Through combination of the three data sets (Figure 6-3a-c) 100 µg/ml 
was determined to be an optimal MSN concentration due to its high protein transfection 
efficiency and low cytotoxicity. 
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Figure 6-3 Protein delivery efficiency analyses and cytotoxicity assay. (a) Fluorescence 
readout from microplate reader. (b) FACS analysis. (c) MTT assay. The results shown in (a) 
were calculated based on six biological repeats, (b) and (c) were triplicated. Error bars 
represent SDs. 
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Next we sought to observe protein delivery in a cell population over time. Using spinning 
disc microscopy, HeLa-FKBP-VN cells incubated with MSN-FRB-VC complexes 
(100 µg/ml) and rapamycin were imaged at time points prior to and following chloroquine 
shock (2 h after MSN-FRB-VCs incubation). Before the chloroquine shock, no released 
FRB-VC protein was detected (Figure 6-4a). However, following destabilization of the 
endosomes with the chloroquine shock, Venus fluorescence was visible within the nuclei of 
some cells (1%) within just 30 minutes. At a time point of 5.5 h after chloroquine shock, 
over 50% of the cells can be seen to have functional proteins released to the nuclei. At 9 h 
protein release had reached a plateau where approximately 85% of the cells exhibit 
fluorescent nuclei. A live cell image of protein release saturation (10 h post chloroquine 
shock) is shown in Figure 6-4c. A timelapse video further demonstrates sensor detection of 
intracellular protein release (Appendix Figure 6-7). An alteration of the above experiment 
was performed where rapamycin addition (250 nM) was delayed until 24 h after MSN-
FRB-VC incubation (Figure 6-4b). We reasoned that at this point the protein was likely 
already released into 80% of the cells and therefore the timing of Venus fluorescence 
should represent sensor complex formation and maturation rather than protein release. 
When comparing the onset of nuclear fluorescence within cells of a population between the 
rapamycin primed and rapamycin delayed experiments (Figure 6-4a-b) a far greater spread 
(50% timings of the two experiments) can be seen in the rapamycin primed experiment 
indicating a staggered release timing in the population. 
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Figure 6-4 Live cell tracking of protein release. (a) HeLa-FKBP-VN cells were primed 
with rapamycin before imaging. MSN-FRB-VC was added to the cells and the first image 
was recorded (time point -2 h). After 2 h, particles were washed away using PBS and 
followed by a chloroquine shock (0.5 mM in the medium, RT, 5 min) (time point: 0 h). Cells 
were tracked using confocal microscopy (spinning disc) for 22 h. (b) MSN-FRB-VC were 
incubated with HeLa FKBP-VN cells for 2 h, and subsequently the endosomal protein release 
was triggered by chloroquine shock. 22 h after endosomal protein release trigger, rapamycin 
was added to the medium, and cells were tracked using confocal microscopy (spinning disc) 
for another 5 h. (c) Live cell confocal imaging of rapamycin-primed sample 10 h after 
chloroquine shock. Scale bar: 200 m. 
However, when we compared the timing of fluorescence increase after onset within 
individual cells between the two conditions, we observed similar durations (Figure 6-5a-b). 
We interpret these results to be consistent with the aforementioned model for MSN uptake 
and his-tag mediated protein release (Figure 6-1c). The delay in fluorescence onset within 
cells in the rapamycin primed experiment can be attributed to the time taken for the 
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relevant endosomal rupture event to occur. (Further evidence that the delay may be due to 
endosomal rupture timing is the prolonged presence of enlarged endosomes after 
chloroquine shock (appendix Figure 6-8). 
 
Figure 6-5 Live cell tracking of protein release in individual cells within a population.  
Fluorescence intensity tracking from 30 cells in (a) rapamycin-primed sample and (b) 
rapamycin-delayed sample. (c) Mean fluorescence increasing time evaluated from (a) and 
(b). The central 70% of the release curves from both (a) and (b) were evaluated. Mean 
values are indicated within the box. Box range represents standard deviation and the 
whisker range displays the minimum and maximum values in the population. (d) 
Fluorescence intensity distribution among 625 cells in the rapamycin-primed sample 
recorded at 15 h post chloroquine shock. 
The similarity between the experiments in single cell fluorescence increase once initiated 
suggests that we are, in all likelihood, observing roughly analogous processes (Figure 6-5c). 
Therefore, it seems probable that the once protein release begins it proceeds in a rapid 
fashion and that in both experimental variations we are simply observing sensor 
complementation and maturation timing. This logically aligns with the proposed 
mechanism of delivery, as bulk release of already MSN-detached protein should occur 
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when the endosomal barrier is breached, thus permitting prompt protein complementation 
between the corresponding halves. 
Unlike sensors that rely upon transcription or amplification mechanisms, the ratio-metric 
nature of our sensor enables us to measure variations not only between but also within 
populations. For example, through image analysis of cell nuclei we can assess parameters 
such as the range of protein released within a population as well as means and standard 
deviations of protein released (Figure 6-5c). In consideration of the significance of cellular 
protein stoichiometry, this should be a useful tool for understanding and adapting 
nanocarriers for various tasks.  
6.3 Conclusion 
In conclusion, we have developed an inducible two-component fluorescent live cell protein 
delivery sensor that facilitates simple relative quantification of bioavailable protein levels and 
cell protein transfection efficiency. We have demonstrated that it can be used in parallel with 
the MTT assay to optimize protein loaded MSN dosage for delivery efficiency and 
biocompatibility. Moreover, we have demonstrated that it can be effectively used to track 
protein uptake in a live cell population with temporal resolution far superior to transcription-
dependent systems. Furthermore, our data demonstrate that when optimal concentrations are 
used, MSNs can achieve formidable protein delivery efficiency with a mean delivery in 
about 80% of cells. We propose that the system demonstrated would be suitable for multi-
parameter optimization, comparison, and investigation of many of the expanding repertoire of 
protein nanocarriers. 
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6.4 Experimental 
Materials 
Tetraethyl orthosilicate (TEOS, Aldrich, ≥ 99%), (3-glycidyloxypropyl)trimethoxysilane 
(GPTMS, Fluka, ≥ 97%), cetyltrimethylammonium p-toluenesulfonate (CTATos, Sigma), 
triethanolamine (TEA, Aldrich, 98%), magnesium sulfate anhydrous (99.9%, Sigma), toluene 
anhydrous (Sigma), bi-distilled water obtained from a Millipore system (Milli-Q Academic 
A10). N(alpha),N(alpha)-bis(carboxymethyl)-L-lysine hydrate (NTA-lysine, Aldrich), 
sodium carbonate (Sigma), sodium bicarbonate (Sigma), nickel chloride hexahydrate (Riedel-
de Haen), tris(hydroxymethyl)-aminomethane (TRIS, ≥ 99%, ROTH), acetic acid (99% -
 100%, ROTH), thiazolyl blue tetrazolium bromide (MTT, ≥ 97.5%, Sigma), dimethyl 
sulfoxide molecular (DMSO, Applichem, biology grade), Dulbecco’s Modified Eagle’s 
Medium (DMEM, Sigma), Dulbecco’s Phosphate Buffered Saline (PBS, Sigma), FBS 
Superior (Biochrom, S0615), Gentamycin solution (SERVA, 50 mg ml
-1
), trypsin-EDTA 
solution (Sigma, T3924), Dulbecco’s Modified Eagle’s Medium – phenol red free (DMEM, 
Gibco) , ethanol (EtOH, Aldrich, absolute). 
Synthesis and functionalization of mesoporous silica nanoparticles (MSNs) 
Un-functionalized MSNs were synthesized using a modification of a previously reported 
procedure
38
. In brief, a mixture of TEA (0.49 g, 3.3 mmol), CTATos (2.73 g, 6 mmol) and 
H2O (144 g, 8 mol) was vigorously stirred (1250 rpm) at 80°C in a 250 ml glass flask until 
the solution became homogeneous. TEOS (20.83 g, 0.1 mol) was then added and the solution 
was continuously stirred (1250 rpm) at 80°C for another 2 h, afterwards the synthesized 
particles can be observed as whitening of the solution. The as-synthesized particles were 
collected by centrifugation (7000 x g, 15 min) and subsequently subjected to organic template 
extraction. The organic template extraction was carried out by heating particles in an 
ethanolic solution (150 mL) containing 3 g of ammonium nitrate at 90 °C under reflux for 1 h 
followed by a second reflux at 90 °C in a 2 M HCl/ethanolic solution (150 mL) for 1 h. The 
un-functionalized mesoporous silica nanoparticles (un-MSNs) were collected by 
centrifugation (7000 x g, 20 min) and were washed with water and EtOH after each 
extraction step.  
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To attach epoxy groups to the surface of the MSNs, a post-synthetic grafting procedure was 
performed. 500 mg of un-MSNs were de-hydrated under reflux (130 °C) in 150 mL of 
toluene in the presence of MgSO4 for 4 h. GPTMS (190 mg, 0.83 mmol, 10 mol% of total 
silica) was subsequently added to the toluene solution, and the solution was stirred (500 rpm) 
at 130 °C for 2 h. After the solution had cooled to room temperature, the toluene was 
removed by rotary evaporator (77 mbar, 45 °C, 250 rpm). The resulting epoxy group-
modified MSNs (MSN-Epoxy) were washed three times with 150 mL of EtOH and preserved 
in 50 mL of absolute EtOH. Centrifugation (7000 x g, 20 min) was used to collect particles 
after each washing step.  
MSN-Epoxy particles were then modified to yield NTA-functionalized MSNs (MSN-NTA). 
360 mg of MSN-Epoxy and 200 mg (0.6 mmol) of NTA-lysine were mixed in 10 ml of 
carbonate-bicarbonate buffer (100 mM, pH 9) and the mixture was stirred at RT overnight. 
The functionalized MSN-NTA particles were washed three times with 100 mL of tris-acetate 
(TA) buffer (pH 8) at RT and re-suspended in 36 mL of EtOH. Centrifugation (7000 x g, 
20 min) was used to collect particles after each washing step. To immobilize Ni
2+
 on the 
surface of MSN-NTAs, 5 mg of MSN-NTA was dispersed in 5 ml of NiCl2 (50 mM in H2O) 
and stirred at RT for 4 h. The un-bound Ni
2+
 was washed out with H2O (three times with 5 ml) 
and the particles were collected following centrifugation (17000 x g , 5 min). The final NTA-
Ni complex modified MSNs (MSN-Ni) were stored in 5 mL of EtOH (MSN concentration: 
1 mg/mL) for further use.  
Characterization of MSNs 
Scanning electron microscopy (SEM) and scanning-transmission electron microscopy (STEM) 
were performed at 30 kV on a Helios NanoLab G3 UC instrument (FEI, USA) with a 
detection system containing a TLD detector and a STEM ADF detector. A drop of EtOH 
diluted MSN suspension was dried on a carbon-coated copper grid at room temperature for 
several hours before SEM/STEM observation. Dynamic light scattering (DLS) measurements 
were performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser 
(633 nm). Nitrogen sorption analysis was performed on a Quantachrome Instrument NOVA 
4000e at 77 K. Samples (15 – 20 mg) were degassed at 120 °C under vacuum (10 mTorr) one 
day before measurement. Pore size distribution curves were obtained based on non-local 
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density functional theory (NLDFT) procedures provided by Quantachrome, using the 
adsorption branch of N2 on silica.  
Plasmid Construction 
A previously described pCAG mammalian expression vector containing an IRES-Blasticidin 
selection gene following the ORF was used for creation of the pCAG-FKBP-VN-T2A-mRFP 
cassette
39
 (Scheme 1a). The protein expression vector pET28a was used for FRB-VC-Histag 
expression (Scheme 1b). The Gibson assembly method was applied for all cloning
40
. 
FRB-VC protein expression and purification 
FRB-VC protein was expressed in E. coli (BL21 strain) and was further purified in a His-trap 
column. Expression was induced through addition of 0.5 mM of isopropyl beta-D-1-
thiogalactopyranoside (IPTG, ROTH) and cells were further cultured at 18 °C overnight. 
Cells were harvested and lysed in PBS buffer containing 100 μg/ml of lysozyme (Serva, 
Germany), 2 mM of phenylmethanesulfonyl fluoride (PMSF, sigma) and 25 μg/ml of DNAse 
(Applichem, Germany) followed by sonication (Branson® Sonifier; 16 x 8 sec, 20% 
amplitude). Cell debris was collected by centrifugation at 20000 x g for 30 min. Protein 
purification was performed using an 8 M Urea purification protocol
41
 including renaturation 
of the protein via FPLC (Äkta Purifier Amersham Biosciences, GE Healthcare, USA) on a 
1 ml His-trap column (GE Healthcare, USA). Elution was performed using an increasing 
imidazole gradient rather than the step-wise imidazole increase outlined in the protocol. 
Eluted protein was desalted using the PD-10 (GE Healthcare, USA) column and concentrated 
by an Amicon filter column (cut-off 10 kDa, Merck Millipore, Germany). Purified protein in 
PBS was aliquoted followed by shock-freezing and storing at -80 °C. 
FRB-VC protein loading to MSN-Ni 
1 mg of MSN-Ni was mixed with 500 g of FRB-VC protein in 500 l of PBS at 4 °C with 
shaking (400 rpm) for 1.5 h. The resulting MSN-FRB-VC complexes were collected by 
centrifugation (3000 x g, 3 min), washed with PBS (1 mL per wash) twice, and re-suspended 
in 100 l of PBS. 
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Cell culture and stable cell line 
HeLa Kyoto cells
41
 (HeLa k, a modified HeLa cell line characterized by little cell motility 
and thus suitable for live cell time-lapse imaging) were cultured in DMEM medium 
supplemented with 10% FBS and gentamycin (50 µg/ml in cell culture medium) under 5% 
CO2 at 37°C. To generate a cell line stably expressing the pCAG-FKBP-VN-T2A-mRFP 
construct, pCAG-FKBP-VN-T2A-mRFP was transfected into HeLa k cells using 
Lipofectamine 3000 reagent (Invitrogen). Blasticidin (10 µg/ml in cell culture medium) was 
used to select cells between 48 h after transfection and 3 weeks. Highly mRFP fluorescent 
cells were then isolated via flow cytometry (FACS Aria II, BD Biosciences) to produce a 
monoclonal cell line (HeLa-FKBP-VN). 
Intracellular protein delivery for MSN concentration optimisation 
HeLa-FKBP-VN cells in DMEM culture medium were seeded on either a 2-wellibiTreat 
slide (ibidi, Germany) or a 6-well plate (Corning, USA) at 50% confluency 12 h before the 
intracellular protein delivery experiment. MSNs loaded with FRB-VC proteins (MSN-FRB-
VCs) in PBS were added to cell culture in a serum free DMEM and incubated with cells at 
37 °C for 2 h. Afterwards, the residual particles in the medium were washed out using PBS 
(1.5 mL per well) followed by a short chloroquine shock (0.5 mM in cell culture medium, 
1.5 mL per well in cell culture medium, RT, 5 min) to trigger endosomal protein release. 
Cells were then incubated in fresh cell culture medium (phenol red free). All the assays (live 
cell imaging, FACS analysis and fluorescence readout) were performed at 24 h post MSN-
FRB-VCs addition.   
Live cell imaging was performed using an UltraVIEW Vox spinning disc confocal system 
(PerkinElmer, UK) in a closed live cell microscopy chamber (ACU control, Olympus, Japan) 
mounted on a Nikon Ti microscope (Nikon, Japan). The microscopy chamber was held at 
37 °C, 5% CO2 and 60% humidity. Venus and RFP were excited with 488 nm (30% output 
power) and 561 nm (30% output power) solid-state diode laser lines, respectively. Image 
acquisition was carried out through a 63x/1.4 NA plan-apochromat oil immersion objective 
lens. Images were obtained by a cooled 14-bit EMCCD camera (C9100-50, CamLink) with a 
frame size of 1024 x 1024 pixels and a pixel size of 110 nm.    
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Flow Cytometry 
Cells were washed with PBS, detached from a 6-well plate using 0.25% Trypsin-EDTA and 
finally re-suspended in PBS (3 mL per well) prior to flow cytometry (FACS Aria II, BD 
Biosciences). Data were analyzed using FlowJo (8.1) software. Non-MSN treated HeLa-
FKBP-VN-RFP cells were used to gate out dead cells and aggregates and to calibrate 
appropriate Venus (using FITC settings) and mRFP gating. Venus +ve and –ve cells were 
analysed from the RFP +ve group. 10,000 cells were measured per sample. Experiments were 
triplicated. Error bars represent standard deviations.  
Microplate reader for cell fluorescence readout 
Cells were detached from a 6-well plate using 0.25% Trypsin-EDTA, harvested and washed 
with PBS. After centrifugation (150 g, 5 min), cells were re-suspended in 100 µl of PBS and 
pipetted into a 96-well microplate (Greiner Bio-One, Germany). Fluorescence was measured 
using a microplate reader (Infinite® M1000 PRO, TECAN) with 515 nm excitation and 
528 nm emission for Venus measurements and 556 nm excitation and 586 nm emission for 
RFP measurements. Four readings were taken per well. Background fluorescence in the 
Venus channel was measured using the stable cell line without addition of the complementing 
protein and subtracted from other readings. Measurements were normalized against the RFP 
channel to account for variations in cell number. Experiments were performed in six 
biological repeats. Error bars represent standard deviations. 
MTT assay 
One day prior to MTT assay HeLa Kyoto cells were plated on a 96-well microplate 
(5 × 10
3
 cells per well) in DMEM and incubated at 37 °C. After removal of culture medium, 
cells were exposed to 100 l of MSN-DMEM solution per well (serum free) with various 
MSN concentrations, while the control group was incubated with 100 l of serum-free 
DMEM. Following 2 h incubation, the cells were washed with PBS three times to remove the 
residual particles. Freshly prepared MTT solution (0.5 mg/ml in DMEM) was added to the 
cells (100 l/well) and the cells were incubated at 37 °C for another 4 h. The purple crystals 
metabolized from healthy cells were then dissolved in 100 l of DMSO and the absorbance 
was measured at 570 nm, while the reference absorbance was measured at 655 nm using a 
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Microplate reader (Infinite® M1000 PRO, TECAN). Experiments were triplicated. Error bars 
represent standard deviations. 
Live cell tracking of protein release 
Rapamycin-primed sample 
HeLa-FKBP-VN-RFP cells were seeded onto a 2-well ibi-Treat slide 12 h before the 
experiment. For the rapamycin-primed protein release tracking experiment, 1 l of rapamycin 
(from 250 M stock solution), 100 mg of MSN-FRB-VC and 0.5 l of SiR-DNA (a nuclear-
staining dye, Spirochrome, Germany) were mixed in 1 mL of serum-free DMEM, and the 
mixture was added to the cells before the first image was acquired. After 2 h, particles were 
washed away using PBS and followed by a chloroquine shock (0.5 mM of chloroquine in 
standard DMEM, 1.5 mL/well) at RT for 5 min triggering endosomal protein release. Cells 
were tracked at indicated time points for 24 h. Microscopic images were acquired with a 
Nikon TiE microscope equipped with perfect focus, Yokogawa CSU-W1 spinning disk unit 
(50 µm pinhole size), Andor ALC600 laser-beamcombiner: 405nm/488nm/561nm/640nm, 
Yokogawa CSU-W1 dichroic mirror 405/488/561/640 LD Quad, Andor Borealis illumination 
unit and Andor IXON 888 Ultra EMCCD camera using a Nikon CFI P-Apo 100x Lambda oil 
immersion objective NA 1.45. The setup was equipped with an environmental chamber 
(Okolab BIO 1, Bold Line CO2 and temperature module, gas chamber and humidifying 
module) and controlled by software from Nikon (NIS elements, version 4.51.01). The 
environmental conditions during the experiment were set to 37 °C, 5 % CO2 and humidified 
atmosphere. Focus drifts during the long-term experiments were compensated by the Nikon 
perfect focus system. Tiled images (10x10 image fields, 15 % overlap, stitched by NIS 
elements) were acquired throughout this study to investigate many cells per experiment. 4 
colour tiles (488 nm, 561 nm, 640 nm and differential interference contrast) were acquired 
with a frequency of 3 images per hour. On chip binning (2x2) was used throughout to reduce 
the data amount and to improve the signal to noise ratio. Fluorescence images were acquired 
with an exposure time of 1 s and an EM gain setting of 160. For the population protein 
delivery tracking analysis, a single large field area with 200 -300 cells were assessed at each 
interval. 
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Rapamycin-delayed sample 
For the Venus reconstitution kinetics tracking (rapamycin-delayed sample), 100 mg of MSN-
FRB-VC and 0.5 l of SiR-DNA were mixed in 1 mL of serum-free DMEM, and the mixture 
was added to the cells before the first image was acquired. After 2 h, particles were washed 
away using PBS and followed by a chloroquine shock. Cells were tracked at indicated time 
points using confocal microscopy (an UltraVIEW Vox spinning disc confocal system, 
PerkinElmer, UK). Rapamycin (1 l, final conc. 250 nM in standard DMEM) was added to 
the sample 22 h after chloroquine shock. Live cell images were acquired at randomly chosen 
areas to prevent Venus fluorescence bleaching. 200 – 300 cells were imaged and counted at 
each time point. Venus positive cells were counted visually. Venus positive cells in % 
correspond to the number of nuclei with Venus fluorescence divided by the number of cells 
with RFP fluorescence * 100.  
Measuring Nuclear Fluorescence Intensity 
Nuclear Venus signal was tracked in individual cells post imaging using Image J software. 
All readings were obtained using a circular ROI of consistent size measuring a region of cell 
nuclei at each time point. The ROIs excluded nucleoli to obtain more homogenous signal. 
The mean fluorescence of each ROI was used for data points. To reduce ambiguity regarding 
start and stop points of fluorescent increase in cells we started timing increase at the first 
timepoint that was consistently 15% above the minimum fluorescent value measured in that 
cell. We timed until the first timepoint above 15% below the maximum value seen, therefore 
timing the central 70% of fluorescent increase in each cell. 
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6.5 Appendix 
 
Figure 6-6 STEM (left) and SEM (right) images of un-functionalized MSNs. Scale bar: 
50 nm. 
 
Table 6-1 Summary of characterization data of un-MSN and MSN-NTA. 
Sample 
Particle size 
(nm) 
Pore size 
distribution (nm) 
Pore volume 
(cm3/g) 
Surface area 
(m2/g) 
Un-MSN 133 ± 50 4 - 45 1.4 390 
MSN-NTA 152 ± 54 4 - 40 1.1 275 
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Figure 6-7 Time course live cell imaging (cropped from a time-lapse video) of venus 
fluorescent nuclei from rapamycin-primed sample. Scale bar: 100 m. 
 
Figure 6-8 Live cell images at 15 h post chloroquine shock. Swollen vesicles can be 
observed in cells after 15 h of chloroquine shock. Scale bar: 50 m. 
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7 Photoswitchable Supported Lipid Bilayers on Large-Pore 
Mesoporous Silica Nanoparticles For Controlled Release 
Applications  
This chapter is based on a collaborative project with Manuel Gebauer, Hanna Engelke, James 
Frank and Dirk Trauner. 
 
 
7.1 Introduction 
Stimuli-responsive nanocarriers have attracted increasing attention for nanomedicine 
applications based on their ability to control the pharmacokinetics and biodistribution of their 
payload. The utilization of nanocarriers for drug delivery promises to offer advantages 
because nanocarriers can offer high loading capacity per particle, protect cargos from 
premature degradation, enhance the circulation half-life in the body, reduce the 
immunogenicity and toxicity of drugs, and potentially target specific cells or tissues for drug 
release.
1-6
 Incorporating stimuli-responsive assemblies on nanocarriers can further allow for 
drug release in spatio-, temporal-, and dosage-controlled manners. Several types of 
nanocarriers have been developed to serve these purposes. Among these, liposomes represent 
one of the well-developed and promising family of nanocarriers for delivery of various 
therapeutics either in vitro or in vivo.
7-9
 Liposomes can feature high drug loading capacity 
(depending on the drug), good biocompatibility, low immunogenicity, flexible formulation, 
and facile scalable synthesis, which render them attractive carriers for nanomedicine 
applications.
8-10
 However, their rather unstable fluidic nature can also cause challenges 
including cargo leakage and uncontrollable payload release profiles (often burst release). 
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These issues can still be problematic for liposomal nanocarriers in terms of storage and long-
term drug release (especially in vivo).
8-10
  
Mesoporous silica nanoparticles (MSNs), consisting of inorganic frameworks and capable of 
stably accommodating diverse cargo molecules in their pore system, can offer properties that 
complement the features of liposomes. MSNs also feature several advantageous properties 
such as high surface area and large pore volume for high level cargo loading, tunable pore 
size and particle morphology for accommodating a variety of guest molecules, and flexible 
surface functionalization for various applications.
11
 Notably, it is possible to combine the 
solid MSNs and fluidic liposomes, that is, coating a liposome on the surface of an MSN to 
form a supported lipid bilayer (SLB) for the construction of a new type of nanocomposite. 
The SLB-coated MSNs (SLB@MSNs) synergistically combine the strengths of liposomes 
and MSNs such that they are able to stably encapsulate the cargo without premature leakage, 
while retaining the high biocompatibility and low toxicity/immunogenicity properties of the 
liposomes.
6,12
  
In our previous studies we created SLB@MSN nanocomposites where the SLB was 
comprised of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP), showing high encapsulation efficiency for anti-
cancer drugs, peptides, nanobodies and dye molecules.
13-15
 When exploiting photosensitizers 
as endosomal escape agents in the SLB@MSN nanocomposites, the loaded cargos can be 
released to the cytosol upon light-induced SLB/endosomal membrane rupture.
14,15
 In addition 
to the non-stimuli responsive DOPC/DOTAP lipid composite, pH-responsive
16,17
 (containing 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE) and pH/thermo dual responsive 
lipid composites
18
 (containing DOPE, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) 
and copolymer poly(N-isopropylacrylamide-methacrylic acid-octadecyl acrylate)) have been 
used for creating SLBs around MSNs, respectively. Apart from the pH- and thermo-
responsive SLBs, photoswitchable SLBs for controlled payload release would also be of great 
interest, as the photonic trigger is non-invasive and offers the possibility of remote 
spatiotemporal control for release of cargo. 
Several photosensitive lipids have been synthesized and used to create photoswitchable 
liposomes for drug delivery purposes.
19,20
 These photoswitchable liposomes can be 
destabilized upon illumination at a certain wavelength, which subsequently induces 
isomerization,
21
 polymerization
22
 or cleavage
23
 of the photosensitive moieties in the lipid 
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phase, leading to the destabilization of liposomal structure. Azobenzene is the most 
frequently used integral group in the photoisomerizable lipids. Upon irradiation with 
ultraviolet light (UV, 320 – 380 nm), azobenzene undergoes conformational change from an 
extended trans form to a twisted cis form. Moreover, this process is reversible such that the 
twisted cis configuration can be relaxed back to the trans configuration by illumination with 
blue light (400 – 450 nm) or heat.24 In collaboration with Prof. Trauner’s group, we 
constructed a photoswitchable SLB (opto-SLB) on MSNs based on this type of 
photoisomerizable phospholipid, named AzoPC. This AzoPC contains an azobenzene in one 
of the aliphatic tails of a phospholipid (Figure 7-1a), where the conformation of the 
azobenzene-containing tail can be switched forth and back to the trans and cis states via UV 
or blue light. We expected that the AzoPC-SLBs will be capable of sealing MSNs and 
preventing cargo leakage when the AzoPC is in trans configuration. Upon UV illumination, 
the AzoPC should isomerize to cis configuration, creating space or causing defects in the 
SLB structure, thereby allowing the cargo to diffuse out of the MSN pore system (Figure 7-
1b). To test this concept, membrane-impermeable calcein was used as a model cargo for an in 
vitro encapsulation and release experiment of the photoswitchable SLB@MSNs. Additionally, 
the commercially available photopolymerizable lipid 1,2-bis(10,12-tricosadiynoyl)-sn-
glycero-3-phosphocholine (DC8,9PC) was employed with DOPC and DOTAP to create a 
second type of photoswitchable SLB on MSNs (Figure 7-1a). The photopolymerization of 
DC8,9PC upon UV (254 nm) illumination is expected to create defects in the SLB structure 
(Figure 7-1c), followed by the destabilization of the SLB. In vitro calcein encapsulation and 
release experiments were also performed with these DC8,9PC-SLB@MSNs. Strikingly, both 
the photoswitchable lipids proved to be able to impart light-induced dye release abilities as 
SLBs on the MSN cores, with a photo-induced dye release efficiency similar to that of 
reference surfactant (Triton X-100)-triggered dye release.   
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Figure 7-1 Lipid compositions for creating supported photosensitive lipid bilayers 
(SLBs) on MSNs and the photo activities of the photosensitive lipids in SLBs upon UV 
illumination. (a) Lipid compositions. (b) AzoPC undergoes photoisomerization when 
irradiated at wavelengths between 320 – 380 nm, generating space and defects in the SLB 
structure. (c) The diacetylene tails on DC8,9PC are polymerized upon UV (254 nm) 
illumination, resulting in destabilization of the SLB. 
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7.2 Results and Discussion 
To test the photoswitching abilities of the lipids, we first formed liposomes and characterized 
their photoswitching properties. Liposomes with different lipid compositions are listed in 
Table 1. In the present work, we employed DOPC and DOTAP as matrix lipids (Figure 7-1a) 
as they showed good MSN sealing abilities in our previous studies.
13-15
 Liposomes prepared 
with 70 wt% DOPC and 30 wt% DOTAP (matrix-liposome) served as the non-photoactive 
control group. AzoPC-liposomes were prepared by substitution of the DOPC content in the 
matrix liposomes with AzoPC, resulting in 70 wt% AzoPC and 30 wt% DOTAP in the 
composition. DC8,9PC-liposomes were prepared by incorporating 20 wt% DC8,9PC into the 
matrix liposomes, yielding 20 wt% DC8,9PC, 56 wt% DOPC and 24 wt% DOTAP in the 
composition (Table 1). All the liposomes were prepared in 0.5X PBS (commercial PBS 
diluted with bidistilled water in the 1:1 v/v ratio) followed by extrusion through a 100 nm-
pore membrane. 
Table 1 Composition of liposomes 
Liposomes Lipid composition 
Matrix-liposome 70 wt% DOPC + 30 wt% DOTAP 
AzoPC-liposome 70 wt% AzoPC + 30 wt% DOTAP 
DC8,9PC-liposome 20 wt% DC8,9PC + 56 wt% DOPC + 24 wt% DOTAP 
Note: All the liposomes were prepared in 0.5X PBS buffer  
Hydrodynamic sizes and zeta potentials of liposomes 
According to the dynamic light scattering (DLS) analysis, the three as-prepared liposomes 
exhibit similar size around 70 – 80 nm in 0.5X PBS buffer (Figure 7-2a). This result indicates 
that the extrusion method has a dominant impact on the size distribution of these liposomes, 
independent of the lipid compositions. However, the hydrodynamic sizes of the liposomes are 
solvent-dependent; they are around 20 nm larger in water that in 0.5X PBS buffer (appendix 
Figure 7-7). The zeta potential of these liposomes in their storage buffer (0.5X PBS, pH 7.4) 
showed that although these liposomes were all made with a combination of zwitterionic 
phosphatidylcholines (PC) and positively charged lipid (DOTAP), matrix-liposomes and 
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DC8,9PC-liposomes are positively charged while AzoPC-liposomes are negatively charged 
(Figure 7-2b). Makino et al. reported that the head-group region (from the choline group to 
the phosphatidyl group) of a neutral phospholipid varies its orientation in a liposome  (i.e., 
with the phosphatidyl groups or choline groups facing the outer surface of liposomes) 
depending on the ionic strength and the temperature of the buffers.
25
 They measured the zeta 
potentials of dimyristoylphosphatidylcholine (DMPC)-liposomes, 
dipalmitoylphophatidylcholine (DPPC)-liposomes and distearoylphosphatidylcholine 
(DSPC)-liposomes, respectively in buffers containing different ionic strength at constant 
temperature as well as in buffers with constant ionic strength at different temperatures. They 
proposed that in low ionic strength buffer, the phosphatidyl groups orient towards the outside 
of the head region (appendix Figure 7-8), resulting in a negative surface charge. When 
increasing the ionic strength at constant temperature, the choline groups approach the outer 
region of the bilayer surface, leading to a more positive surface charge. In the present work, 
the three prepared types of liposomes all consist of more than one type of lipids, and the 
interactions between the lipids in the liposomes could also influence the orientation of the 
phosphocholine heads. Therefore, the variation of the zeta potential within these three types 
of liposomes is possibly attributed to the distinct orientation of their phosphocholine heads 
affected by the interactions of the mixed lipids. 
 
Figure 7-2 Hydrodynamic sizes and zeta potentials of liposomes in 0.5X PBS (pH 7.4). (a) 
Hydrodynamic sizes of liposomes measured by dynamic light scattering (DLS). (b) Zeta 
potentials of liposomes at pH 7.4. Matrix-liposome: 70 wt% DOPC + 30 wt% DOTAP; 
AzoPC-liposome: 70 wt% AzoPC + 30 wt% DOTAP; DC8,9PC-liposome: 20 wt% DC8,9PC + 
56 wt% DOPC + 24 wt% DOTAP. 
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Photoswitching behavior of AzoPC-liposomes in 0.5X PBS buffer 
The azobenzene group in the AzoPC can be switched from the thermally stable trans 
configuration to the cis configuration by UV irradiation (320 – 380 nm). This isomerization is 
reversible under blue light (400 – 450 nm) or heat (Figure 7-3a). Ultraviolet-visible (UV-Vis) 
spectroscopy was applied to identify the trans and cis isomers of the azobenzene. At room 
temperature in the dark, the AzoPCs in liposomes exist predominantly in their thermally 
stable extended trans form,
24
 as illustrated in the UV-Vis absorption spectrum where the 
corresponding π→π* transition (300 nm – 350 nm) is observed (Figure 7-3b, black line). 
Upon UV (365 nm) irradiation for 5 min, the azobenzene moieties in the liposomes isomerize 
to the cis form (Figure 7-3b, red line), causing the emergence of an n→π* transition (400 –
 480 nm) in the spectrum while the π→π* absorption band shifts towards shorter wavelength 
and decreases in intensity.
24
 We examined the feasibility to switch the AzoPC-liposomes 
back to their trans configuration using blue light (455 nm). As shown in Figure 7-3b (blue 
line, overlap with black line), the azobenzene moieties in the liposomes was successfully 
converted back to the trans configuration after illuminating with  = 455 nm for 5 min. To 
investigate their continuous conformation switching ability, the AzoPC-liposomes were then 
illuminated with  =  365 nm followed by  = 455 nm for 5 min, respectively, and measured 
their UV-Vis spectra after each illumination. The results (Figure 7-3b, pink line and green 
line) indicated that the conformation of azobenzene moieties is able to be switched back and 
forth, meaning the possibilities of switching “open” and “close” of the AzoPC-liposomes.  
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Figure 7-3 Photoswitching behavior of AzoPCs in liposomes. (a) Conformational change 
of AzoPC under light/heat induction. (b) UV-Vis spectra of AzoPC-liposomes (70 wt% 
AzoPC + 30 wt% DOTAP) in 0.5X PBS. Black line: liposomes preserved in dark. Red line: 
AzoPC-liposomes were illuminated with  = 365 nm for 5 min. Blue line and green line: 
AzoPC-liposomes in cis configuration (the sample shown with red line) were irradiated with 
 = 455 nm for 5 min. Pink line: AzoPC-liposomes in trans configuration (the sample shown 
with blue line) were irradiated with  = 365 nm for 5 min. Green line: AzoPC-liposomes in 
cis configuration (the sample shown with pink line) were irradiated with  = 455 nm for 
5 min. 
Photoswitchable supported lipid bilayers on mesoporous silica nanoparticles (opto-
SLB@MSNs) 
Next, we synthesized large-pore stellate MSNs with particle sizes of about 100 nm and a pore 
size distribution ranging from about 8 - 40 nm as the “hard cores” for creating opto-SLBs 
(Figure 7-4). In vitro fluorescent dye release experiments were performed to confirm the 
efficacy of opto-SLB@MSNs for controlled release applications. 
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Figure 7-4 Large-pore stellate MSNs. (a) TEM micrograph. (b) DLS analysis of particle 
size distribution in ethanol. (c) N2 sorption isotherm and (d) NLDFT pore size distribution. 
Before dye loading, MSNs collected from the stock solution (in ethanol) were washed with 
PBS once to balance their surface charge. Membrane impermeable calcein was used as model 
cargo for release experiments and was loaded into MSNs via a simple MSN-calcein solution 
(1 mM in H2O, pH 7.4) co-incubation method. Liposomes were then added to the MSN-
calcein solutions for the fusion to create a supported lipid bilayer on the MSNs (Figure 7-5a). 
The opto-SLB@MSN samples were washed with 0.5X PBS to remove the free dyes followed 
by dispersing in 0.5X PBS for in vitro dye release experiments at 22 °C. As indicated in 
Figure 7-5, a negligible amount of calcein was released from the samples control-
SLB@MSNs (Figure 7-5a) and AzoPC-SLB@MSNs (Figure 7-5b) while we found a small, 
but slightly enhanced leakage from the sample DC8,9PC-SLB@MSNs (Figure 7-5c) in the 
first 2 h. After UV illumination (365 nm for control-SLB@MSNs and AzoPC-SLB@MSNs, 
254 nm for DC8,9PC-SLB@MSNs), the control-SLB still tightly capped the MSNs as there 
was no photo-responsive lipid in the SLB. On the other hand, both the photoswitchable 
AzoPC-SLBs and DC8,9PC-SLBs were strongly destabilized followed by a significant release 
of calcein from the MSN pore system. In order to clarify whether the calcein release rate 
from the AzoPC-SLB@MSNs and DC8,9PC-SLB@MSNs was already at maximum, we 
added Triton X-100 surfactant to the samples for complete SLB destabilization. As shown in 
Figure 7-6, calein now started to diffuse out from the control-SLB@MSNs (destabilized by 
Triton) whereas the AzoPC-SLB@MSNs and DC8,9PC-SLB@MSNs exhibited similar 
calcein release profiles as the photo-induced calcein release. This confirms that the photo-
induced SLB destabilization for both photoswitchable opto-SLB systems occurred with the 
same high efficiency as the SLB destabilization achieved with Triton surfactant. 
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Figure 7-5 In vitro dye release experiments from SLB@MSN samples in 0.5X PBS at 
22 °C. (a) SLB@MSNs were created by fusion of liposomes to MSNs. Calcein release from 
(b) control-SLB@MSNs, (c)  AzoPC-SLB@MSNs  and (d) DC8,9PC-SLB@MSNs. Control-
SLB: 70 wt% DOPC + 30 wt% DOTAP; AzoPC-SLB: 70 wt% AzoPC + 30 wt% DOTAP; 
DC8,9PC-SLB: 20 wt% DC8,9PC + 56 wt% DOPC + 24 wt% DOTAP. To trigger the light-
induced dye release, control-SLB@MSNs and AzoPC-SLB@MSNs were illuminated with 
LED 365 nm (Thorlabs) in a constant current (500 mA) mode with a path length of 1 cm for 
5 min. The DC8,9PC-SLB@MSNs were illuminated with a UV lamp at a wavelength of 254 
nm with a path length of 1 cm for 5 min. Trition (5 l, 20 wt% in H2O) was then added to the 
sample to trigger a complete SLB destabilization.  
To explore the potential of these novel opto-SLB@MSNs as nanocarriers for nanomedicine, 
we further performed the in vitro dye release experiments at 37 °C. As illustrated in Figure 7-
6, the AzoPC-SLB capped MSNs now exhibit slight calcein leakage in the first 2 h. Upon 
photo-switching, a strong increase of the release rate of calcein from the AzoPC-
SLB@MSNs was observed. Moreover, addition of Triton for complete SLB destabilization 
did not change the calcein release profile. Hence, we conclude that the AzoPC-SLB is 
photoswitchable and that the photo-induced dye release rate is as high as the Triton-induced 
dye release rate (at complete SLB destabilization) not only at 22 °C but also at body 
temperature (37 °C).  
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Figure 7-6 In vitro dye (calcein) release experiment from AzoPC-SLB@MSNs in 0.5X 
PBS at 37 °C. AzoPC-SLB@MSNs were illuminated with LED 365 nm (Thorlabs) in a 
constant current (500 mA) mode with a path length of 1 cm for 5 min. Trition (5 l, 20 wt% 
in H2O) was then added to the sample to trigger a complete SLB destabilization. 
7.3 Conclusions and Outlook 
In summary, we have successfully created two types of photoswitchable supported lipid 
bilayers, AzoPC-SLB and DC8,9PC-SLB, on large-pore MSNs for controlled release 
applications. The incorporated photosensitive lipids, AzoPC and DC8,9PC, exhibit distinct 
photochemical responses and are sensitive to different wavelengths of light. AzoPC 
undergoes photoisomerization in liposomes when irradiated at  = 365 nm, followed by 
generating space or defects in the supported lipid bilayers for payload release. DC8,9PC lipids 
are photopolymerized when illuminated at  = 254 nm, leading to SLB destabilization and 
offering a means to release cargo from MSNs. In the in vitro dye release experiments, both 
AzoPC-SLB@MSNs and DC8,9PC-SLB@MSNs showed calcein encapsulation as well as 
efficient light-induced release in 0.5X PBS buffer at 22 °C. AzoPC-SLB@MSNs further 
demonstrated their photoswitchable ability for controlled cargo release at 37 °C. In the future, 
both types of opto-SLB@MSN nanocomposites will be attractive candidates for research 
with 3D cell cultures embedded in hydrogels to release chemo-attractants or other drugs 
under spatio-temporal control.  
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7.4 Experimental 
Materials 
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC, Avanti Polar Lipids), 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP, Avanti Polar Lipids), AzoPC (azobenzene-containing 
lipid)
26
 was synthesized in Prof. Dirk Trauner’s group (LMU). 1,2-Bis(10,12-tricosadiynoyl)-
sn-glycero-3-phosphocholine (DC8,9PC, Avanti Polar Lipids), calcein (Aldrich), phosphate 
buffered saline (PBS, Sigma), Triton X-100 (Aldrich), tetraethyl orthosilicate (TEOS, Aldrich, 
≥ 99%), cetyltrimethylammonium p-toluenesulfonate (CTATos, Sigma), triethanolamine 
(TEA, Aldrich, 98%), ethanol (EtOH, Aldrich, absolute), hydrochloric acid (HCl, Aldrich, 
37%). Bidistilled water is obtained from a Millipore system (Milli-Q Academic A10). 0.5X 
PBS was prepared by mixing PBS buffer and bidistilled water in a 1:1 v/v ratio. 
Preparation of liposomes 
Lipids were dissolved in chloroform at the concentration of 10 mg/mL as lipid stock solutions 
and were stored at -20 ºC for further liposome preparation. Lipids from stock solutions were 
mixed in the required mass ratio (see Table 1) in an Eppendorf tube, which contained 2.5 mg 
lipids in total. The lipid mixture was dried in a round-bottom flask to form lipid thin films 
using a rotary evaporator (15 min, 40 °C water bath, 100 mbar, 200 rpm). The dried lipid thin 
films were re-suspended in 1 mL of 0.5X PBS buffer, and the lipid suspension was further 
rotated (250 rpm) at RT for 1 h. The lipid suspension then stayed static for 2 h at RT for 
aging, and was stored at 4 °C overnight. To reduce and homogenize the size of the liposomes, 
the lipid suspension was extruded by a mini-extruder (Avanti Polar Lipids) with a 100 nm-
pore membrane for 11 extrusion cycles. The final liposome solution (2.5 mg/mL) was stored 
at 4 °C in the dark till further use. Light was avoided in all procedures for the preparation of 
photosensitive liposomes.  
Characterization of liposomes 
Dynamic light scattering (DLS) and zeta potential measurements were performed on a 
Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser (633 nm) and an 
avalanche photodiode. DLS measurements were directly recorded in diluted suspensions of 
liposomes at a concentration of 50 g/ml in 0.5X PBS buffer. For zeta potential 
measurements, liposomes were measured in 0.5X PBS (pH 7.4) with the concentration of 
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25 µg/mL. UV-Vis spectroscopy was performed on a Perkin Elmer Lambda 1050 
UV/Vis/NIR spectrophotometer equipped with a deuterium arc lamp (UV), a tungsten 
filament (visible) and an InGaAs integrating sphere detector. AzoPC-liposomes were diluted 
to the concentration of 50 g/ml in 0.5X PBS buffer in a quartz cuvette for the measurement. 
The initial spectrum (dark adapted state) was first recorded. The sample was illuminated with 
 = 365 nm (power density: 255 mW/cm2) for 10 min (cis-adapted state), then the second 
spectrum was subsequently recorded. The third spectrum was recorded after irradiation with 
 = 455 nm (power density: 226 mW/cm2) for 10 min on the cis-adapted state sample. The 
illumination was conducted using mounted LEDs (Thorlabs, USA) having wavelengths of 
365 nm and 455 nm, respectively, at constant current (500 mA) mode and an illumination 
path length of 1 cm for 10 min at room temperature. 
MSN synthesis and characterization  
Large-pore stellate MSNs were synthesized based on an adapted recipe reported in the 
literature.
27
 Briefly, TEA (0.047 g, 0.32 mmol), CTATos (0.263 g, 0.58 mmol) and H2O 
(13.7 g, 0.77 mmol) were mixed in a 100 mL round bottom flask and stirred vigorously 
(1250 rpm) at 80 °C until the surfactants were totally dissolved. TEOS (2.013 g, 9.6 mmol) 
was added to the surfactant solution drop-wise, and the mixture was continuously stirred at 
80 °C for 2 h. The molar ratio of the above mixture was TEOS : CTATos : TEA : H2O = 1 : 
0.06 : 0.033 : 80. The as-synthesized particles were cooled down to RT and were collected by 
centrifugation (7197 g, 20 min). To remove the organic surfactant from MSNs, the as-
synthesized particles were heated in an ethanolic solution (150 mL) containing 3 g of 
ammonium nitrate at 90 °C under reflux for 1 h. The solution was then cooled and the 
particles were collected by centrifugation (7197 g, 20 min). A second extraction step was 
subsequently performed in a 2 M HCl/ethanolic solution (150 mL) under reflux at 90 °C for 
1 h. Afterwards, samples were washed in the sequence of EtOH, H2O, EtOH and were finally 
kept in EtOH. Particles were collected by centrifugation (7197 g, 20 min) after each washing 
step.  
MSN Characterization 
For transmission electron microscopy (TEM), samples were prepared by drying a diluted 
MSN suspension (in ethanol) on a carbon-coated copper grid at room temperature for several 
hours before measurement. The measurement was performed on a FEI Titan 80-300 kV 
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microscope operating at 300 kV . Nitrogen sorption analyses were performed on a 
Quantachrome Instrument NOVA 4000e at 77 K. Sample outgassing was performed at 
120 °C under vacuum (10 mTorr) 16 hbefore measurement. Pore size distribution curves 
were calculated with non-local density functional theory (NLDFT) procedures provided by 
Quantachrome based on the adsorption branch of N2 on silica. Dynamic light scattering (DLS) 
was performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser 
(633 nm) and an avalanche photodiode. DLS measurements were directly recorded in diluted 
suspensions of the particles at a concentration of 1 mg/ml in ethanol. 
Fusion of liposomes with MSNs 
The amount of 2 mg of MSNs from stock solution (in ethanol) was collected by 
centrifugation (14000 rpm, 5 min) and washed with PBS buffer once before loading with 
calcein. The MSNs were dispersed in 400 µL of calcein solution (1 mM in H2O, pH 7) and 
incubated under shaking at RT for 1 h in the dark. 100 µL of the MSN-calcein solution 
(containing 0.5 mg of MSNs) was mixed with 100 µL of liposome solution (containing 250 
µg of liposomes), and the mixture was incubated at RT under shaking for 1 h in the dark for 
the liposome-MSN fusion. The resulting opto-SLB@MSNs were subsequently washed with 
0.5X PBS three times. In each washing step, centrifugation (8000 rpm, 4 min, 15 °C) was 
applied to remove the residual dyes and liposomes. The final opto-SLB@MSN sample was 
re-suspended in 200 µL of 0.5X PBS buffer for the following release experiment. 
Release experiments 
SLB@MSNs in 200 l of 0.5X PBS were transferred to a custom-made Teflon cap fitting on 
a fluorescence cuvette. The cap was sealed with a dialysis membrane (ROTH Visking type 
8/32, MWCO 14,000 g/mol) and placed on top of a fluorescence cuvette filled with 3 mL 
0.5X PBS. Time-based fluorescence release experiments were performed at 22 °C or 37 °C 
on a PTI spectrofluorometer equipped with a xenon short arc lamp (UXL-75XE USHIO) and 
a photomultiplier detection system (model 810/814). The excitation wavelength was set to 
λ = 495 nm and the emission fluorescence intensity was recorded at λ = 520 nm. All slits 
were adjusted to 2.0 mm. To trigger the light-induced dye release, control-SLB@MSNs and 
AzoPC-SLB@MSNs were illuminated with LED 365 nm (Thorlabs) in a constant current 
(500 mA, power density: 255 mW/cm
2
) mode with a path length of 1 cm for 5 min. The 
DC8,9PC-SLB@MSNs were illuminated with a UV lamp at a wavelength of 254 nm with a 
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path length of 1 cm (power density: 0.7 mW/cm
2
) for 20 min. Afterwards, all samples were 
sealed with the dialysis membranes and the release setups were reassembled. The 
fluorescence cuvettes were re-filled with fresh 0.5X PBS before reassembly. Fluorescence 
spectra (λex = 495 nm, λem = 520 nm) were recorded continuously for 2 to 4 h. To destabilize 
the SLBs completely, 5 l of Triton X-100 (20 w/v% in H2O) was added to each sample, 
respectively. Fluorescence spectra (λex = 495 nm, λem = 520 nm) were recorded continuously 
overnight. 
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7.5 Appendix  
 
Figure 7-7 Hydrodynamic sizes of liposomes in different buffers. (a) Matrix-liposomes 
(70 wt% DOPC + 30 wt% DOTAP). (b) AzoPC-liposomes (70 wt% AzoPC + 30 wt% 
DOTAP. (c) DC8,9PC-liposomes (20 wt% DC8,9PC + 56 wt% DOPC + 24 wt% DOTAP). 
 
 
Figure 7-8 Schematic illustration of the orientation of the head groups in phospholipids. 
This figure is adapted from Makino et al.
25
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8 Conclusions and Outlook  
In the present work, we have established diverse multifunctional large-pore mesoporous silica 
nanoparticles (MSNs) for macromolecule immobilization and transportation, especially for 
intracellular protein delivery. We demonstrated the approaches regarding tailoring the 
particle sizes, pore structures and surface chemistry of these newly developed large-pore 
MSNs to fit the purposes of different applications.  
In the first project (chapter 3), we adopted a dual-surfactant synthesis strategy containing 
fluorocarbon surfactant FC-4 and triblock-copolymer P123 for the synthesis of nanosized 
SBA-15 particles. The SBA-15-like MSNs feature well-ordered 2D hexagonal mesostructure 
with pore size of 7 nm. After size separation by filtration, we obtained particles with a size of 
100 –200 nm. A delayed co-condensation method was further applied to the synthesis 
approach, yielding spatially defined, core-shell bifunctional SBA-15 MSNs. Cellular studies 
with the SBA-15 MSNs illustrated that these particles can be efficiently taken up by HeLa 
cells and are non-cytotoxic up to a concentration of 200 g/ml, promising prospects for using 
these particles for cellular delivery applications. However, the as-synthesized materials often 
contain bulk precipitates as well as particles with irregular morphology. A further 
investigation regarding optimization of the synthesis parameters, for example the molar 
composition of the reaction solution, the stirring rate during the reaction and reaction time, 
etc., to gain more homogeneous particle morphology and narrow particle size distribution 
would be highly desirable. 
In the project described in chapter 4, we synthesized and tailored the surface properties of 
ultra-large-pore stellate MSNs. The impact of different organosilanes on the formation of 
mesostructure and particle morphology was studied. A core-shell bifunctional MSN structure 
was also created using a sequential co-condensation method to spatially confine one 
functional group in the interior core while the second functional group resides on the external 
surface. With this core-shell structure, we demonstrated the feasibility of both external and 
internal MSN surface modification. DBCO derivatives were covalently attached on the 
interior surface of the MSNs, allowing for a facile cargo conjugation via copper-free click 
chemistry. In combination with redox-sensitive disulfide bridged or pH-sensitive acetal 
linkers in our multifunctional MSN system, we were able to control the cargo release in 
specific buffer conditions. An outlook for this work will focus on exploiting the copper-free 
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click chemistry for bioorthogonal conjuation of biomolecules and applying the system for 
cellular delivery as well as for different controlled release applications.  
In the work described in chapter 5, we designed a nitrilotriacetic acid-metal ion-complexed 
moiety on the surface of MSNs for pH-responsive coordination binding and release of His-
tagged chromobodies (fluorescent nanobodies). Chromobodies offer high antigen binding 
specificity and affinity comparable to conventional antibodies and can be used in live cell 
imaging for specific spatio-temporal visualization of cellular processes. The results 
demonstrated that MSN-Ca
2+
, MSN-Ni
2+
 and MSN-Zn
2+
 carriers all exhibit high chromobody 
loading capacities (about 70 g/mg MSNs) and are applicable for successful intracellular 
chromobody delivery. Various endosomal destabilization strategies were investigated in this 
study where DMSO and chloroquine performed as the most effective triggers for cytosolic 
release. By combining chromobodies and MSNs, we aimed to establish a powerful and 
generalized platform that provides an easy transportation route for all types of chromobodies 
into living cells for quick antigen targeting and visualization.  
In chapter 6, we developed a chemically inducible two-component fluorescent live cell 
sensor for the investigation of MSN-mediated protein delivery efficiency. This live cell 
sensor features background-free and molecular ratio-metric fluorescence properties that 
facilitate direct relative quantification of bioavailable protein levels and cell protein 
transfection efficiency. MSN-NTA-Ni was used as a vector here for protein transfection. In 
pararell with an MTT assay, we maximized the protein delivery efficiency up to about 80%. 
We further demonstrated a real-time protein delivery process with good temporal resolution 
to study the protein release kinetics and the system fluorescence complementation rate. 
Unlike sensors that rely upon transcription or amplification mechanisms, the ratio-metric 
nature of our sensor enables us to measure protein delivery variations not only between but 
also within cell populations. With this system, we envision a protein delivery efficiency 
measurement that can be extended to precisely calculate delivered molecular numbers 
within individual cells.  
Apart from the direct conjugation of cargos via chemical bonding, we also created supported 
lipid bilayers on MSNs for guest molecule encapsulation. In chapter 7, we developed two 
types of photoswitchable supported lipid bilayers (opto-SLBs), AzoPC-SLB and DC8,9PC-
SLB, on MSNs and demonstrated their photo-induced cargo release abilities. The azobenzene 
groups in AzoPC-SLB undergo photoisomerization upon irradiation at  = 350 nm that 
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generates space between the SLB structure for payload release. The diacetylene acyl chains in 
DC8,9PC-SLB are photopolymerized when illuminated at  = 254 nm, causing defects in the 
SLB structure thus enabling cargo release. As an outlook, we can envision embedding the 
opto-SLB capped MSNs in hydrogels for use in 3D cell culture research.  
In summary, we have developed a general and highly tunable platform based on large-pore 
MSNs for large biomolecule delivery. The versatile surface modifications with release-on-
demand properties established here allow for a broad spectrum of applications involving 
spatiotemporal control of drug or protein release. These properties make them powerful 
nanoagents in theranostic applications as well as cell biology research. While the high 
efficacy of MSNs in protein delivery has been demonstrated in vitro, it would be highly 
desirable to extend these strategies to future in vivo studies.  
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